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Abstract 
 
Human embryo implantation is the rate-limiting step for successful pregnancy in 
assisted reproductive technology, and inappropriate endometrial embryo-quality 
biosensing is also associated with recurrent pregnancy loss. Elucidating the 
mechanisms underpinning the peri-implantation endometrium would enable the 
development of treatments for patients suffering with chronic fertility disorders. 
However, implantation is difficult to study. Therefore, simple in vitro models of human 
endometrial cells have been developed. However, the endometrium is a complex 
tissue made up of stromal cells (EnSC), epithelial glands, vasculature, and immune 
cells. An in vitro model that encompasses all aspects of the human endometrium 
would require a complex co-culture system. Therefore, three-dimensional (3D) 
culturing techniques are the most suitable. This study aimed to establish a protocol 
for a novel in vitro model of the peri-implantation endometrium by co-culturing primary 
EnSC and epithelial cells (EEC) using 3D culture techniques. In this study, two 
approaches were undertaken. The first involved the use of the Endometrial 
Regenerative Bodies (ERB) model, which was unsuccessful in achieving the study’s 
aim. However, the second approach, involving the 3D co-culture of EnSC with 
endometrial gland organoids led to the establishment of a complex organoid culture. 
The growth conditions of the complex organoids were optimised by modifying the 3D 
matrix and medium conditions. The standard organoid growth matrix, Matrigel, a 
basement membrane derived hydrogel, was replaced with a purified Type I collagen 
hydrogel to provide a more physiological ECM for the EnSC. Direct interaction 
between the EnSC and EEC in the complex organoids was examined through the 
establishment of a minimal differentiation medium and single cell RNA-sequencing of 
a decidual time course of gland organoids and complex organoids. EnSC were able 
to induce the differentiation of EEC into a secretory phenotype in complex organoid 
cultures. The established complex organoid protocol offers a starting point for 
 ix 
 
developing a faithful in vitro model of the human peri-implantation endometrium, 
which will provide a step change in our collective ability to study human embryo 
implantation. A system that would be patient-specific, and in the long term developed 
into a high-throughput system for personalised medicine for the treatment of infertility.  
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1.1 The human peri-implantation endometrium  
The human female reproductive tract 
The human internal female reproductive tract is composed of the uterus, Fallopian 
tubes, ovaries, cervix, and vagina. Unlike many other mammalian species, the human 
uterus consists of a singular uterine cavity (Spencer et al., 2012). The fetal uterus 
develops from the fusion of the paramesonephric (Müllerian) ducts before eight weeks 
gestation, forming a tubular structure consisting of a luminal epithelium enveloped by 
a layer of undifferentiated mesenchyme (O’Rahilly et al., 1973). The mesenchymal 
layer differentiates into an underlying smooth muscle layer (myometrium) and a 
luminal endometrial stroma at 22 weeks (Song, 1964).  
 
The human endometrium 
The human endometrium is the secretory mucosal lining of the uterus and it provides 
the immunoprivileged and nourishing local environment vital for embryo implantation 
and placentation (Tabibzadeh, 1998, Gellersen and Brosens, 2014). The 
endometrium consists of two major layers, the stratum basalis and the stratum 
functionalis (Padykula, 1991, Brenner et al., 1994) (Fig. 1.1). The functionalis, or 
functional layer, lies above the basalis, or basal layer, and is epithelialised (Padykula, 
1991, Gray et al., 2001a). The arcuate arteries of the uterus provide the endometrial 
blood supply (Rogers, 1996, Farrer-Brown et al., 1970). The arcuate arteries infiltrate 
through the myometrium and terminate in the endometrium as spiral arteries, which 
supply the endometrium, and the placenta during pregnancy (Farrer-Brown et al., 
1970). The human functionalis is hormone responsive and cycles through phases of 
proliferation, differentiation, and degradation (menstruation), in what is called the 
menstrual cycle, in preparation for a potential implanting embryo. However, the 
underlying basalis remains stable and instead functions as the endometrial germinal 
layer, maintaining a perivascular  
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Figure 1.1. A schematic of the human endometrium. Cell types are labelled in the 
key below the diagram. The endometrium comprises two layers: the stratum 
functionalis and the stratum basalis.  The functionalis is superficial and is covered in 
luminal epithelium. Glandular epithelium grows deep into the persistent basalis layer 
of the endometrium. The endometrium is vascularised and contains a population of 
uterine natural killer (uNK) cells. The endometrium is vascularised with spiral arteries 
and around these blood vessels are perivascular stromal cells (PVC) and resident 
mesenchymal stem cells (MSC). Adapted from (Gargett et al., 2015) 
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niche for resident mesenchymal stem cells (MSC) from which the functionalis 
regenerates each cycle (Gargett, 2006, Gargett et al., 2015).  
 
The endometrial stroma is a highly glandular tissue (Fig. 1.1). The endometrial glands 
are essential in early pregnancy as they provide nutrition to the implanting embryo 
through secretions of glycogen and glycoproteins, collectively designated as 
histotroph (Gray et al., 2001a). The process of endometrial gland development, or 
adenogenesis, comprises of the initial budding of the luminal epithelium, followed 
subsequently by invagination into the stroma. Later, as the endometrial glands further 
develop, there is extensive branching and coiling into the underlying stroma (Cooke 
et al., 2013). However, despite the mesenchyme forming an endometrial stroma at 
22 weeks gestation, adenogenesis at this stage is superficial (Cooke et al., 2013, 
Song, 1964, Valdes-Dapena et al., 1973, O’Rahilly et al., 1973). Neonates possess 
only sparse and shallow glandular epithelium. Indeed, much of endometrial 
adenogenesis occurs postnatally (Cooke et al., 2013, Gray et al., 2001a). Table 1.1 
summarises a list of factors that influence endometrial adenogenesis (Gray et al., 
2001a). The endometrial glands continue to develop until puberty, where they reach 
maturity, extending through the endometrium into the myometrium (Valdes-Dapena 
et al., 1973).  
 
The structural integrity of the endometrium is maintained by its extracellular matrix 
(ECM). Like many tissues, the major structural component of the endometrial stromal 
ECM is collagen. In the stroma, collagen is deposited by endometrial cells and 
organised into fibrils. The major fibril-forming collagens of the endometrial ECM are 
collagens I, III, and V, with collagen I being the most abundant collagen species (Aplin 
et al., 1988, Aplin and Jones, 1989, Iwahashi et al., 1996, Kisalus et al., 1987). 
Microfibrils, such as collagen VI and fibrillin, associate with the bundles of larger 
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collagen fibrils and provide further integration and stability of the ECM (Aplin and 
Jones, 1989, Aplin et al., 1995).  
 
The ECM not only provides structural support but also mediate essential cellular 
functions such as cell-matrix adhesion, survival, migration, proliferation, and 
differentiation. The ECM interacts with endometrial cells through integrins and other 
cell surface receptors.  Several adhesive glycoproteins such as fibronectin, tenascin 
C, and thrombospondin 1, are found in the endometrial ECM and are important for 
cell adhesion and migration (Glasser et al., 1987, Aplin et al., 1988, Rider et al., 1992, 
Iruela-Arispe et al., 1996, Vollmer et al., 1990). Additionally, the endometrial ECM 
contains glycosaminoglycans (GAGs). GAGs are polar and hydrophilic 
heteropolysaccharides usually consisting of repetitive disaccharide units of a 
hexosamine with either uronic acid or galactose (Kresse and Schönherr, 2001). GAGs 
covalently bind to proteins and form proteoglycans (PGs). The major GAGs of the 
endometrial ECM are Chondroitin sulphate, dermatan sulphate, heparan sulphate 
and hyaluronic acid (HA) (Cidadão et al., 1990, Oliveira et al., 2015). HA is unlike 
other GAGs due it being not sulphated, and therefore does not form a PG (Berto et 
al., 2001). PGs are found on the cell surface as well as the ECM and can interact with 
laminins, collagens, and fibronectin as well as a variety of cytokines and growth 
factors. These interactions are involved in angiogenesis, cell proliferation, migration, 
adhesion, and differentiation (Merle et al., 2000, Couchman and Pataki, 2012, 
Schaefer and Schaefer, 2010, Oliveira et al., 2015). 
 
The ECM structure surrounding the glandular and luminal epithelium, as well as blood 
vessels, is called the basement membrane (BM) (Wewer et al., 1985, Aplin et al., 
1988, Aplin and Jones, 1989). Microfibril fibrillin 1 is associated with connecting the 
stromal ECM interface with the BM (Fleming and Bell, 1997). The BM contains a 
different assortment of proteins, including laminins, type IV collagen and heparan 
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sulphate PG (Faber et al., 1986, Wewer et al., 1985, Aplin et al., 1988). The structural 
framework of the BM is provided by a lattice of collagen IV (Timpl, 1996). Enactin, a 
glycoprotein, links laminin to the collagen IV lattice network (Yelian et al., 1993).  In 
the BM surrounding epithelium, laminins are large heterotrimeric glycoproteins where 
they function in epithelial cell attachment, polarisation, and differentiation (Timpl, 
1996).  
 
The menstrual cycle 
The functionalis of the endometrium is sensitive to ovarian hormone stimulation. This 
tissue cycles through periods of proliferation, differentiation and menstruation and 
repair (Brosens et al., 2002, Gellersen and Brosens, 2014) (Fig. 1.2). The human 
endometrium is exceptionally malleable and maintains its regenerative capacity 
through puberty until menopause. Typically, a woman from a developed nation will 
experience approximately 350-400 menses in their lifetime (Strassmann, 1997, 
Strassmann, 1999).  
 
Proliferative phase 
The proliferative phase (Cycle day: 5-13) commences following the completion of 
menstruation (Cycle day: 1-4) (Fig. 1.2). Endometrial regeneration is driven by the 
rise in estradiol levels from ovarian follicle granulosa cells. In fact, the proliferative 
phase endometrial estradiol concentration is 5-8 times higher than in serum (Huhtinen 
et al., 2012). This surge drives regeneration through intense proliferation from the 
underlying stable basalis. Proliferative endometrial stromal cells (EnSC) maintain a 
fibroblast-like morphology, including mature secretory pathway organelles, limited 
cytoplasm and elongated indented nuclei (Cornillie et al., 1985, Lawn et al., 1971).   
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Table 1.1: Factors involved in endometrial adenogenesis. Data distilled from 
(Gray et al., 2001a) 
 
 
 
 
Factor Role in adenogenesis References 
Epithelial-
stromal 
interactions 
 
• Tissue recombination studies in mice 
demonstrate that EnSC play a direct role 
in gland development 
 
(Cunha et al., 1985, 
Donjacour and Cunha, 
1991, Cunha and Young, 
1992, Cooke et al., 1997) 
ECM 
 
• Glycosaminoglycans (GAG) affect EEC 
development directly and indirectly.  
• Mediate epithelial-stromal interactions 
• GAG facilitate growth factors binding to 
receptors on EEC 
• Non-sulphated GAGs such as hyaluronic 
acid accumulate at tips of proliferating 
glands 
• MMP affect gland development by ECM 
remodelling 
• ECM affects glandular branching 
morphogenesis through influencing cell 
cycle arrest and apoptosis 
 
(Bartol et al., 1993, Bartol 
et al., 1988, Spencer et al., 
1993, Werb et al., 1996) 
Growth 
factors 
• EnSC derived growth factors mediate 
gland development: 
• Fibroblast growth factor (FGF)-7 
stimulates EEC proliferation 
• FGF-10 is essential for branching 
morphogenesis 
• Hepatocyte growth factor (HGF) induces 
epithelial proliferation 
• Insulin-like growth factor (IGF) I and II 
induce EEC differentiation 
 
(Bellusci et al., 1997, 
Ohmichi et al., 1998, 
Weidner et al., 1993, 
Yamasaki et al., 1996, 
Rubin et al., 1995, Wang 
and Chard, 1999, Thiet et 
al., 1994) 
Estrogen • ERα expression is increased in 
proliferating gland epithelium in mice 
post-natally 
• Glandular proliferation 
 
(Fishman et al., 1996, 
Greco et al., 1991, 
Branham et al., 1985) 
Prolactin  • PRL stimulates EEC differentiation  
• PRLR is expressed in glands 
• Possibly involved in proliferation but not 
confirmed 
(Freeman et al., 2000, 
Stewart et al., 2000, 
Telleria et al., 1998) 
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Figure 1.2. The menstrual cycle. The menstrual cycle describes the cyclic changes 
in ovarian hormones estrogen and progesterone. Rising estrogen leads to the 
proliferation of the endometrium (proliferative phase). A surge in luteinising hormone 
(LH) and increasing follicle stimulating hormone lead to ovulation where a mature egg 
cell is released from the ovary on day 14. Ovulation gives rise to the corpus luteum in 
the ovary which produces progesterone, where EnSC decidualise into decidual cells 
in preparation for an implanting embryo (secretory phase). In the absence of an 
implanting embryo, the ovarian hormone stimulation drops, and the endometrial 
tissue breaks down and sheds (menstruation). The cycle then repeats with 
subsequent regeneration from resident progenitor cells and rising estrogen.   
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The regenerative capacity of the endometrium is unsurpassed in the human body, 
with the thickness of the endometrium growing from approximately 4-5 mm (Cycle 
day: 4) to 10 mm at ovulation (Cycle day: 14) each cycle (Bromer et al., 2009). In 
addition, the endometrial epithelial cells (EEC) in the glands regrow, leading to the 
expansion of narrow tubes (Okulicz et al., 1997, Padykula et al., 1989). Unlike fetal 
adenogenesis, post-menstrual gland development originates from progenitor cells in 
the basalis and proliferates up to the luminal epithelium (Gray et al., 2001a). 
Endothelial cells of the spiral arteries efficiently revascularize the freshly regenerated 
tissue. The rising levels of estradiol ultimately induce a surge of luteinizing hormone 
(LH), triggering ovulation, and the completion of the proliferative phase (Gellersen 
and Brosens, 2014). 
 
Secretory phase 
Following ovulation, the remaining ruptured follicle transforms into the corpus luteum. 
This transient structure produces the steroid hormone progesterone, where rising 
circulatory levels inhibit EnSC proliferation (Johansson and Wide, 1969). 
Progesterone also induces endometrial differentiation (decidualisation). Prior to 
morphological changes in the EnSC, endometrial edema is observable at cycle day 
18-21, before regressing by cycle day 23 (Rock and Bartlett, 1937, Gellersen and 
Brosens, 2014) (Fig. 1.2). At cycle day 23, morphological differentiation of EnSC 
bordering the terminal spiral arteries is observable (Rock and Bartlett, 1937). 
Decidualising EnSC become engorged with prominent cytoplasm and the nuclei 
enlarge (Kajihara et al., 2014). Further observable morphological changes to the 
EnSC include expansion of  secretory organelles, accumulation  of cytoplasmic 
glycogen and lipid droplet and an increase in nucleoli (Kajihara et al., 2014).  
 
The composition of endometrial ECM is hormonally controlled and is extensively 
remodelled during decidualisation. The ratios of stromal ECM collagens III and V shift 
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quantitatively upon decidualisation (Iwahashi et al., 1997, Aplin et al., 1988, Aplin and 
Jones, 1989). In addition, BM proteins collagen IV and laminin encapsulate 
decidualising EnSC (Iwahashi et al., 1997).  Decidualising EnSC also produce 
pseudopodia-like processes that extend into the ECM and to other EnSC (Lawn et 
al., 1971). These cells also attain phagocytic activity, enabling them to participate in 
the decidual remodelling of the ECM (Cornillie et al., 1985).  
 
Cues for EnSC decidualisation 
Progesterone acts upon EnSC by binding and activating its cognate nuclear receptor, 
the progesterone receptor (PGR). Like other nuclear receptors, PGR comprises 
functionally district domains to enable ligand binding, DNA binding and transcriptional 
regulation (Brosens et al., 2004, Beato and Klug, 2000). Progesterone is lipophilic 
and therefore can pass across the plasma membrane of EnSC freely and bind to 
PGR. Ligand binding induces a conformational change enabling the chaperone 
dissociation and dimerization. The bound, dimerized PGR then binds to promoters of 
gene targets, inducing transcription.  There are two major isoforms of PGR, PGR-A 
and PGR-B, which derive from the same gene but are transcribed by different 
promoters (Kastner et al., 1990). PGR-A and -B respond differently to progesterone 
binding (Gellersen and Brosens, 2014). When bound to progesterone, PGR-A inhibits 
PGR-B activity (Vegeto et al., 1993). Furthermore, PGR-A and PGR-B expression is 
dynamic through the menstrual cycle. PGR-B is abundant in both EnSC and EEC in 
the proliferative phase, but expression falls post-ovulation (Jabbour and Critchley, 
2001). PGR-A expression persists in EnSC throughout the menstrual cycle, rendering 
it the dominant isoform (Mote et al., 1999).   
 
However, the lag period following rising progesterone circulation and the onset of 
EnSC morphological differentiation suggests that other cues are required for decidual 
initiation (Gellersen and Brosens, 2003). Moreover, in vitro studies of primary EnSC 
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have demonstrated that there are very few genes acutely responsive to progesterone 
treatment alone (Brosens et al., 1999, Aghajanova et al., 2010). There have been 
several in vitro experiments that have demonstrated that other factors are necessary 
for decidualisation. Table 1.2 summarises various EnSC decidual cues. Therefore, 
although progesterone is essential for EnSC decidualisation, these studies evidence 
that progesterone is insufficient to mount a decidual response in the human 
endometrium alone.  
 
In addition to progesterone, there is tremendous evidence suggesting the activation 
of the cyclic adenosine monophosphate (cAMP) pathway is essential for 
decidualisation (Brosens et al., 1999). cAMP is a second messenger produced by 
ligand bound G protein coupled receptors (GPCR). GPCR, when bound, activate 
adenylyl cyclase, which catabolises adenosine triphosphate (ATP) into adenosine 
diphosphate (ADP) and cAMP. A major target of cAMP is protein kinase A (PKA). 
PKA is a holoenzyme composed of 2 regulatory and 2 catalytic subunits. The 
regulatory subunits can bind cAMP, which releases the catalytic subunits, enabling 
PKA to phosphorylate downstream targets (Skalhegg and Tasken, 2000, Kopperud 
et al., 2003). Targets for phosphorylation include the cAMP response element (CRE) 
binding protein (CREB) and CRE modulator (CREM) (Mayr and Montminy, 2001, 
Lamas et al., 1996). Both CREB and CREM are members of the basic region/leucine 
zipper (bZIP) transcriptional regulator family and bind to CRE DNA sequences in 
target promoters as dimers (Luscombe et al., 2000). 
 
One study demonstrated that cAMP concentration is significantly higher in secretory 
phase endometrial biopsies than in proliferative samples (Bergamini et al., 1985). In 
addition, adenylyl cyclase activity is significantly higher in the endometrium than in 
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Table 1.2: Decidualisation cues and related pathways. Data distilled from 
(Gellersen and Brosens, 2014) 
 
 
 
 
Decidual 
cues 
Mode of action References 
Endocrine 
cues 
• Progesterone drives differentiation of 
the endometrium 
• Lag period of 9 days post ovulation 
before morphological EnSC 
differentiation present 
• Relaxin enhances decidualisation in 
EnSC in vitro.  
• Prostaglandin E2 (PGE2) increases 
intracellular cAMP levels 
(Johansson and Wide, 
1969, Gellersen and 
Brosens, 2003, 
Palejwala et al., 2002, 
Ivell et al., 2003, 
Tabanelli et al., 1992, 
Milne et al., 2001, 
Salamonsen et al., 2016) 
Paracrine 
cues 
• EEC, immune cells and endothelial 
cells secrete cytokines, growth 
factors involved in decidualisation. 
• Removal of luminal epithelium 
abrogates EnSC decidualisation in 
rodents  
(Gellersen and Brosens, 
2014, Lejeune et al., 
1981) 
Interleukins • Inhibition of IL-11 reduces decidual 
gene expression 
• IL-1β promotes implantation and 
decidualisation by upregulating 
integrin αvβ3. This binds ECM 
ligands. This upregulates cyclo-
oxygenase 2 (COX-2) and therefore 
increases cAMP levels intracellularly.  
• Leukaemia inhibitory factor (LIF) is a 
IL-6 type cytokine. Critical in 
implantation and produced only by 
epithelial cells. Enhances 
decidualisation of EnSC. 
(Karpovich et al., 2005, 
Geisert et al., 2012, van 
Mourik et al., 2009, 
Hwang et al., 2002, 
Tamura et al., 2002, 
Shuya et al., 2011) 
TGFβ 
signalling 
• Activins, inhibins and follistatin 
regulate decidualisation.  
• Morphogen bone morphogenetic 
protein (BMP) 2 drives expression of 
decidual genes. 
(Jones et al., 2002, 
Jones et al., 2006, Li et 
al., 2007) 
Notch 
signalling 
• Inhibition of Notch reduces 
decidualisation of EnSC.  
• Notch receptors expressed in EnSC 
(Afshar et al., 2011, 
Mikhailik et al., 2009) 
Lipids • Endocannabinoid system is involved 
in decidualisation 
(Brar et al., 2001) 
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the myometrium (Tanaka et al., 1993). Studies have shown that in vitro primary EnSC 
cultures treated with estradiol and a progestin not only induce decidual genes but also 
elevate intracellular cAMP levels, albeit modestly. Furthermore, decidual gene 
induction is inhibited when differentiated in the presence of a PKA inhibitor. These 
studies indicate that cAMP signalling is essential for EnSC decidualisation (Matsuoka 
et al., 2010, Yoshino et al., 2003, Brar et al., 1997). Phosphodiesterases (PDE) are 
endogenous enzymes that degrade cAMP. The most abundant PDE in the 
endometrium is PDE4. Studies have shown that cAMP accumulates in EnSC when 
PDE4 is inhibited, and decidual gene induction is enhanced (Bartscha and Ivell, 2004, 
Bartsch et al., 2004). Moreover, a study reported that EnSC maintain a feed-forward 
mechanism to enhance PKA activity by downregulating the regulatory PKA subunits 
instead of using an inhibitory feedback loop (Telgmann and Gellersen, 1998). 
 
Overall, both the cAMP and PGR pathways have been demonstrated to be essential 
for EnSC decidualisation. These pathways converge in order to induce the extensive 
decidual reprogramming of gene expression in EnSC (Gellersen and Brosens, 2014).  
 
Decidual markers 
The major decidual marker is prolactin, encoded by PRL (Maslar and Riddick, 1979). 
In pregnancy, prolactin levels peak between 18 to 26 weeks in the amniotic fluid. It 
was discovered prolactin is produced by the decidua and since then it has been 
demonstrated that decidualising EnSC induce PRL transcription from day 22 of the 
cycle (Kletzky et al., 1985, Ben-Jonathan et al., 1996). Another decidual maker is 
IGF-binding protein-1 (IGFBP-1), encoded by IGFBP1 (Rutanen et al., 1985). IGFBP-
1 is also enriched in amniotic fluid and peaks a few weeks before the rise of PRL 
(Wathen et al., 1993). IGFBP1 transcripts are also present in non-pregnant 
decidualising EnSC. Studies have demonstrated that IGFBP-1 is involved in the 
regulation of IGF-1 bioavailability and trophoblast invasion (Gleeson et al., 2001, 
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Carter et al., 2004). Since, PRL and IGFBP1 have become an established marker 
genes for the assessment of EnSC decidualisation (Gellersen and Brosens, 2014).  
 
Other highly expressed EnSC decidual markers include left-right determination factor 
2 (LEFTY2). LEFTY2 is a nodal signalling pathway inhibitor and member of the TGFβ 
super family. In addition, when it was first discovered, LEFTY2 named endometrial 
bleeding-associated factor (Kothapalli et al., 1997, Tabibzadeh, 1998). Other makers 
include transcription factors forkhead box protein O1 (FOXO1) and 
CCAAT/enhancer-binding protein-β (C/EBPβ), both induced in EnSC when treated 
with 8-Bromoadenosine-3', 5'-cyclic monophosphate (cAMP) in vitro (Christian et al., 
2002).  
 
Decidualising EnSC, acute senescence and immune surveillance 
More recently, studies have purported that a proportion of decidualising EnSC 
differentiate into acute senescent decidual cells (Brighton et al., 2017, Lucas et al., 
2018) (Fig. 1.3). These cells are progesterone resistant, secrete inflammatory 
mediators and express recognised senescence marker genes, such as tumour 
suppressor gene p16INK4 (Brighton et al., 2017). In general, cellular senescence 
describes cells in permanent cell cycle arrest that secrete a combination of molecules 
collectively named as senescence associated secretory phenotype (SASP). Chronic 
senescence accumulates gradually over time through aging and cumulatively has a 
negative impact on organ or tissue function. However, acute senescence often 
involves orchestrated biological processes related to inflammation and tissue 
remodelling (van Deursen, 2014, Childs et al., 2017, Brighton et al., 2017). 
Furthermore, acute senescent cells are only transiently present in a tissue, as they 
are cleared by immune cells. The SASP of these acute senescent cells intensify the 
initial decidual inflammatory response. Therefore, these data indicate this transient 
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population of cells is crucial for EnSC differentiation and endometrial embryo 
receptivity (Brighton et al., 2017, Lucas et al., 2018).  
 
However, in order to clear acute senescent cells from the endometrium, decidual cells 
recruit and activate a unique population of immune cells: the uterine natural killer 
(uNK) cells. The uNK cells have been shown to eliminate acute senescent cells 
through perforin- and granzyme-containing granule exocytosis (Brighton et al., 2017). 
This subpopulation of NK cells is positive for cluster of differentiation 56 (CD56) and 
CD16 negative (Croy et al., 2006). Post-ovulation, uNK cell numbers increase 
substantially in the endometrium. Decidualised EnSC produce cytokines interleukin 
(IL) 11, IL-15 and IL-33 which are all implicated in the proliferation and activation of 
uNK cells (Ashkar et al., 2003, Ain et al., 2004, Godbole and Modi, 2010, Salker et 
al., 2012a). In turn, uNK cells clear the acute senescent decidual population allowing 
for a potential embryo to implant into a tissue enriched with decidual cells (Brighton 
et al., 2017). Furthermore, during pregnancy uNK cells are implicated in the 
remodelling of the spiral arteries prior and during trophoblast invasion (Xiong et al., 
2013, Chazara et al., 2011).  
 
Endometrial gland differentiation  
The post-ovulatory rise in progesterone levels also has a profound effect on 
endometrial glands. First, progesterone downregulates the expression of both PGR 
isoforms in the glands (Wang et al., 1998). The glands undergo secretory 
transformation by which the EEC become highly secretory and the gland lumens 
widen (Burton et al., 2007, Burton et al., 2010). The composition of the secretions 
from the endometrial glands have been studied extensively during the menstrual 
cycle. The glandular secretions largely consist of glycogen and glycoproteins, as well 
as other components such as amino acids and lipid droplets. The major glandular 
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Figure 1.3. A schematic of the EnSC decidual subpopulation dynamics. It has 
been proposed that during decidualisation, a subpopulation of stressed EnSC do not 
differentiate into mature decidual cells, but instead undergo acute senescence. The 
acute senescent cells secrete SASP, containing many inflammatory mediators. 
Decidual cells secrete IL-15 which activates uNK cells to clear the acute senescent 
cells by granule exocytosis. The cell clearance allows for remodelling and 
rejuvenation of the endometrium for embryo implantation. Adapted from (Brighton et 
al., 2017). 
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product is glycodelin, a dimeric glycoprotein, also referred to as progestogen-
associated endometrial protein (PAEP) and encoded by PAEP (Burton et al., 2002). 
These carbohydrate-rich secretions are referred to as histotroph as they provide 
nutrition for potential pre-implantation embryos as well as for an implanted conceptus 
(Burton et al., 2002).  
 
Besides providing a source of nutrients for the implanting embryo, the glands induce 
of genes related to embryo receptivity and implantation. In humans, glandular and 
luminal epithelium have distinct molecular signatures. Analysis of mid-secretory 
phase uterine fluid as well as spent media from in vitro differentiated epithelial cultures 
has identified many types of secreted protein important for implantation such as 
cytokines, chemokines, growth factors, proteases and inhibitors (Salamonsen et al., 
2016, Spencer et al., 2012, Hannan et al., 2010b, Hempstock et al., 2004a, Vilella et 
al., 2013)  
 
Research relating to the role of the endometrial glands in implantation has been 
undertaken using animal model systems. For example, uterine gland knock-out 
(UGKO) sheep, produced by progestin-induced gland knock out, exhibit normal 
fertilisation. However, embryo implantation was restricted (Gray et al., 2001b). 
Progestin uterine gland knockout (PUGKO) mice also exhibit implantation failure. 
Uteri from PUGKO mice also have reduced expression of key implantation genes 
(Kelleher et al., 2016). These data suggest that the endometrial glands are essential 
for embryo implantation.  
 
Many proteins secreted by glands implicated in endometrial receptivity are also 
associated with blastocyst adhesion to the luminal epithelium. For example, secreted 
phosphoprotein 1, encoded by SPP1, also termed osteopontin (OPN), is secreted by 
the endometrial glands and contains RGD, a tripeptide integrin-binding motif 
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containing amino acids arginine, glycine, and aspartate, which facilitates the adhesion 
of an embryo to the luminal epithelium (Singh and Aplin, 2009, Berneau et al., 2019). 
Furthermore, Leukaemia inhibitory factor, encoded by LIF, is an important protein 
related to blastocyst adhesion, as well as having roles in embryonic development and 
trophoblast differentiation (Salleh and Giribabu, 2014). Furthermore, the 
aforementioned glycodelin is implicated in embryonic interactions with the luminal 
epithelium. An in vitro study demonstrated that the induction of glycodelin improves 
trophoblast spheroid attachment to a monolayer endometrial cell line culture. 
Furthermore, silencing PAEP completely abrogated the attachment (Uchida et al., 
2007).  
 
Growth factors such as epidermal growth factor (EGF), vascular endothelial growth 
factor (VEGF) and transforming growth factor beta (TGFβ) are also expressed by 
human endometrial glands (Hempstock et al., 2004b). The cognate receptors for 
these growth factors are present in the trophectoderm of blastocysts. These growth 
factors have all been implicated in embryo implantation. For example, EGF induces 
proliferation of cytotrophoblasts and stimulates human chorionic gonadotropin (hCG) 
and human placental lactogen (hPL) secretion by syncytiotrophoblasts (Maruo et al., 
1997, Ladines-Llave et al., 1991). In addition, VEGF promotes trophoblast adhesion 
to the luminal epithelium (Binder et al., 2014). Finally, studies have shown that TGFβ 
increases ECM remodelling, such as increased secretion of fibronectin, thereby 
facilitating endometrial adhesion for invading trophoblasts (Feinberg et al., 1994). 
 
Regulation of endometrial gland secretions 
Decidualising EnSC, the implanting embryo and the corpus luteum all regulate 
endometrial gland secretions (Fig. 1.4). Studies suggest that glandular differentiation 
by corpus luteum secreted progesterone is most likely achieved indirectly, through 
paracrine signalling from decidualising EnSC (Cooke et al., 1997, Arnold et al., 2001). 
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For example, decidualising EnSC regulate gland differentiation through the secretion 
of PRL. The PRL receptor (PRLR) is most highly expressed in the endometrial glands 
during the mid-secretory phase (Jones et al., 1998). It has been demonstrated that 
EnSC-secreted PRL activates the Janus kinase/signal transducers and activators of 
transcription (JAK/STAT) and mitogen activated protein kinase (MAPK) pathways in 
the endometrial glands, stimulating glandular differentiation. In parallel, the 
phosphatidylinositol 3 kinase (PI3K) pathway is also activated, inhibiting gland cell 
apoptosis (Jabbour et al., 2002).  
 
Animal models demonstrate that uterine stroma is essential for epithelial 
differentiation (Cooke et al., 1997, Cunha and Young, 1992). For example, in one 
study, stromal and epithelial tissue from bladder and vagina were recombined and 
grown in intact female mice. Three weeks later an ovariectomy was performed and 1 
week after this, the hosts were subjected to hormonal treatment.  Bladder epithelium 
grown with vaginal stroma exhibited a multi-fold estrogen-induced proliferative 
response when compared to vaginal epithelium grown with bladder stroma. The 
blunted response by the vaginal epithelium could be reversed if recombined with fresh 
vaginal stroma. These observations demonstrated that estrogen-induced epithelial 
proliferation depends upon an appropriate stromal environment (Cunha and Young, 
1992).  
 
As well as the stroma, the implanting embryo regulates glandular function. In the 
absence of an embryo, gland secretions diminish in the late secretory phase (Dockery 
et al., 1988). However, in a pregnant cycle, glycogen continues to accumulate through 
to at least 6 weeks gestation, indicating secretion is sustained in early pregnancy by 
the conceptus (Spencer et al., 2004, Burton et al., 2007). Invading 
syncytiotrophoblasts secrete hPL, which shares 67% sequence homology with PRL,  
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Figure 1.4. Schematic of the proposed interrelationships between endometrial 
glands, decidualised EnSC, corpus luteum and invading trophoblast cells 
during early pregnancy. In this model the invading trophoblasts (CTB: 
cytotrophoblasts; STB: syncytiotrophoblasts) produce hCG which maintains the 
corpus luteum. The corpus luteum therefore continues to produce progesterone 
which maintains the decidualised EnSC and differentiated gland EEC. The EnSC also 
secrete PRL which enacts upon the gland EEC through the PRLR to maintain a 
secretory phenotype. The trophoblasts also act upon the glands directly with hCG 
and hPL. The glands in turn produce growth factors, nutrients and receptivity markers 
(such as leukaemia inhibitory factor (LIF) and glycodelin (PAEP)). These secreted 
products in turn improve trophoblast invasion, forming a positive feedback loop. 
Overall, the human conceptus may be able to manipulate glandular EEC activity to 
further establish the pregnancy. Red arrows indicate how these cell types act upon 
the glands directly and indirectly. Adapted from (Burton et al., 2007, Kelleher et al., 
2019) 
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enabling it to bind PRLR of endometrial glands and maintain gland secretions (Burton 
et al., 2007). A study in which PL was infused into ovine uteri increased the 
abundance of endometrial glands and upregulated the expression of SPP1 (Noel et 
al., 2003).  
 
The hCG receptor (LHCGR) of the endometrial glands is purportedly maximally 
expressed during the secretory phase (Reshef et al., 1990). A study demonstrated 
that treatment with exogenous hCG induced female baboons to upregulate the 
secretion of glycodelin (Hausermann et al., 1998). A positive feedback mechanism 
between the glands and the conceptus has been described. In this feedback loop, the 
endometrial glands secrete EGF, stimulating embryonic release of hPL and hCG by 
syncytiotrophoblasts. In turn, hPL and hCG induce further glandular secretion 
including more EGF, therefore ensuring the growth and maintenance of the implanted 
conceptus (Burton et al., 2007, Burton et al., 2010).  
 
Implantation and receptivity 
Embryo implantation requires both a receptive endometrium and a competent embryo 
to be successful. Endometrial receptivity is transient, and the ‘window of implantation’ 
is approximately 6-10 days after the LH surge (Cycle day: 20-24) (Paria et al., 2001) 
(Fig. 1.1). The transient nature of endometrial receptivity ensures that successful 
implantation requires the coordinated development of both the embryo and 
endometrium. This coordination reduces the risk of implanting a poor-quality embryo 
(Gellersen and Brosens, 2014). Clinically, assisted reproduction technologies (ART) 
provide sub-fertile couples the option of treatment for successful pregnancy. 
However, implantation failure continues to be the major rate limiting step for achieving 
successful pregnancy. In general, only approximately 25% of transferred embryos 
successfully implant (Boomsma et al., 2009, Ferraretti et al., 2012). Currently, the 
physiological and molecular mechanisms underpinning successful implantation and 
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implantation failure are only partly understood (Weimar et al., 2013). Recently, many 
studies have been conducted in search of identifying key molecular mechanisms and 
potential receptivity biomarkers. Table 1.3 summarises a list of endometrial genes 
implicated in receptivity (Bhagwat et al., 2013).  
 
Traditionally, embryo implantation has been described as a consequential 
process of apposition, adhesion, penetration of the luminal epithelium and 
invasion into a passive stroma (Simón et al., 2001, Meseguer et al., 2001). 
Human embryo implantation involves extensive tissue remodelling and has 
been described as paralleling the stages of tumour invasion. However, recent 
evidence has described maternal endometrial cells actively encapsulating an 
implanting embryo (Brosens and Gellersen, 2010). Decidualised EnSC 
transiently attain a myo-fibroblastic phenotype, in which they become migratory 
and can produce ECM-degrading matrix metallopeptidases (MMP) (Anacker et al., 
2011). In vitro studies have demonstrated primary decidualised EnSC, grown as a 
monolayer, can actively migrate to engulf a competent blastocyst and this process is 
essential for trophoblast outgrowth (Grewal et al., 2008, Grewal et al., 2010). 
However, the endometrium has been described as a biosensor for embryo quality. 
Decidualised EnSC migration has been shown to be dependent on the quality of the 
embryo attempting to implant (Teklenburg et al., 2010b, Brosens et al., 2014) (Fig. 
1.5). Several studies have demonstrated that decidualised EnSC can sense high- and 
poor-quality embryos. For example, in one in vitro study, primary decidualised EnSC 
selectively migrated towards high quality human embryos only, but did not migrate 
towards poor quality embryos (Teklenburg et al., 2010b, Weimar et al., 2012). 
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Table 1.3. Human Gene Expression Endometrial Receptivity database (HGEx-
ERdb) top 25 Receptivity Associated Genes (RAGs). Analysis of 84 data sets (24 
studies) available on the human endometrial gene expression revealed expression of 
12,099 genes during the secretory phase. These genes were scored for their 
expression status and also for their expression pattern in the secretory phase. 
Information collected from (Bhagwat et al., 2013).  
Gene 
Symbol 
Gene Name 
SPP1 secreted phosphoprotein 1 
GPX3 glutathione peroxidase 3 (plasma) 
PAEP progestagen-associated endometrial protein 
IGFBP7 insulin-like growth factor binding protein 7 
IL15 interleukin 15 
CD55 CD55 molecule, decay accelerating factor for complement (Cromer blood 
group) 
CLDN4 claudin 4 
DPP4 dipeptidyl-peptidase 4 
COMP cartilage oligomeric matrix protein 
LAMB3 laminin, beta 3 
TIMP1 TIMP metallopeptidase inhibitor 1 
DCN decorin 
LIF leukemia inhibitory factor (cholinergic differentiation factor) 
TCN1 transcobalamin I (vitamin B12 binding protein, R binder family) 
C4BPA complement component 4 binding protein, alpha 
IL6ST interleukin 6 signal transducer (gp130, oncostatin M receptor) 
MAOA monoamine oxidase A 
MFAP5 microfibrillar associated protein 5 
TSPAN8 tetraspanin 8 
FAM148B family with sequence similarity 148, member B 
GADD45A growth arrest and DNA-damage-inducible, alpha 
S100P S100 calcium binding protein P 
IGFBP3 insulin-like growth factor binding protein 3 
FXYD2 FXYD domain containing ion transport regulator 2 
ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 
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Figure 1.5. Schematic of the outcomes of differing interactions between the 
endometrium and implanting blastocyst. Successful pregnancy requires a high-
quality embryo and a receptive endometrium. Divergence from this can lead to 
several different reproductive outcomes.  Although blastocysts are genomically 
diverse and some mosaicism is common (Munne and Wells, 2017), poor quality 
embryos should be selected against by the endometrium, leading to no implantation. 
However, highly receptive endometria may still implant these blastocysts, leading to 
a miscarriage alter when the blastocyst development ceases prematurely, as 
hypothesised in RPL patients (Quenby et al., 2002). On the other hand, the 
endometrium may be poorly receptive, leading to high selectivity, leading it to reject 
high quality embryos leading to implantation failure. Adapted from (Gellersen and 
Brosens, 2014). 
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Recurrent Pregnancy Loss 
Miscarriage is one of the most common pregnancy complications, with 1 in 7 
recognised pregnancies ending in miscarriage within the first trimester (NHS 
maternity statistics). Miscarriage is defined as the spontaneous loss of pregnancy 
prior to fetal viability. Approximately half of all reported miscarriages are caused by 
embryonic chromosomal aneuploidy. In addition, the likelihood of a successful 
pregnancy decreases with each additional miscarriage. However, the incidence of 
chromosomally normal, euploidic fetal loss increases with each additional miscarriage 
(Gellersen and Brosens, 2014). This indicates that the endometrium may play a role 
in high order miscarriages. Recurrent pregnancy loss (RPL) is defined by the 
European Society for Human Reproduction and Embryology as two or more 
miscarriages (The et al., 2018). In an in vitro study, primary EnSC cultures from 
patients with RPL were demonstrated to display a reduced decidual response. 
Moreover, RPL endometrium has been associated with a protracted proinflammatory 
response (Salker et al., 2012b). It has been hypothesised that a disordered decidual 
response increases the likelihood of an out-of-phase implantation event, in which 
embryo and endometrium are not ‘in-sync’ and therefore this leads inappropriate 
embryo implantation, and therefore miscarriage (Salker et al., 2012b, Gellersen and 
Brosens, 2014). Furthermore, RPL patients have a lower average abundance of MSC 
indicating cellular senescence, which may be a factor involved in the disordered 
decidual response (Lucas et al., 2013, Lucas et al., 2016).  
 
Menstruation and repair 
Implanting embryos produce human chorionic gonadotropin (hCG) which maintains 
the ovarian corpus luteum. Therefore, continued progesterone production maintains 
the integrity of the endometrium until the placenta begins producing progesterone at 
6 to 8 weeks gestation (Hallast et al., 2005, Talmadge et al., 1983). However, in the 
absence of hCG, or an implanted competent embryo, the corpus luteum degrades 
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and progesterone levels drop. Progesterone withdrawal marks the degradation and 
shedding of the endometrial functionalis, a process called menstruation (Gellersen 
and Brosens, 2014). Only humans, elephant shrew, fruit bats and some old-world 
primates cyclically menstruate.  In addition, these species are the only mammals to 
spontaneously decidualise, meaning decidualisation occurs without an embryo 
present (Emera et al., 2012, Brosens et al., 2009).  
 
The beginning of menstruation includes a rise in inflammatory mediators produced by 
decidualised EnSC. Reduced progesterone levels promote nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) leading to the activation of 
proinflammatory gene networks (Evans and Salamonsen, 2014). This inflammatory 
phenotype leads to an influx of inflammatory cells, leading to a large upregulation of 
matrix metalloproteinases (MMPs) (Rodgers et al., 1994, Abramson et al., 1995). 
MMPs are a family of zinc-dependent endopeptidases that have been demonstrated 
to digest a range of substrates within the endometrial ECM (Irwin et al., 1989). During 
menstruation, the upregulation of MMPs contribute a major role in the degradation of 
the endometrial functionalis. Furthermore, regulation of MMPs is through inhibition by 
tissue inhibitors of metalloproteinases (TIMPs) in the endometrium (Salamonsen and 
Woolley, 1996, Zhang and Salamonsen, 1997). 
 
Following each menses, the endometrium must repair itself, scar-free. Endometrial 
regeneration is thought to be effected by endogenous resident epithelial and 
mesenchymal progenitor cells residing in the ovarian hormone resistant endometrial 
basalis layer (Chan and Gargett, 2006, Chan et al., 2004, Gargett et al., 2009, Gargett 
and Ye, 2012, Kanematsu et al., 2011). Both cell types are clonogenic, highly 
proliferative, self-renew in vitro and can produce mature daughter cells. At low levels, 
some MSC are derived from the bone marrow which migrate to the endometrium in 
response to uterine inflammation (Morelli et al., 2013, Cervelló et al., 2012). Specific 
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markers for isolating MSC have been identified. Either CD146+ PDGFRβ+ (platelet-
derived growth factor receptor beta) or SUSD2+ (sushi domain containing-2) can be 
utilised to isolate perivascular EnSC which contain MSC (Schwab and Gargett, 2007, 
Masuda et al., 2012, Sivasubramaniyan et al., 2013).  
 
Endometrial regeneration is still poorly understood but what is known is that the 
endometrium is rapidly re-epithelialised following menses (Garry et al., 2009). Studies 
in induced-menstruation mouse models have indicated that mesenchymal-to-
epithelial transition accounts for the rapid re-epithelialisation of the endometrium. 
Furthermore, endometrial glands have been demonstrated to be monoclonal in vivo, 
suggesting they originate from a single epithelial progenitor cells.  (Cousins et al., 
2014, Ferenczy, 1976, Patterson et al., 2012, Huang et al., 2012). Overall the 
evidence suggests endometrial stem cells are essential for endometrial repair 
following menstruation. 
 
1.2. Modelling the human peri-implantation endometrium 
In vivo and in vitro models of the peri-implantation endometrium 
Embryo implantation is challenging to study in humans. In vivo experiments studying 
the implantation window are unethical and impossible to perform (Weimar et al., 
2013). Therefore, both in vivo and in vitro model systems have been developed. 
Murine, ovine, and bovine animal models have furthered our understanding of 
endometrial biology and pregnancy (Genbacev et al., 2003, Illera et al., 2000, Wang 
and Dey, 2006, Banerjee and Fazleabas, 2010). Non-human primates better replicate 
the human endometrium than other mammalian models and have been utilised to 
unravel the processes underpinning embryo implantation (Slayden and Keator, 2007, 
Nyachieo et al., 2007). However, the extent animal models represent human 
physiology may be limited due to the differences between human and animal model 
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reproductive systems  (Lee and DeMayo, 2004). For example, human decidualisation 
is spontaneous and occurs cyclically without an implanting embryo present. However, 
in mice, for example, an implanting embryo is required for a decidual response and 
mouse embryos can undergo diapause (Lopes et al., 2004). Furthermore, PGR 
expression dynamics greatly varies between humans and mice (Teilmann et al., 
2006).  
 
Therefore, in vitro models using primary cells from human endometrial biopsies have 
been developed and established to circumvent the inter-species differences. In vitro 
endometrial models aim to represent at least certain aspects of the in vivo human 
implantation environment. In combination with a range of molecular techniques, these 
models act as effective tools to close the knowledge gap regarding human embryo 
implantation (Weimar et al., 2013). Many studies have used primary endometrial EEC 
or EnSC cultures, as well as endometrium-derived cell line cultures, to answer these 
questions.  
 
EEC monolayer in vitro modelling 
One of the first examples of an in vitro model utilising monolayer EEC was to study 
the interactions between the endometrial luminal epithelium and human embryos 
(Lindenberg et al., 1985). Table 1.4 and Figure 1.6 summarises the various 
monolayer models. One study investigated whether in vitro fertilisation (IVF) embryos 
co-cultured with an EEC monolayer prior to embryo transfer would improve the 
implantation rate. Embryos of women with implantation failure were cultured until 
blastocyst stage (day 6) on a patient matched EEC monolayer. The cultured embryos 
were transferred to the patients on day 6. The study reported  that culturing the 
embryos with EEC prior to embryo transfer increased blastocyst formation as well as 
an increasing in the rate of implantation (Simón et al., 1999). In another study using 
a similar protocol, when co-cultured with embryos, the EEC upregulated expression 
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Table 1.4: In vitro human endometrial culture models of embryo implantation. 
Data collected from (Weimar et al., 2013). 
 
 
 
 
 
 
 
 
Model  Subtype References  
EEC Monolayer 
culture 
EEC + human embryo (Lindenberg et al., 1985, Simón et 
al., 1997, Simón et al., 1999, 
Meseguer et al., 2001, Caballero-
Campo et al., 2002, Dominguez et 
al., 2003, Gonzalez et al., 2011) 
EEC + trophoblast 
spheroid 
(Hohn et al., 2000, Galán et al., 
2000, Heneweer et al., 2003, 
Heneweer et al., 2005, Mo et al., 
2006, Uchida et al., 2007, 
Aboussahoud et al., 2010, Liu et al., 
2011, Ho et al., 2012) 
EnSC Monolayer 
culture 
EnSC + human embryo (Carver et al., 2003, Grewal et al., 
2008, Teklenburg et al., 2010b, 
Weimar et al., 2012, Teklenburg et 
al., 2012) 
EnSC + mouse embryo (Hanashi et al., 2003, Shiokawa et 
al., 1996, Grewal et al., 2010, 
Estella et al., 2012) 
EnSC + trophoblast 
spheroid 
(Harun et al., 2006, Gonzalez et al., 
2011, Holmberg et al., 2012, 
Weimar et al., 2012) 
EEC + EnSC 
multi-layer 
culture 
EEC + EnSC + human 
embryo 
(Bentin-Ley et al., 1994, Bentin-Ley 
et al., 2000, Park et al., 2003, 
Petersen et al., 2005) 
EEC + EnSC + trophoblast 
spheroid 
(Evron et al., 2011, Wang et al., 
2011) 
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Figure 1.6. A Schematic of various in vitro culture methods for modelling the 
human endometrium.  
A: Primary or cell line derived EEC monolayer cultured on cell-culture plastic grown 
in standard cell culture medium. 
B: Primary or cell line derived EnSC monolayer cultured on cell-culture plastic grown 
in standard cell culture medium. 
C: Primary or cell line derived stacked monolayer co-culture model. A layer of EnSC 
are grown in a hydrogel matrix such as Matrigel. A monolayer of EEC are grown on 
top of the gel to simulate the luminal epithelium. The co-culture is grown in standard 
cell culture medium. 
D: Primary EEC derived endometrial gland organoid cultures. Glandular EEC are 
seeded into Matrigel droplets and grown in a complex medium of growth factors and 
inhibitors. EEC expand into spheroidal shaped structures that morphologically and 
functionally represent glandular epithelium.  
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of receptivity genes C-X-C chemokine receptor type 1 (CXCR1), CXCR4 and CCR5 
as well as endometrial epithelial chemokine IL-8 (Dominguez et al., 2003, Caballero-
Campo et al., 2002). Other studies also evidenced embryonic regulation of EEC in 
culture, for cell surface molecules implicated in embryo implantation, such as mucin 
1 (MUC1) (Meseguer et al., 2001, Simón et al., 1997, González et al., 2000). Overall, 
monolayer EEC models demonstrate that preimplantation embryos can regulate the 
receptivity of the endometrial epithelium to prepare the endometrium for implantation. 
These models have also provided evidence that the EEC can support embryonic 
development prior to implantation (Dey et al., 2004, Teklenburg et al., 2010a). 
However, in comparison to EnSC, EEC have been reported to be technically 
challenging to grow in monolayer in vitro. In addition, the EEC harvested from 
endometrial biopsies are a mixture of both glandular and luminal EEC. As these cell 
types have been shown to maintain distinct gene signatures, monolayer EEC do not 
necessarily represent exclusively the uterine luminal epithelium interacting directly 
with an implanting embryo (Weimar et al., 2013).   
 
Endometrial EEC cell lines have also been developed to reduce dependency on 
biopsies from donors. Cell lines should represent the cell type of origin both 
functionally and morphologically. Cell lines offer some benefit over primary culture. 
For example, a cell line will proliferate indefinitely, therefore removing the limitation of 
sample supply. The supply is also a consistent sample, reducing variation and 
improving reproducibility. They require more simple culture conditions, are 
inexpensive and bypass ethical concerns of using primary tissue or animal models. 
(Weimar et al., 2013). Table 1.5 summarises commonly used EEC cell lines. Due to 
their reduced culturing requirements, gene silencing experiments are often easier in 
cell lines than primary cells (Cervero et al., 2007). However, cell lines are 
immortalised cells, derived from cancers harbouring significant genetic mutations. 
These mutations may have secondary effects on the cells, impacting cellular  
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Table 1.5: Endometrial cell lines. Endometrial epithelial cell line embryo 
implantation characteristics. Data collected from (Hannan et al., 2010a) 
 
 
 
 
 
 
 
 
 
 
 
 
Cell line Origin Implantation  Epithelial 
phenotype 
Polarisation References 
ECC-1 Adenocarcinoma  Luminal Moderate 
 
(Satyaswaroop 
and 
Tabibzadeh, 
1991) 
Ishikawa Adenocarcinoma Adhesive Luminal 
and 
glandular 
Moderate 
 
(Nishida et al., 
1985, 
Heneweer et 
al., 2005) 
HEC-1A Adenocarcinoma Poorly 
adhesive 
 High 
 
(Kuramoto et 
al., 1972, Ball 
et al., 1995) 
HEC-1B Adenocarcinoma   Moderate 
 
(Kuramoto et 
al., 1972) 
HES  Embryotropic luminal  
 
(Desai et al., 
1994) 
RL95-2 adenosquamous 
carcinoma 
Highly 
adhesive 
 Unpolarised  (Hohn et al., 
2000, Way et 
al., 1983) 
 33 
 
stimulus responses or morphology (Weimar et al., 2013). It has also been reported 
that cell lines can also easily become contaminated with other cell lines, confounding 
results (Korch et al., 2012). 
 
EnSC monolayer in vitro modelling 
Primary human endometrial EnSC are the work horse of many laboratories studying 
human decidualisation and the peri-implantation endometrial environment. EnSC 
monolayer cultures are suitable for elucidating human implantation because, in vivo, 
an implanting embryo will encounter EnSC once it penetrates the luminal epithelium.   
 
Primary human EnSC are generally collected from secretory phase endometrial 
biopsies obtained with consent from donors or patients of reproductive age (Carver 
et al., 2003, Evron et al., 2011, Weimar et al., 2012). Endometrial cells are isolated 
from the tissue biopsy by mechanical digestion of the endometrial tissue, followed by 
enzymatic digestion using collagenase I and DNase (Barros et al., 2016). The 
digested suspension is filtered through a 40 μm cell sieve in which the flow through 
contains the EnSC, and the endometrial glands are retained in the sieve. Endometrial 
EnSC are cultured in standard cell culture medium supplemented with 10% fetal 
bovine serum (FBS) and 1 nM estradiol (Barros et al., 2016). Endometrial EnSC label 
positive immunohistochemically for vimentin and negative for cytokeratin. Cultured 
endometrial EnSC monolayers can be decidualised by treatment with cAMP and 
medroxyprogesterone acetate (MPA), a progestin (Brosens et al., 1999, Gellersen 
and Brosens, 2014).  
 
In an initial study, a monolayer of human EnSC were co-cultured a hatched day 5 
human blastocyst stage embryo for three days. (Carver et al., 2003). This implantation 
model demonstrated that the blastocyst could attach and implant into the EnSC 
monolayer. This initial system was utilised to determine the response of differentiated 
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and undifferentiated EnSC to the presence of embryos (Carver et al., 2003). In 
another study, decidualised EnSC exhibited a downregulation of expression of 
implantation genes when co-cultured with an arresting embryo (Teklenburg et al., 
2010a). This experiment demonstrated that decidualised EnSC can act as a 
biosensor, detecting embryo quality. The model has also been used to investigate 
reproductive disorders. One study compared EnSC response to embryo quality from 
endometrial biopsies collected from normal fertile women and women suffering with 
RPL. EnSC of RPL patients failed to inhibit implantation genes when co-cultured with 
a poor-quality embryo  (Weimar et al., 2012). This observation indicates that the 
endometrium of RPL patients may have defects in their embryo quality biosensing. 
This suggests that the endometrium of women with RPL may be less selective for 
embryo quality than in fertile women. This would enable a poor-quality embryo to 
implant, and later miscarriage. This proposed phenomenon has been described as a 
‘selection failure hypothesis’ (Quenby et al., 2002, Teklenburg et al., 2010b, Lucas et 
al., 2013). 
 
Overall, the EnSC monolayer model provides a simple and robust model for studying 
human early embryo implantation. However, the main disadvantage of both EnSC 
and EEC monolayer models is that they only include one cell type, ignoring the in vivo 
endometrial EnSC and EEC interactions, as well as the resident immune and 
endothelial cell populations (Weimar et al., 2013).  
 
Colony forming unit assay 
The endometrium contains resident populations of progenitor cells (Gargett et al., 
2015, Chan et al., 2004, Schwab and Gargett, 2007, Gargett et al., 2009). Isolation 
of adult stem cells is difficult for cell culture because they reside in tissues in very 
small populations and usually possess very few distinguishing surface markers (Chan 
et al., 2004, Weissman, 2000, Robey, 2000). In other tissues, adult stem cells have 
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been identified by their clonogenic phenotype. Clonogenicity is defined as the ability 
of a single cell to produce a colony when seeded at very low densities. (Gronthos et 
al., 2000, Hudson et al., 2000, Pellegrini et al., 1999). Clonogenicity can be quantified 
using a colony forming unit (CFU) assay. The CFU assay is an in vitro culture assay 
in which cells are seeded at a defined low density on cell culture plastic and the 
number of colonies that form indicate the number of stem cells present in a sample 
as a proportion of the total population. A single colony is usually defined as consisting 
of at least 50 cells. Endometrial MSC were characterised using a CFU assay (Chan 
et al., 2004, Schwab et al., 2005, Schwab and Gargett, 2007, Masuda et al., 2012). 
(Chan et al., 2004). Since this discovery, there have been several studies looking at 
endometrial stem cells and their role in infertility. For example, patients suffering with 
RPL have fewer MSC than women who have normal fertile mid-secretory phase 
endometrium (Lucas et al., 2016). 
 
Layered EEC and EnSC co-culture in vitro modelling 
The peri-implantation environment of the endometrium involves synchronous 
paracrine signals, cell-cell and cell-matrix interactions between multiple cell types of 
the decidualising endometrium. For example, many studies have demonstrated that 
endometrial EnSC influence the development and differentiation of glandular EEC 
(Mahfoudi et al., 1992, Cunha et al., 1985, Cooke et al., 1986, Cooke et al., 1997, 
Cooke et al., 2013).  Therefore, more recent in vitro models of the endometrium have 
been established to replicate the complexity of the in vivo endometrium. These more 
complex models are generally multi-layered co-culture models of stacked monolayers 
of different cell types (Bentin-Ley et al., 1994, Evron et al., 2011, Wang et al., 2011, 
von Arnim and Deng, 1994). 
 
The stacked multilayer cultures consist of a layer of endometrial EnSC, which are set 
up in a matrix scaffold mimicking ECM, and a monolayer of EEC on top (Table 1.4) 
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(Fig. 6C). This scaffold is usually a ECM-derived hydrogel, such as Matrigel or 
collagen hydrogels (Bentin-Ley et al., 1994, Weimar et al., 2013). Matrigel is a 
solubilised basement membrane preparation isolated from Engelbreth-Holm-Swarm 
(EHS) mouse sarcoma cells. Sarcoma cells are rich in BM proteins such as laminin 
(a major component), collagen IV, heparin sulphate proteoglycans, entactin, and 
several growth factors. Collagen hydrogels tend to contain ECM proteins such as 
purified type I collagen. 
 
Layered co-culture models aim to represent the complex 3D endometrial tissue 
architecture more closely than simple monolayer cultures grown on plastic. The 
monolayer of endometrial EEC is grown on top of the stromal layer to resemble a 
luminal epithelium above a stroma, analogous to a simplified human endometrium. In 
one study, the stacked multi-layered co-culture model induced EEC polarisation, 
resulting in embryo attachment within 48 hours (Bentin-Ley et al., 2000). Furthermore, 
electron scanning microscopy revealed the interactions between embryo and the 
polarised EEC luminal surface and penetration through the BM layer and into the 
underlying EnSC layer (Bentin-Ley et al., 2000). These observations presented a 
novel insight into the process of human embryo implantation. 
 
In addition to this model, trans-well models for studying trophoblast invasion have 
been adapted to incorporate EnSC and EEC. Trophoblast invasion assays use dual 
chambered systems in which the trophoblast cells adhere to Matrigel-coated filter 
insert with 8 μm pores (Aplin, 2006, Lash et al., 2007). Adherent trophoblast cells 
invade the Matrigel and the number of cells that reach the surface beneath the 
Matrigel can be quantified. This trophoblast invasion assay has been adapted to 
incorporate elements of the layered co-culture model. EEC are seeded on top of the 
Matrigel in the trans-well prior to adding trophoblast cells  and the EnSC are cultured 
underneath the filter (Arnold et al., 2001, Bläuer et al., 2005, Pierro et al., 2001). This 
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setup therefore loses the cell-cell contact between EEC and EnSC seen in other co-
culture systems. However, the trans-well approach provides an easily manipulatable 
assay for quantifying trophoblast invasion in the presence of EnSC and/ or EEC. This 
model therefore provides scope for studying different parameters, such as additional 
endometrial cell types, or culturing cells from biopsies of women with different 
pathologies to assess differences in trophoblast invasion. 
 
Organoid in vitro modelling 
More recently, a new method of 3D culturing has emerged that improves upon 
previous monolayer approaches: organoids. Organoids are derived from stem or 
progenitor cells that self-organise into multicellular 3D structures that both 
morphologically and functionally recapitulate the tissue or organ from which the cells 
originate (Lancaster and Knoblich, 2014b). The progenitor cells that form organoids 
are derived from biopsies of adult tissue containing tissue-specific adult progenitor 
cells or from induced pluripotent stem cells (iPSC). Organoids exemplify the potent 
regenerative potential of progenitor or stem cells and by modelling the developmental 
processes of organogenesis, cell organisation and lineage commitment (Lancaster 
and Knoblich, 2014b). Organoid cultures have been established to model many 
different organs such as: intestine, kidney, lung, prostate, brain, stomach, and kidney 
(Zimmermann, 1987, Koo et al., 2012, Karthaus et al., 2014, Lancaster and Knoblich, 
2014b, Lancaster and Knoblich, 2014a, Crespo et al., 2017, Bartfeld and Clevers, 
2015). 
 
Endometrial gland organoids have been recently established (Boretto et al., 2017, 
Turco et al., 2017) (Fig. 6D). These two pioneering studies describe protocols for the 
endometrial gland organoid expansion, differentiation and cryopreservation (Turco et 
al., 2017, Boretto et al., 2017). Turco et al. 2017, optimised their organoid protocol 
using biopsies of normal and malignant human endometrium, and Boretto et al. 2017, 
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from biopsies of normal human and mouse endometrium. The organoids are 
expanded by culturing dissociated endometrial glands in Matrigel. In addition, both 
studies optimised a defined culture medium of growth factors, inhibitors, 
supplements, and antioxidants that enable organoid expansion and maintenance. 
Table 1.6 compares the media composition from both studies. Both studies also 
demonstrated that human endometrial organoids are clonal and can be passaged. 
The organoids also recapitulate physiological responses to ovarian hormone 
stimulation. Treatment with estradiol increases proliferation and promotes 
differentiation of secretory and ciliated cells (Haider et al., 2019, Turco et al., 2017, 
Boretto et al., 2017). Endometrial gland organoids can also be maintained in culture 
long term by passaging or stored by cryopreservation, enabling the prospect of 
producing endometrial gland organoid biobanks (Turco et al., 2017).  
 
There are many benefits to organoid culture over monolayer culture. First, in previous 
models, EEC have been cultured in monolayer, either singularly or in a stacked 
layered co-culture, to represent the luminal epithelium (Bentin-Ley et al., 1994, 
Bentin-Ley et al., 2000). However, endometrial gland organoids provide a model for 
glandular epithelium containing both ciliated and non-ciliated EEC when exposed to 
estradiol (Haider et al., 2019). Furthermore, the clonal properties of these organoids 
indicate that progenitor or stem cell populations can be studied using this technique. 
Furthermore, the organoids have already been used to develop disease models 
related to glandular defects which offer insight into endometrial gland biology 
underpinning infertility (Boretto et al., 2019). In addition, endometrial gland organoids 
could provide a tool for novel drug discovery for endometrial disorders. Patient-
derived organoids could be used to develop personalised medicine approaches for 
treating infertility.  
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Table 1.6: A comparison of medium optimised for endometrial gland organoid 
expansion.  
 
 
 
Medium 
component 
Turco, et al. 
2017 
Boretto, et al.  
2017 
Action 
Base medium Advanced  
DMEM/F12 
DMEM/F12 + 
insulin-
transferrin-
selenium 
 
NAC ✓ ✓ Antioxidant 
A83-01 ✓ ✓ Potent inhibitor of TGF-β type I receptor 
superfamily activin-like kinase ALK5 
and its relatives ALK4 and ALK7 
Nicotinamide ✓ ✓ Incorporated into coenzymes NAD+ 
(nicotinamide adenine dinucleotide) and 
NADP+ (nicotinamide adenine 
dinucleotide phosphate) essential for 
metabolism 
EGF ✓ ✓ Promotes cell growth, proliferation and 
differentiation. 
Noggin ✓ ✓ BMP inhibitor 
WNT activator R-spondin-1 R-spondin-1 + 
 WNT3A 
Promotes canonical WNT/β catenin 
signalling 
 
FGF10 ✓ ✓ EnSC derived. Promotes cell growth 
and proliferation 
HGF ✓ NA EnSC derived. Promotes cell growth 
and proliferation 
N2 supplement ✓ ✓ Supplement for serum free medium 
Antibiotics Primocin penicillin/  
streptomycin 
Prevent Infection 
L-Glutamine L-Glutamine Glutamax Essential amino acid 
B27 
supplement 
✓ ✓ Supplement for serum free medium 
SB202190 NA ✓ p38 inhibitor 
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Taken together, historically, the endometrial epithelium has been difficult to culture 
and maintain in vitro. Organoids provide a method of modelling glandular epithelium 
that is functionally and morphologically representative of the endometrium. (Deane et 
al., 2017). The future of endometrial gland organoid culture lies in the co-culture with 
EnSC and other endometrial cell types. Long term, a complex organoid co-culture 
model could be utilised to study embryo implantation like previous in vitro models, but 
with additional insight of the role of the glandular epithelium in early maternal-embryo 
interactions. The incorporation of endometrial gland organoids into a complex 
organoid co-culture would provide the most comprehensive in vitro model of the 
human peri-implantation endometrium to date. 
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1.3 Research justification and aims 
Human embryo implantation is currently the rate-limiting step for achieving a 
successful pregnancy in ART. Inappropriate endometrial embryo-quality biosensing 
is also associated with RPL. Elucidating the mechanisms underpinning the peri-
implantation endometrium will enable the development of treatments for patients 
suffering with chronic fertility disorders. However, human embryo implantation is 
difficult to study as it is unethical to study in women and in vivo animal models do not 
fully recapitulate the human endometrial environment. Therefore, to avoid inter-
species variability, in vitro culture of human endometrial cells is used routinely to study 
implantation. However, the endometrium is a complex tissue made up of EnSC, 
epithelial glands, as well as a vasculature and immune cell population. An in vitro 
model that encompasses all aspects of the human endometrium requires a complex 
co-culture system, containing several endometrial cell types. Therefore, 3D in vitro 
culturing methods are the most suitable for developing a faithful model of human 
embryo implantation. The advent of endometrial gland organoids has allowed for the 
culture of endometrial glandular epithelium, an essential part of the peri-implantation 
endometrium and for embryo implantation. Currently, 3D co-cultures of endometrial 
gland organoids with EnSC have yet to be described in the literature. The co-culture 
of endometrial gland organoid and EnSC to establish complex organoids could 
provide a starting point for a step change in our collective ability to study human 
embryo implantation in vitro. This system will be patient specific, and in the long term 
be developed into a high-throughput system for personalised medicine treatments for 
infertility. 
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Thesis aims: 
1. To establish and optimise a protocol for a novel in vitro complex organoid 
culture. 
2. To functionally characterise the complex organoids for both morphological 
and functional recapitulation of the human endometrium 
3. To evaluate the impact of EnSC on EEC differentiation in the complex 
organoids. 
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Chapter 2:  
Materials and Methods 
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2.1. Materials  
Cell culture materials 
EnSC culture materials 
Reagent Manufacturer 
Charcoal Sigma-Aldrich 
Collagenase type IA Sigma-Aldrich 
Dextran Fisher Scientific 
Deoxyribonuclease I (DNase I) Roche 
Foetal bovine serum (FBS) heat inactivated  
Insulin Sigma-Aldrich 
L-Glutamine Gibco 
Penicillin (10,000 µg/ml)- Streptomycin (10,000µg/ml) solution Invitrogen 
RNA-later Sigma-Aldrich 
Trypsin-EDTA solution Gibco 
Plastic-ware VWR 
Matrigel Fisher Scientific 
Medium 200 Gibco 
Dulbecco’s Modified Eagle Medium/ Ham's F-12 (DMEM)/F12 
(1:1) with L-glutamine with phenol red 
Fisher Scientific 
DMEM/F12 (1:1) with L-glutamine, phenol free Fisher Scientific 
 
Organoid culture materials 
Expansion medium (ExM) components 
Medium 
component 
Source Purity/ Composition Manufacturer 
A83-01 Synthetic ≥98% (HPLC) Sigma-Aldrich 
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Antibiotic-
Antimycotic 
(100X) 
 10,000 units/mL of penicillin, 
10,000μg/mL of streptomycin, 
and 25μg/mL of Fungizone™ 
Gibco 
B27 supplement Synthetic Biotin, DL Alpha tocopherol 
acetate, DL alpha-tocopherol, 
BSA, catalase, human 
recombinant insulin, human 
transferrin, superoxide 
dismutase, corticosterone, D-
galactose, ethanolamine HCl, 
glutathione (reduced), L-
carnitine HCl, linoleic acid, 
linolenic acid, progesterone, 
putrescine 2HCl, sodium 
selenite, T3 (triodo-I-thryonine). 
Concentrations are confidential 
to manufacturer.  
Gibco 
Epidermal growth 
factor (EGF) 
Escheric
hia coli 
(E. coli) 
≥ 98% by SDS-PAGE gel and 
HPLC analyses. 
Peprotech 
Fibroblast growth 
factor 10 (FGF10) 
E. coli ≥ 95% by SDS-PAGE gel and 
HPLC analyses. 
Peprotech 
Hepatocyte 
growth factor 
(HGF) 
(BTI-Tn-
5B1-4) 
Hi-5 
Insect 
cells 
≥ 98% by SDS-PAGE gel and 
HPLC analyses. 
Peprotech 
L-Glutamine Synthetic 200mM L-Glutamine Gibco 
N2 supplement Synthetic Human transferrin 10 mg/ml; 
Insulin Recombinant Full Chain 
500 ng/ml; Selenite 520 pg/ml; 
Putrescine 1.6 mg/ml; 
Progesterone 630 pg/ml 
Gibco 
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Organoid culture materials 
Reagent Source Composition Manufacturer 
Advanced DMEM/F12   Gibco 
Albumax II Bovine Purified BSA Fisher Scientific 
Cell Recovery Solution Synthetic nonenzymatic 
proprietary solution 
Fisher Scientific 
Collagenase type IA Clostridium 
histolyticum 
250mg of lyophilized 
powder. May 
contain caseinase, 
clostripain, and 
tryptic activities 
Sigma-Aldrich 
Matrigel (Growth Factor 
Reduced) * 
See below* See below* Fisher Scientific 
Plastic-ware   VWR 
PureCol® EZ Gel 
solution** 
See below** See below** Sigma Aldrich 
Serum Replacement 1 
50× 
Bovine Contains highly 
purified, heat-
treated BSA, bovine 
transferrin and 
bovine insulin.  
Sigma-Aldrich 
N-Acetyl-Cysteine 
(NAC)  
Synthetic ≥99% (TLC) Sigma-Aldrich 
Nicotinamide Synthetic ≥98% (HPLC) Sigma-Aldrich 
Noggin HEK293 
cells 
≥ 95% by SDS-PAGE gel and 
HPLC analyses. 
Peprotech 
R-spondin-1 CHO 
cells 
≥ 95% by SDS-PAGE gel and 
HPLC analyses. 
Peprotech 
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TrypLE select 10x Synthetic  Trypsin 
replacement; 
Protease 
concentration 
confidential to 
manufacturer 
Fisher Scientific 
 
*Matrigel (Growth Factor Reduced) 
Matrigel matrix hydrogel (Corning) is a solubilised basement membrane preparation 
isolated from Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells. Sarcoma cells 
are rich in BM proteins such as laminin, collagen IV, proteoglycans, entactin, and 
several growth factors. The contents of the Matrigel protein preparation is 
approximately 60% laminin, 30% collagen IV, and 8% entactin. The typical 
concentration of Matrigel is 8 – 12 mg/ml. Matrigel also contains several growth 
factors, as seen below. In the present study, the growth factor reduced (GFR) Matrigel 
is used to minimise the impact of the growth factors on the cells used in experiments 
(Fisher Scientific).  
Growth Factor Average GF 
Concentration 
in Corning 
Matrigel Matrix 
Average GF 
Concentration in 
GFR Corning 
Matrigel Matrix 
EGF 
Basic fibroblast growth factor (bFGF) 
Nerve growth factor (NGF)  
Platelet-derived growth factor (PDGF) Insulin-
like growth factor 1 (IGF-1) 
Transforming growth factor beta 1 (TGF-β1) 
0.7 ng/ml 
N/A 
˂ 0.2 ng/ml 
12 pg/ml 
16 ng/ml 
2.3 ng/ml 
˂ 0.5 ng/ml 
N/A 
˂ 0.2 ng/ml 
˂ 5 pg/ml 
5 ng/ml 
1.7 ng/ml 
 
**PureCol® EZ Gel solution  
The PureCol EZ Gel is a pre-formulated collagen hydrogel solution. The gel is a 
solution of 5 mg/ml purified Type I collagen in DMEM/F12 medium. It also contains a 
mixture of L-glutamine and L-alanine-L-glutamine dipeptide. The collagen type I is 
purified from bovine skin (Sigma Aldrich). 
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Cell culture treatments 
Reagent Concentration Manufacturer 
8-br-cAMP 0.5 mM Sigma-Aldrich 
bFGF 10 ng/ml Merk-Millipore 
Estradiol 1 nM Sigma-Aldrich 
Medroxyprogesterone 
acetate (MPA)  
1 µM 
Sigma-Aldrich 
TGFβ1 (recombinant protein) 200 nM Bio-Techne Ltd 
A8301 1, 10 or 100 µM Sigma Aldrich 
Y27632 1 or 10 µM Sigma-Aldrich 
KD025 
1 µM Stratech Scientific 
Limited 
Y15 
50 μM Stratech Scientific 
Limited 
 
Chemical reagents 
Reagent Manufacturer 
30% acrylamide protogel/Bis solution Bio-rad 
Ammonium Persulphate (APS) Fisher Scientific 
Bio-Rad Protein Assay Dye Bio-Rad 
Bovine serum albumin (BSA) Sigma-Aldrich 
CellTracker™ Green CMFDA Dye Fisher Scientific 
CellTracker™ Red CMTPX Dye Fisher Scientific 
Chloroform AnalaR 
cOmplete EDTA free protease inhibitors Roche   
Dimethyl sulphoxyde (DMSO) Life Technologies 
Ethylenediaminetetraacetic acid (EDTA) Fisher Scientific 
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Fibronectin Sigma-Aldrich 
Formalin Leica 
Isopropanol Sigma-Aldrich 
Milk powder AppliChem 
N,N,N,N’-tetramethyl-ethane-1,2-diamine (TEMED) Sigma-Aldrich 
Phosphatase inhibitor cocktail Sigma-Aldrich 
PrecisionPlus SYBR Green Mastermix Life Technologies 
ProLong® Gold Antifade Reagent with DAPI 
Cell Signaling 
Technology 
Protein ladders Life Technologies 
RIPA Millipore 
RNase free tubes Life-Technologies 
RNase free water Life Technologies 
RNase ZAP AMS Biotechnology 
Sodium dodecyl sulphate (SDS) Fisher Scientific 
STAT-60 AMS Biotechnology 
Tris base Sigma-Aldrich 
Tris HCl Sigma-Aldrich 
Tris-borate Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Tween 20 Sigma-Aldrich 
β-mercaptoethanol Fisher Scientific 
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Pre-Set Kits 
Kit Manufacturer 
AllPrep DNA/RNA Micro Kit Qiagen 
ECL Prime Western Blotting detection system GE Healthcare 
jetPRIME Transfection Kit VWR 
QIAshredder Qiagen 
QuantiTECT Reverse Transcription Kit Qiagen 
ReadyProbes™ Cell Viability Imaging Kit, 
NucBlue/NucGreen 
Fisher Scientific 
RNase-Free DNase Set Qiagen 
RNeasy Plus Micro Kit Qiagen 
 
ELISA materials 
ELISA Materials Manufacturer 
Clear Polystyrene Microplates BIO-TECHNE 
Human CXCL14/BRAK DuoSet ELISA BIO-TECHNE 
Human Osteopontin (OPN) DuoSet ELISA BIO-TECHNE 
Human Prolactin (PRL) DuoSet ELISA BIO-TECHNE 
Stop Solution 2N Sulfuric Acid BIO-TECHNE 
Substrate Reagent BIO-TECHNE 
 
Magnetic-activated cell sorting (MACS) materials 
Material Manufacturer 
Anti SUSD2-PE human MILTENYI BIOTEC 
Anti-PE MicroBeads MILTENYI BIOTEC 
MACS separation columns MILTENYI BIOTEC 
MiniMACS Separator MILTENYI BIOTEC 
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Buffer Recipes 
TBS TBS-Tween (TBST) TBE  
130 mM NaCl  
20 mM Tris, pH 7.6  
0.1% Tween in 1x TBS  
 
0.9 M Tris-borate  
2 mM EDTA, pH8.0RIPA 
Buffer  
50 mM Tris HCl pH 7.4  
1% NP40  
0.5% deoxycholate  
0.1% SDS  
150 mM NaCl  
2 mM EDTA  
50 mM NaF 
 
Western Blot Materials 
Western Blot Buffer Recipes: 
Running Buffer (10x) Transfer Buffer  Blocking/ Antibody Incubation Solution  
250mM Tris Base  
192mM glycine   
1% (w/v) SDS  
 
250 mM Tris Base  
192 mM glycine   
20% (v/v) 
methanol  
 
5% BSA (w/v) in TBS-Tween or  
5% skimmed milk powder (w/v) in TBS-
Tween (antibody dependent) 
 
 
Western Blot Gel Components: 
Running Gel Stacking Gel  
30% acrylamide Protogel 
1.5 M Tris-HCL pH 8.8 
H2O 
10% SDS 
30% acrylamide Protogel  
0.5 M Tris-HCL pH  
H2O  
10% SDS  
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10% APS 
TEMED 
10% APS 
TEMED  
 
Western blot antibodies 
Primary Antibody Dilution Host BSA/Milk Manufacturer 
αSMA 1:1000 Rabbit 5% BSA 
Cell Signaling 
Technology 
β-actin 1:10000 Mouse 5% BSA ABCAM 
MYPT1 1:1000 Rabbit 5% BSA 
Cell Signaling 
Technology 
p-MYPT1 1:1000 Rabbit 5% MILK 
Cell Signaling 
Technology 
 
RT-qPCR Primers 
All primer efficiencies were calculated previously by the Brosens group. Purchased 
from Sigma-Aldrich. 
Primer Sequence (5’-) Efficiency 
L19 Forward GCGGAAGGGTACAGCCAAT 1.98 
L19 Reverse GCAGCCGGCGCAAA 1.98 
PRL Forward AAGCTGTAGAGATTGAGGAGCAA 1.89 
PRL Reverse TCAGGATGAACCTGGCTGACTA 1.89 
CXCL14 Forward GCGACGTGAAGAAGCTGGAA 1.87 
CXCL14 Reverse TACCTGGCACGCTCTTGGT 1.87 
PAEP Forward GAGCATGATGTGCCAGTACC 1.91 
PAEP Reverse CCTGAAAGCCCTGATGAATCC 1.91 
SPP1 Forward TGCAGCCTTCTCAGCCAAA 1.95 
SPP1 Reverse GGAGGCAAAAGCAAATCACTG 1.95 
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Antibodies - IHC 
Primary Antibody Host Antigen retrieval pH Dilution Manufacturer 
EpCAM 
Rabbit 
6.4 
1:200 New England 
Biolabs 
E-cadherin 
Rabbit 
6.4 
1:200 Cell Signaling 
Technology 
Cytokeratin-18 Rabbit 6.4 1:200 ABCAM  
Laminin Rabbit 6.4 1:100 ABCAM  
PR 
Mouse 
6.4 
1:50 Agilent 
Technologies  
Glycodelin Rabbit 9.5 1:100 ABCAM 
Ki67 Rabbit 6.4 1:200 ABCAM 
Vimentin  
Mouse 
6.4 
1:200 New England 
Biolabs 
 
 
Secondary Antibody (1:500) Manufacturer 
IgG (H+L) Cross-Adsorbed, Host-Rb, 2mg/mL, 250uL,  
Species Reactivity-Mouse, Polyclonal, Alexa Fluor 594, 
Invitrogen 
IgG (H+L) Cross-Adsorbed, Host: Gt, 2 mg/mL, 500uL,  
Species Reactivity: Rabbit, Alexa Fluor 488 
Invitrogen 
 
 
 
 
 
 
 
 
 54 
 
scRNA-seq Materials 
Material Manufacturer 
Agencourt AMPure XP beads Beckman Coulter 
Barcoded Oligo dT primer ON Beads 
Chemgenes 
Corporation 
Bioanalyzer High Sensitivity DNA chip Agilent 
C-Chip Fuchs-Rosenthal Haemocytometer Labtech 
Droplet generation oil 
Bio-Rad 
Laboratories 
Illumina Nextera XT DNA Sample Kit Illumina 
Illumina Nextera XT Indexing Kits Illumina 
Nadia Cartridges for scRNA 
The Dolomite 
Centre 
Nadia Instrument Blacktrace Holdings 
NextSeq High Output 75 cycle V2 kit Illumina 
Qubit High Sensitivity DNA assay ThermoFisher 
 
Small interfering RNA 
Reagent Manufacturer 
ON-TARGETplus Non-targeting Pool 1.   
 
HORIZON 
DISCOVERY 
ON-TARGETplus Human MYLK (4638) siRNA -
SMARTpool 
 
HORIZON 
DISCOVERY  
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2.2. Methods  
Human Endometrial Biopsy Collection 
Patients were recruited for endometrial biopsy from the Implantation Clinic, a research 
unit of University Hospitals Coventry and Warwickshire National Health Service Trust. 
Written informed consent was obtained from all patients in accordance with the 
Declaration of Helsinki 2000. The study was approved by the NHS National Research 
Ethics Committee of Hammersmith and Queen Charlotte’s Hospital NHS Trust 
(1997/5065). Biopsies were all timed to the mid secretory phase, 5 to 11 days after 
the post-ovulatory LH surge. No patients were taking hormonal treatment for at least 
3 months prior to biopsy. Processing of tissue samples is fully compliant with Human 
Tissue Act regulations and completed within 4 hours of collection. All experiments 
were conducted using primary cells isolated from human endometrial biopsies. 
 
EnSC cell culture 
DCC-FBS preparation  
500 ml fetal bovine serum (FBS) was treated with dextran coated charcoal (DCC). 
1.25 g charcoal and 125 mg dextran added to FBS and incubated at 57oC for 2 hours, 
with regular mixing, to remove hormones and other factors from the FBS. FBS was 
centrifuged at 400 g for 30 minutes. Supernatant was sterile filtered and aliquoted for 
use in medium preparation. 
 
Isolation of EnSC from endometrial biopsy.  
Fresh endometrial biopsies were mechanically dissociated by finely mincing the 
tissue for 5 minutes by scalpel in a petri dish. The minced tissue was then 
enzymatically digested with collagenase I (0.5 mg/ml) and deoxyribonuclease 
(DNase) type I (0.1 mg/ml) in 5 ml phenol red-free Dulbecco’s Modified Eagle Medium 
(DMEM)/F12 for 1 hour at 37°C, with regular vigorous shaking. Enzyme activity was 
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stopped by adding 10 ml 10% DCC-FBS supplemented DMEM/F12. 10% DCC-FBS 
supplemented DMEM/F12 containing 1% penicillin-streptomycin, 2 mM L-glutamine, 
1 nM estradiol and 2 mg/ml insulin was used for all EnSC cell culture unless stated 
otherwise. Samples were flushed through a 40-µm cell sieve. EnSC and other cells 
(blood cells, uNK cells, endothelial cells, single EEC). Epithelial glands remained in 
the sell sieve. Samples were centrifuged at 400 g for 5 min. Cell pellets were 
resuspended in 10 ml 10% DCC-FBS supplemented DMEM/F12. Cell suspensions 
were plated into an appropriately sized cell culture grade flask. Cell cultures were 
incubated at 37°C and 5% v/v CO2. To isolate EnSC from other cells, the medium 
was refreshed after 24 hours as only the EnSC attach to plastic within this time frame.  
 
Primary EnSC cell culture 
EnSC were cultured in standard cell culture incubator conditions: a humidified 
atmosphere, 5% v/v CO2 and 37oC. A class II microbiology safety cabinet was used 
for all EnSC culture. Cultures were refreshed with 10% DCC-FBS supplemented 
medium every 48 hours. Confluent monolayers were passaged by 1 ml trypsin-EDTA 
treatment for 5 minutes at 37oC. Treated cell culture flasks were tapped to dislodge 
remaining attached cells. Trypsin activity was stopped by addition of 9 ml 
supplemented 10% DCC-FBS. EnSC were centrifuged at 400 g for 5 min and the cell 
pellet was resuspended in supplemented 10% DCC-FBS supplemented medium and 
split into a 1:3 ratio for further plating.  
 
EnSC decidualisation treatment  
Confluent monolayers were placed in phenol red-free 2% DCC-FBS supplemented 
DMEM-F12 overnight. 2% DCC-FBS supplemented DMEM/F12 contained only 1% 
penicillin-streptomycin and 2 mM L-glutamine. For decidualization treatment, 24 
hours after medium down regulation, EnSC cultures were treated with phenol red-
free DMEM/F12 containing 2% DCC-FBS with 0.5 mM 8-bromo-cAMP (cAMP) and 1 
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µM medroxyprogesterone acetate (MPA). For the experiment excluding either MPA 
or cAMP, the concentrations of the maintained factor remained the same as standard 
protocol. All treatments were performed in the second passage.  
 
Isolation of stromal sub-populations 
Stromal cell subtypes were isolated from endometrial tissues as described previously 
(Murakami et al., 2013). Following the EnSC isolation protocol, instead of plating the 
cells, the cell suspension was layered over Ficoll-Paque PLUS and centrifuged to 
remove erythrocytes. The medium/Ficoll-Paque PLUS interface, containing EnSC, 
was carefully aspirated, and washed with 10% DCC-FBS supplemented medium. 
Magnetic bead separation was performed using SUSD2+ antibody W5C5, to isolate 
PVC (W5C5+ cells) as described (Murakami et al., 2013). PVC were either cultured 
in a cell culture flask (PVC) or used to isolate MSC by CFU assay. W5C5- cells were 
either cultured in a cell culture flask (EnSC) or used to isolate TAC by CFU assay.  
 
CFU-assay  
CFU assay was performed by seeding EnSC or PVC at a clonal density of 50 cells/ 
cm2 to ensure equal loading onto fibronectin-coated 60 mm culture dishes and 
cultured in 10% DCC-FBS supplemented medium supplemented with 10 ng/ml basic 
fibroblast growth factor (BFGF) (Murakami et al., 2013). Culture medium was not 
refreshed until day 7 of culture. Colonies were defined as containing ≥ 50 cells and 
derived from one cell. Colonies were monitored daily to ensure that they were derived 
from single cells. Cultures were harvested at 10 days for ERB formation assays. 
 
ERB formation / endometrial fibroblast activation model (EFAM) 
All stromal cell sub populations for ERB formation were recovered by aspirating the 
culture medium and washed with 1 ml sterile PBS. Cultures were subjected to trypsin-
EDTA incubation for 5 minutes at 37oC to resuspend the cells. 10% DCC-FBS 
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supplemented medium was added to stop trypsin enzymatic activity, and the cells 
were collected and resuspended in medium 200. Medium 200 was prepared by 
adding 1× low serum growth supplement (LSGS) to basal medium 200. The cell 
number was counted using an automated cell counter (LUNA). Aliquoted Matrigel 
(stored at -20oC) was kept on wet ice. 50 µl Matrigel was pipetted using ice-cold 
pipette tips into a 96-well cell culture plate to form a flat plug covering the full surface 
of the well. The Matrigel was allowed to cure before use following method optimisation 
(See Chapter 3). 1×105 stromal cells, suspended in medium 200, were seeded into 
each well on top of the Matrigel layer. The medium was topped up to 200 µl total 
volume per well. The plates were incubated in standard cell culture conditions for 24 
hours for ERB formation to occur.  For the experiment testing the collagen hydrogel, 
it was used the same as Matrigel.  
 
ERB formation was designated as successful if a small mass of cells was observed 
24 hours after seeding. Later experiments replaced this designation with time-lapse 
microscopy in which the kinetics of the contraction were observed by measuring the 
area of the cell mass over time (See: Measurement of ERB area).  
 
ERB recombinant protein/inhibitor treatments  
Transforming Growth Factor-1 (TGFβ1) recombinant protein was prepared as a 1 mM 
solution by being resuspended in sterile distilled water and aliquoted. For treatment, 
EnSC were subject to 200 nM TGFβ1 recombinant protein in medium 200 or control 
at the time of seeding onto Matrigel for ERB formation. The treatment was maintained 
for 24 hours and then the area of the ERB was measured at 24 hours post seeding 
(See: Measurement of ERB area) . 
 
TGFβ1 superfamily activin-like kinase ALK5 inhibitor A83-01 was resuspended in 
DMSO (5 mg/ml) and aliquoted. EnSC were subject to 1, 10 or 100 µM A83-01 or 
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vehicle control diluted in Medium 200 at the time of seeding onto Matrigel for ERB 
formation. The treatment was maintained for 24 hours and then the area of the ERB 
was measured (See: Measurement of ERB area). 
 
ROCK inhibitor Y-26732 was re-suspended in DMSO (5 mg/ml) and aliquoted. EnSC 
were subject to 1 or 10 µM Y-26732 diluted in medium 200 or vehicle control at the 
time of seeding onto Matrigel for ERB formation. The samples were imaged by time-
lapse microscopy for 36 hours.  The area of the ERB was measured every 4 hours 
(See: Measurement of ERB area). 
 
ROCK 2 inhibitor KD025 was resuspended in DMSO (5 mg/ml) and aliquoted. EnSC 
were subject to 1 µM KD025 or vehicle control in 200 µl of Medium 200 at the time of 
seeding onto Matrigel for ERB formation. The samples were imaged by time-lapse 
microscopy for 36 hours.  The area of the ERB was measured every 4 hours (See: 
Measurement of ERB area). 
 
Focal adhesion kinase (FAK) inhibitor Y15 was resuspended in DMSO (5 mg/ml) and 
aliquoted. EnSC were subject to 50 μM Y15 or vehicle control in 200 µl of Medium 
200 at the time of seeding onto Matrigel for ERB formation. The samples were imaged 
by time-lapse microscopy for 36 hours.  The area of the ERB was measured every 4 
hours (See: Measurement of ERB area). 
 
Endometrial gland organoid culture  
Endometrial gland organoid culture  
All endometrial gland organoids were cultured in an adapted protocol first described 
by Turco et al., 2017. As described elsewhere, fresh biopsies were digested 
mechanically and enzymatically and filtered through a 40-μm cell filter to separate the 
EnSC and endometrial gland fragments. The endometrial gland fragments were 
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collected by inverting the sieve onto a sterile falcon centrifuge tube and adding 10 ml 
phenol-free DMEM/F12 medium and centrifuged at 400 g for 5 min. The endometrial 
gland fragments were resuspended in 500 µl phenol-free DMEM/F12 medium in an 
Eppendorf microcentrifuge tube and centrifuged at 600 g for 5 minutes. The medium 
was removed and ice-cold neat Matrigel was added with the volume dependent on 
the size of the pellet (a ratio of 1:20 between pellet and Matrigel). Samples mixed in 
Matrigel were kept on ice until plating. 20 µl of the Matrigel suspension was aliquoted 
using ice cold pipette tips into a 48 well plate and allowed to cure in the cell culture 
incubator (37°C and 5% v/v CO2) for 15 minutes.  Expansion medium (ExM) (see 
table below) was then laid over the top and samples were cultured for up to 7 days 
and is the same formulation as Turco, et al. 2017.  
 
ExM composition  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medium component Final Concentration 
Advanced DMEM/F12 1× 
A83-01 500 nM 
Antibiotic-Antimycotic (100×) 1× 
B27 supplement 1× 
EGF 50 ng/ml 
FGF10 100 ng/ml 
HGF 50 ng/ml 
L-Glutamine 2 mM 
N2 supplement 1× 
NAC  1.25 mM 
Nicotinamide 10 mM 
Noggin 100 ng/ml 
R-spondin-1 500 ng/ml 
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ExM was refreshed every 48 hours. For experiments using collagen hydrogel instead 
of Matrigel, the only difference is the curing time was longer, as collagen required 45 
minutes of incubation before adding ExM. 
 
Endometrial gland organoid passaging 
Endometrial gland organoids were passaged 7 days after seeding. This protocol is 
adapted from the method described by Turco et al., 2017.  First, samples were 
collected into Eppendorf microcentrifuge tubes by scraping the Matrigel droplet. The 
samples were centrifuged at 600 g for 6 minutes at 4oC. Samples were resuspended 
in ice-cold phenol red-free DMEM/F12 and subjected to manually 300× pipetting to 
disrupt the organoids. The samples were centrifuged at 600 g for 6 minutes at 4oC. 
Samples were resuspended in ice cold additive free DMEM/F12 and subjected to a 
further manual 80× pipetting to further disrupt the organoids. The samples were 
centrifuged at 600 g for 6 minutes at 4oC again and resuspended in Matrigel and 
plated as described elsewhere, or for complex organoid cultures.  
 
Complex organoid culture 
Complex organoid formation and culturing 
P1 EnSC and endometrial gland organoids were passaged by their respective 
passaging protocols described elsewhere. The EnSC and gland organoid cell pellets 
were mixed at a ratio of 1:1. Ice cold collagen hydrogel added was dependent on the 
size of the pellet (a ratio of 1:20 between EnSC and gland organoid mixture and 
Collagen hydrogel). Samples were kept on ice until plating. 20 µl of the mixed 
suspension was aliquoted using ice cold pipette tips into a 48 well plate and allowed 
to cure in the cell culture incubator (37°C and 5% v/v CO2) for 45 minutes. Complex 
organoid expansion medium (co-ExM) containing 1 nM estradiol was then laid over 
the top and samples were cultured for up to 7 days. Co-ExM was refreshed every 48 
hours. See Chapter 4 for further details.  
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Complex organoid growth medium optimisation  
Complex organoid cultures from three independent biopsies were aliquoted into a 48 
well plate such that there were duplicate wells of cultures for each growth medium 
composition. Samples were subjected to the different media for 8 days to allow for 
growth and expansion. On day 8, all samples were imaged and observed for visual 
signs of expansion.  
 
Complex organoid decidualisation treatment  
Complex organoid cultures were grown in co-ExM for 4 days to allow for growth and 
expansion. On day 4, samples were treated with differentiation medium (DM) 
containing 0.5 mM 8-bromo-cAMP and 1 μM MPA for 4 days or maintained in co-ExM 
as control. After 4 days of differentiation, all samples were harvested for RNA. On D0, 
D2 and D4 of differentiation, spend media was collected, and DM was replaced.  
 
Complex organoid minimal differentiation medium optimisation 
Complex organoid cultures from three independent biopsies were aliquoted into a 48 
well plate such that there were duplicate wells of cultures for each DM composition. 
All samples were grown in co-ExM for 4 days to allow for growth and expansion. On 
day 4, each sample was subject to the different DM compositions (See Chapter 4 for 
specific compositions) or co-ExM as control. After 4 days of differentiation, all samples 
were harvested for RNA.  
 
Microscopy 
Brightfield microscopy 
All microscopy was performed on the EVOS FL Auto Imaging System instrument. For 
ERB formation studies, brightfield images were captured using 2× objective in 
brightfield.  For ERB formation studies using time-lapse microscopy, EnSC were 
seeded onto Matrigel as described in a 96-well cell culture plate, and then mounted 
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onto microscope vessel holder contained in a sealed environment chamber 
maintained at 37oC with humidified 5% v/v CO2. Brightfield images were taken every 
4 hours for 36 hours.  
 
Live cell tracker stain microscopy 
Co-cultured ERB containing EnSC and EEC were stained with CellTracker Green 
CMFDA and CellTracker Red CMPTX dyes, respectively, prior to being mixed and 
seeded onto Matrigel. CellTracker dyes were resuspended in DMSO to a final 
concentration of 10 mM. The CellTracker dye working solutions were prepared by 
diluting the CellTracker stock solutions to 25 µM in serum free phenol free 
DMEM/F12, exactly by the manufacturer’s instructions. Cultured EnSC were 
harvested with Trypsin-EDTA as described previously. Fresh, patient matched 
cryopreserved EEC were thawed by first warming the sample until almost fully thawed 
and adding 8 ml 10% DCC-FBS supplemented DMEM/F12 into a 14 ml Falcon 
centrifuge tube. Both EnSC and EEC were centrifuged separately and resuspended 
in their respective CellTracker working solution. Samples were incubated at 37oC for 
30 minutes and then centrifuged at 400 g for 5 minutes and resuspended in Medium 
200. The ERB forming assay was performed as described above. However, for co-
culture with EEC, 1x104 CellTracker stained EEC were either mixed with 1x105 
CellTracker stained EnSC prior to seeding onto 50 µl Matrigel or 1x104 EEC were 
seeded 24 hours after seeding the EnSC onto Matrigel (original method) (See 
Chapter 3 for optimisation details). Red fluorescence was imaged by the EVOS Auto 
TxRed colour cube (Excitation: 585/29 nm, Emission: 628/32 nm) (CellTracker™ Red 
CMTPX Dye excitation/emission spectra (577/602 nm maxima)) and green 
fluorescence was imaged by the GFP colour cube (Excitation: 470/22 nm, Emission: 
525/50 nm) (CellTracker Green CMFDA excitation/emission spectra (492/517 nm 
maxima)). 
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Live/ dead stain microscopy  
ERB were measured for live and dead cells following formation. ERB were stained 
with NucBlue (Excitation/Emission: 360/460 nm) and NucGreen (Excitation/Emission: 
504/523 nm) 24 hours after EnSC were seeded onto Matrigel exactly as described by 
the manufacturer’s instructions. NucBlue is a dye that can diffuse across cellular 
membranes and bind DNA and stain live cells, representing the live cell population. 
NucGreen cannot pass through cellular membranes and therefore can only stain cells 
of which their membranes have been disrupted, as an indicator of cell death. Images 
were taken 1, 2 and 4 days after EnSC seeding onto Matrigel. Blue fluorescence was 
imaged by the EVOS DAPI light cube (Excitation: 357/44 nm, Emission: 447/60 nm). 
and the green fluorescence was imaged by the EVOS GFP light cube (Excitation: 
470/22 nm, Emission: 525/50 nm).   
 
Immunohistochemistry  
Complex organoids were harvested by peeling the gel off the well plate with tweezers 
carefully to maintain the droplet in one piece and placed into a bijou tube. Samples 
were washed in PBS and formalin fixed in the tube for 15 minutes. Samples were 
washed three times with PBS and stored for use. The samples were then dehydrated 
by being subjected to increasing concentrations of ethanol (70%, 90% and 100%) for 
1 hour each. Samples were then transferred to a glass tube and resuspended in 
xylene for 1 hour. Samples were then paraffin embedded and placed on an ice-cold 
surface to set. Embedded samples were sectioned into 5 µm slices by microtome and 
mounted onto microscopy slides and stored at 4oC.  
 
For immunohistochemistry (IHC) studies, sections were then subjected to a series of 
hydration steps of xylene, 100% isopropanol, 70% isopropanol and distilled water. 
Samples were then subject to antigen retrieval by being submerged in buffer (pH 
dependent on antibody) and placed in a Pickcell pressure cooker for ~1 hour, allowing 
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further time for the instrument to cool fully. Slides were then placed into a dark 
moisture chamber and wash with distilled water. Following this step, a hydrophobic 
pen (PAP) was used to mark a border around the sample. For samples to be 
immunolabelled for internal markers, samples were permeabilised by triton x-100 for 
30 minutes. Samples were then washed with PBS and blocked in 2% BSA/ TBST for 
30 minutes. Primary antibodies were diluted (See antibodies table) in 2% BSA/ TBST 
overnight at 4oC. Samples were then washed in TBST three times and secondary 
rabbit and mouse antibodies conjugated to Alexa Fluor 488 or 594, respectively, (See 
antibodies tables) diluted 1:500 in 2% BSA/ TBST were added for 2 hours at room 
temperature. Samples were then washed in TBST three times and mounted in 
Vectashield with DAPI for nuclear counterstain. Samples were visualised using the 
EVOS Auto system using the GFP, TxRed and DAPI cubes to visualise Alexa Fluor 
488 and 594, and DAPI, respectively. The microscopy parameters (LED intensity, 
camera gain, and exposure) for imaging were set the same for all images and 
maintained throughout image acquisition (See IHC Microscopy Parameters table on 
the next page).  
 
IHC Microscopy Parameters 
EVOS Light Cube LED intensity Camera gain (dB) Exposure (ms) 
DAPI 6 0.0 28 
TxRed 25 1..0 65 
GFP 35 1.2 88 
 
Image analysis 
ERB area measurement 
Image analysis program ImageJ was utilised for all image analysis. Images of ERB 
were processed by converting the image to an 8-bit and then a threshold was 
manually used to highlight the ERB. The images were assigned a scale by using the 
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‘Set Scale’ command and manually drawing over the pre-set scale bar from the EVOS 
Auto system and assigning it the measurement provided by the EOVS. This scale 
was set as the ‘global’ scale for all images being analysed, as all images were imaged 
using the same objective. The area highlighted was measured by using the ‘Measure’ 
command, ensuring ‘Area’ was checked in the ‘Set Measurements’ box.  
 
Immunohistochemistry  
The EVOS Auto system saves individual channel data as .TIF images. In ImageJ, the 
images were merged into a single colour image using the ‘Merge Channels’ tool and 
saved as jpeg files. Brightness and contrast were enhanced in images that were being 
compared to each other to the same degree.  
 
Protein analysis  
Protein extraction 
Cultures of EnSC were subject to whole cell protein extraction by direct lysis using 
RIPA buffer. The RIPA buffer was supplemented with cOmplete EDTA-free protease 
inhibitor. For extraction, cell culture medium was aspirated from the cultures. EnSC 
were washed with PBS twice. RIPA buffer solution (60 μl) was added per 6-well plate 
well. Plates were scraped using a silicon scraper to detach any unlysed cells. The 
solution was collected into microcentrifuge tubes per sample. For ERB cultures, 
Matrigel was first removed by harvesting the ERB and gel plugs into a microcentrifuge 
tube per sample and centrifuging the samples 400 g for 5 min at 4oC. The samples 
were washed three times with ice cold PBS and centrifuged in between each wash 
until there was a visible cellular pellet and Matrigel removed. RIPA buffer solution (60 
μl) was added per in triplicate ERB sample.  All samples were centrifuged at 12000 g 
for 15 min at 4°C. Supernatants were collected (containing extracted protein) and 
stored at -80°C. 
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Protein concentration quantification 
Extracted protein concentration was determined by Bradford assay. The Bradford 
assay reagent contains Coomassie blue dye. The assay is a colorimetric assay in 
which the Coomassie blue changes absorbance when bound to certain protein 
residues (As seen by a colour change from brown to blue, visible by eye). Stock 
Bovine Serum Albumin (BSA) was diluted to produce a concentration curve of 0 to 
3.5 μg in 0.5 μg increments in a clear 96 well plate. Bio-Rad protein assay dye reagent 
(20 μl) was added to each well for both the standard curve and samples, in duplicate. 
Whole cell protein extract samples were diluted 1:400 in distilled water and added to 
the sample wells. PheraStar microplate reader measured the plate at 595 nm 
absorbance. Protein concentrations were determined by reference to the constructed 
concentration curve.   
 
SDS-PAGE  
Samples were diluted to 20-40 μg protein in 3.5 μl 1 M DTT, 8.75 μl NuPage buffer 
as well as distilled water topped up to a total volume of 35 μl. Protein solutions were 
heated to 70oC and then placed rapidly on wet ice and briefly mixed and centrifuged. 
SDS-Page gels were prepared in disposable plastic cassettes. The lower resolving 
gel was prepared to pH 8.8. The percentage of acrylamide protogel used was 
dependent on the size of the protein of interest. The upper stacking gel was always 
prepared to pH 6.8 and 5% acrylamide protogel. Gel polymerisation was initiated by 
TEMED and 10% APS. First, the resolving gel was poured into the cassette and 
overlaid with 100% isopropanol. Once set, the isopropanol was rinsed off with distilled 
water and the stacking gel was poured on top and the 10-well comb was inserted. 
Once fully cast, gel cassettes with the comb removed were inserted into Invitrogen 
XCell SureLock Mini-cell and then into the electrophoresis tank with running buffer. 
Equal volumes of the prepared protein solutions were loaded into the wells as well as 
a pre-stained molecular weight ladder. A 100V constant voltage was applied until 
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protein separation occurred. After electrophoresis, gel cassettes were removed and 
opened to remove the gel for Western blot immunoprobing.  
 
Western blot 
Resolved protein sample gels were transferred to nitrocellulose membrane for 
antibody immunoprobing using a wet-blot method. The sample gel and pre-soaked 
nitrocellulose membrane were placed on top of pre-soaked blotting pads and 
Whatman filter paper, followed by more filter paper and blotting pads to form a 
gel/membrane sandwich. The sandwich was rolled to remove bubbles, which can 
interfere with visualisation. The assembled chamber was placed into a transfer tank 
with transfer buffer. Transfer was performed at a constant voltage of 280 mA for 1 
hour 50 minutes. Following transfer, the nitrocellulose membrane was blotted and 
transferred to a 50 ml Falcon centrifuge tube and blocked in 5% milk or BSA in TBST 
for 1 hour at room temperature on a roller, antibody dependent. The membrane was 
subsequently incubated with the primary antibody diluted in 5% milk or BSA in TBST 
overnight on a roller at 4˚C. The membrane was washed in TBST three times. The 
membrane was then incubated with a secondary antibody conjugated to horseradish 
peroxidase in 5 % milk TBST for 1 hour on a roller at room temperature. The 
secondary antibody needs to be immunoreactive for the primary antibody host 
species. The membrane was washed in TBST three times. Finally, the ECL Plus 
solution was prepared and pipetted immediately onto the blotted membrane and 
incubated at room temperature for 5 minutes and visualised by G-Box for 
luminescence. 
 
ELISA 
Solid Phase Sandwich enzyme-linked immunosorbent assay (ELISA) kits were used 
for the detection of PRL, OPN and CXCL14. For detection of PRL in Chapter 3, total 
protein lysate was used and harvested as previously described. For detection of PRL, 
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OPN and CXCL14 in Chapter 4, spend medium from complex organoid culture was 
used. Spent medium was collected every two days during a 4-day decidual time 
course. ELISA were performed exactly as per manufacturer’s instructions (DuoSet 
ELISA kits for PRL (DY682), OPN (DY1433), CXCL14 (DY866), Bio-Techne, 
Abingdon, UK). Once completed, the colour development was stopped using the stop 
solution and a PheraStar microplate reader was used to measure absorbance at 450 
nm and background absorbance measured at 540 nm. Protein concentration was 
obtained using a 4-paramenter logistic regression analysis and interpolation from the 
curve. The data were normalised to total protein concentration, explained elsewhere. 
 
Transient transfection 
Primary EnSC cultures were transiently transfected using the jetPRIME PolyPlus 
transfection kit following the manufacturer’s instructions. All siRNA were resuspended 
to 25 µM, aliquoted and stored at -20oC. For transfection, siRNA was diluted in the 
jetPRIME buffer to a concentration of 55 nM and briefly vortexed. Then, 4 µl jetPRIME 
reagent was added per 200 µl jetPRIME buffer used, briefly vortexed and centrifuged 
and incubated at room temperature for 10 minutes. 200 µl of the transfection solution 
was added per 2 ml of 10% DCC-FBS supplemented DMEM/F12 (used per well of a 
6 well plate). This medium was then added dropwise to the ~80% confluent EnSC 
culture. Media was refreshed after 24 hours with 10% DCC-FBS supplemented 
DMEM/F12. All targeted siRNA used were Dharmacon SMARTpool siRNA, and the 
Dharmacon Non-Targeting siRNA Pool 1 was used as a non-targeting (NT) control.   
 
RNA extraction 
RNA extraction of EnSC and ERB cultures 
For all RNA extraction procedures, RNase-free plastic-ware and nuclease free water 
were utilised, and surfaces and pipettes were cleaned with RNase ZAP, in order to 
minimize RNA degradation. Per well of a 6-well plate, 400 μl of STAT-60 reagent was 
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added to ensure full coverage and incubated for 5 minutes at room temperature. A 
cell scraper was used to disrupt any remaining attached cells. The solution was 
transferred to RNase-free 1.5 ml Eppendorf microcentrifuge tubes on wet ice or snap 
frozen and stored at -80oC. For RNA extraction, 20% volume of ice-cold chloroform 
was added to the STAT-60 solution and briefly vortexed. The STAT-60/chloroform 
mixtures were centrifuged at 12000 g at 4°C for 30 minutes to separate out the 
aqueous and organic phases. The aqueous phase, containing the RNA, was 
transferred to an Eppendorf microcentrifuge tube containing 0.5× volume ice-cold 
100% isopropanol and incubated for 10 minutes at room temperature. The RNA was 
pelleted by configuration at 12000 g at 4°C for 15 minutes. The RNA pellet was then 
washed twice with 1 ml ice cold 75% ethanol and centrifuged at 12000 g at 4°C for 5 
minutes between wash steps. The RNA pellet was then allowed to air dry and then 
resuspended in nuclease free water. RNA concentration and purity were determined 
by Nano-Drop. RNA samples with values of ≥ 1.80 on the 260/280 absorbance scale 
were used for downstream analyses. All RNA samples were stored at -80°C.    
 
RNA extraction of complex organoid cultures 
For all RNA extraction procedures, RNase-free plastic-ware and nuclease free water 
were utilised, and surfaces and pipettes were cleaned with RNase ZAP, in order to 
minimize RNA degradation. Gland organoid cultures were recovered scraping the 
samples into RNase-free 1.5 ml Eppendorf microcentrifuge tubes. Samples were 
centrifuged at 600 g for 6 minutes. The cellular pellet was resuspended in 500 µl 500 
µg/ml collagenase I and incubated at 37oC for 10 minutes (See Chapter 5 for method 
optimisation). Samples were centrifuged at 600 g for 6 minutes and resuspended in 
PBS for washes (repeated 2 times) and then cellular pellets were either snap frozen 
or placed into lysis buffer for RNA extraction. RNA extraction was performed using 
the RNeasy Micro Kit (Qiagen) exactly following manufacturer’s instructions. RNA 
concentration and purity were determined by Nano-Drop. RNA samples with values 
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of ≥ 1.80 on the 260/280 absorbance scale (were used for downstream analyses. All 
RNA samples were stored at -80°C.    
 
cDNA synthesis 
cDNA was reverse transcribed from the collected mRNA using a QuantiTect Reverse 
Transcription Kit following manufacture’s instruction. In brief, all reagents were first 
thawed on wet ice and briefly vortexed and centrifuged. Then, for to up to 1 μg of 
sample RNA, 2 μl of 7× gDNA Wipeout buffer was added to each sample. However, 
for most simple and complex organoid samples 1 μg was not possible, and therefore 
instead the lowest concentration of RNA across the samples was used for all 
samples.  This solution was then made to a total volume of 14 μl with RNase-free 
water and incubated at 42°C for 2 minutes to remove any genomic DNA. After, the 
samples were quickly placed and kept wet ice. Per sample, 1μl of Quantiscript 
Reverse Transcriptase (RT), 4 μl 5x Quantiscript RT Buffer and 1 μl RT Primer Mix 
were added while kept on ice. For RT negative controls, the Quantiscript RT was 
replaced with nuclease free water. Samples were incubated at 42°C for 30 minutes 
and then the RT was inactivated by sample incubation at 95˚C for 3 minutes. 
 
Real time quantitative polymerase chain reaction  
Real time quantitative polymerase chain reaction (RT-qPCR) was used to determine 
relative mRNA abundance of genes of interest, as a method of measuring relative 
gene expression. Genes of interest were amplified using PrecisionPlus detection 
reagent, premixed with SYBR Green. The qPCR master mix contained 10 μl 
PrecisionPlus 2× master mix, 0.3 μl of forward and reverse primer (20 μM) and 8.4 μl 
nuclease free water to total 19 μl, per reaction.  For a reaction, 1 μl of cDNA was 
added to 19 μl of RT-qPCR master mix per well in triplicate for a total of 20 μl per 96-
well. Non-template controls replaced cDNA with nuclease free water. The plate was 
sealed, briefly centrifuged and placed into the RT-qPCR machine (ABI PRISM 7500 
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Sequence Detection System). The thermocycling conditions were: 50oC for 2 
minutes, 95°C for 10 minutes, 95°C for 15 seconds and 60°C for 1 minute for 40 
cycles.  
 
The SYBR green of the PrecisionPlus detection reagent binds to double stranded 
DNA and produces a fluorescent signal. This signal is measured at each cycle, 
allowing the DNA to be quantified and assigned a Ct (cycle threshold) value. The Ct 
value represents the cycle in which the fluorescent signal reaches above background 
noise. Ct values were normalised to housekeeping gene L19 and the Pffafl method 
was employed to account for variable primer efficiencies (see Primer table in 
Materials section). The normalised data was then directly compared to control 
samples to provide relative fold change of expression between the treatment and 
control samples.   
 
Data mining 
The dataset ‘Endometrium through the menstrual cycle: GDS2052’ from the GEO 
repository was data-mined for gene expression data in Chapter 3. ScRNA-seq data 
from Lucas et al. (2018) was data-mined for gene expression data through an in vitro 
primary EnSC 8-day decidual time course. In addition, genes of interest related to 
fibroblast activation in Chapter 3 were plotted onto the previously constructed co-
regulated gene networks produced by Lucas et al. (2018). 
 
Statistical analysis 
Data were analysed using GraphPad Prism. All data were given as mean ± standard 
deviation (SD).  For paired, non-parametric significance testing between two groups, 
the Wilcoxon matched-pairs signed rank test was used. For paired, non-parametric 
significance testing between multiple groups, the Friedman test and Dunn’s multiple 
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comparisons post hoc test were performed. Only values of P < 0.05 were considered 
statistically significant.  
 
Single cell RNA sequencing 
Sample preparation 
A single human endometrial biopsy was cultured as both simple and complex 
organoid cultures at passage 2. For both the simple and complex organoids, 10 
technical replicates per time point were grown to ensure enough mRNA material for 
scRNA-seq. The samples were grown for 4 days in co-ExM and then harvested on 
day D0, D2 and D4 of decidualisation with minimal differentiation medium (DMmin.). 
Harvest was by collagenase I treatment, described as previous, and 5× TrypLE Select 
treatment (See Chapter 5 for method optimisation) to ensure a single cell suspension 
for droplet generation and single cell RNA sequencing (scRNA-seq).  
 
Droplet generation and scRNA-seq. 
The harvested single cell suspensions were loaded into a cartridge and placed into 
the microfluidic system (Nadia Instrument). The transcriptomes of single cells in 
simple and complex organoid cultures were captured in aqueous droplets containing 
barcoded beads according to the manufacturer’s instructions and the Drop-Seq 
method described by Macosko, et al. (2015).  
 
cDNA synthesis 
Following droplet formation, the droplets were broken, and the beads were isolated.  
Reverse transcription of the bound mRNA was performed exactly as described by 
Macosko and Goldman (Drop-Seq Laboratory Protocol version 3.1). AMPure XP 
beads were used for PCR clean-up as described by Illumina RNA-seq protocols. The 
reverse transcribed cDNA was eluted in 12 µl. cDNA quality was measured by a 
Bioanalyzer High Sensitivity DNA chip. 
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Library preparation and Sequencing 
XT DNA sample and indexing kits were used to produce tagmented libraries from the 
cDNA, as previously explained in Lucas. et al, 2018. AMPure XP beads were used 
for DNA clean up, as described elsewhere. A Bioanalyzer High Sensitivity DNA chip 
was used to assess quality and determine library size. Sample concentration was 
measured by Qubit High Sensitivity DNA assay. The library was sequenced using a 
NextSeq High Output 75 cycle V2 kit. 
 
Data analysis and quality control 
Data processing was performed initially as described by Nemesh, as previously 
explained in Lucas. et al, 2018.  In brief, differential gene expression analysis was 
performed using the Seurat v2 68 package. Quality control (QC) was performed by 
only including genes that appear in at least three cells, and cells that express ≥ 200 
genes.  Only cells with ≤ 6000 genes and < 10% mitochondrial genes were included, 
to minimize inclusion of data from doublets and low-quality (broken or damaged) cells, 
respectively. In addition, cell-cycle regression was applied to the dataset. Principal 
component (PC) analysis was performed and the first 10 PC were utilised for 
clustering by shared nearest neighbour (SNN) and Uniform Manifold Approximation 
and Projection (UMAP) algorithms. This produced a visual representation of the cell 
aggregation, colour coded by statistically significant clusters. Marker genes for each 
cell state cluster in the UMAP representation were identified using the Seurat function 
'FindAllMarkers'.  
 
Gene ontology (GO) analysis using the Gene Ontology Consortium database 
(Ashburner et al., 2000, The Gene Ontology Consortium, 2018, Mi et al., 2013) was 
performed on significantly differential genes (P < 0.05 with Bonferroni-correction), 
where genes were clustered by annotated biological process categories. The GO 
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terms generated were further summarised using REVIGO, a web server that groups 
redundant GO terms by semantic similarity (Supek et al., 2011) 
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3.1 Introduction 
The human endometrium undergoes defined cycles of proliferation and differentiation 
in order to prepare for the embryo implantation (Gellersen and Brosens, 2014). In the 
absence of an implanting embryo, the upper layer of the human endometrium is 
sloughed off at menstruation in preparation for another cycle. Tissue repair, rapid 
growth and angiogenesis encompass the proliferative phase of the next cycle, under 
the influence of estradiol (Gellersen and Brosens, 2014). This rapid regeneration is 
principally due to a population of bone marrow-derived mesenchymal stem cells 
(MSC) that reside in the perivasculature of the basal layer of the endometrium 
(Schwab and Gargett, 2007, Chan and Gargett, 2006, Gargett et al., 2015).  
 
As the MSC drive the rapid proliferation of the endometrial stroma, the main structural 
support of the endometrium, it was reasonable to utilize these cells as a starting point 
for developing a 3D model of the endometrium in vitro. Isolation of endometrial MSC 
and other sub-populations of the endometrial stroma have been described in the 
literature (Chan et al., 2004, Schwab et al., 2005). Perivascular endometrial stromal 
cells (PVC) express a specific surface antigen, called Sushi domain-containing 2 
(SUSD2), which can be used to isolate them from a mixed population of cells by 
Magnetic-Activated Cell Sorting (MACS) (Masuda et al., 2012, Sivasubramaniyan et 
al., 2013) (Fig. 3.1). In this study, mixed populations of endometrial stromal cells 
(EnSC) are incubated with the antibody for SUSD2, originally named the W5C5 
antibody (Masuda et al., 2012, Murakami et al., 2013), conjugated to a magnetic 
bead. The suspension is passed through a magnetic column, which retains SUSD2+ 
cells only. However, the MSC represent only a fraction (approximately 4%) of the total 
PVC, which in turn is approximately 4% of total EnSC (Masuda et al., 2012). MSC are 
highly clonal as demonstrated by a colony forming unit (CFU) assay (Masuda et al., 
2012). The SUSD2- EnSC fraction also contains clonal cells (Masuda et al., 2012),  
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Figure 3.1: Schematic of the protocol for culturing endometrial stromal cell 
subtypes.  Endometrial biopsies are enzymatically and mechanically dissociated. 
EnSC are separated from the mixture by a 40 μm cell sieve. MACS is performed using 
SUSD2+ antibody (W5C5).  SUSD2+ and SUSD2- cell fractions are cultured as 
standard culture (Std) or by CFU. Right Panel: Immunohistochemistry image of 
SUSD2+ immunolabelling of PVC around endometrial blood vessels. (Human Protein 
Atlas, SUSD2 Antibody HPA004117, Human Endometrium 1, Patient id: 2941,  
https://www.proteinatlas.org/ENSG00000099994-SUSD2/tissue/endometrium, 
Uhlén et al., 2015) 
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which are referred to here as transit amplifying cells (TAC). TAC are the 
undifferentiated but committed daughter cells of stem cells, which are found outside 
the stem cell niche. They are highly proliferative and exhibit clonal properties, like 
MSC (Gargett, 2006).  
 
While investigating the angiogenic potential of the MSC, a former PhD student of 
Professor Brosens observed that MSC rapidly reorganise into singular tissue-like 
structures overnight when seeded onto Matrigel and cultured in an angiogenic 
medium (Medium 200) (Peter Durairaj, 2017). These tissue structures were 
designated Endometrial Regenerative Bodies (ERB), due to the presumed 
regenerative capacity of MSC (Peter Durairaj, 2017). ERB formation was purportedly 
a MSC-specific phenomenon; fresh unseparated EnSC failed to reorganise into the 
same tissue-like mass, further emphasizing the regenerative potential of endometrial 
MSC. ERB responded to ovarian hormone stimulation and expressed decidual 
marker genes upon differentiation by cAMP and MPA (Peter Durairaj, 2017). 
Therefore, the ERB provided a starting point to develop a 3D in vitro model of the 
endometrium.  
 
In this chapter, I aimed to develop the ERB into a novel 3D in vitro model of the 
endometrium. This was to be achieved by completing the following objectives:  
1. To establish a protocol for co-culturing the MSC-derived ERB with epithelial cells.  
2. To study ERB growth and differentiation.  
3. To elucidate the mechanisms underpinning the rapid cellular reorganisation.  
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3.2 Results 
Endometrial Regenerative Bodies 
Previous observations indicate that ERB are formed when MSC are seeded on top of 
Matrigel (Fig. 3.2A). Overnight, MSC form a singular 3D triangular mass (Peter 
Durairaj, 2017) (Fig. 3.2B). First, to investigate the MSC specificity, ERB formation 
was assessed in MSC and TAC and freshly isolated EnSC. Freshly isolated EnSC 
failed to form ERB, therefore confining ERB formation to progenitor cells. ERB 
formation was reported in MSC cultures (64% formation efficiency), and to a lesser 
extent in TAC cultures (12% formation efficiency). However, freshly isolated EnSC 
failed to form ERB (0% formation efficiency) (Fig. 3.2C) (Peter Durairaj, 2017). This 
indicated ERB formation was a specific phenomenon of the endometrial progenitor 
cells. It was therefore hypothesised that this process was regenerative in nature, and 
that these could form the basic cellular scaffold for developing a 3D in vitro model of 
the endometrium for human embryo implantation studies. 
 
To further characterise the ERB, we previously investigated their ability to differentiate 
upon treatment of 8-bromo-cAMP (cAMP) and medroxyprogesterone acetate (MPA), 
a progestin. The MSC of three independent patient biopsies were isolated by MACS 
followed by CFU assay. The MSC from each biopsy were then subjected to ERB 
formation followed by differentiation with cAMP and MPA for 8 days in triplicate.  By 
RT-qPCR, we demonstrated the induction of PRL, encoding decidual prolactin, by 
ERB treated with cAMP and MPA, establishing their ability to differentiate in response 
to deciduogenic cues (Fig. 3.2D).  
 
Additionally, ERB (Day 1 ERB) from three independent patient biopsies were co-
cultured with patient-matched endometrial epithelial cells (EEC) overnight and then 
fixed in formalin and paraffin embedded for sectioning. The sectioned ERB where  
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Figure 3.2: Initial characterisation of the ERB.  
A: Schematic of ERB formation methodology: 1. Human endometrial biopsies are 
processed mechanically and enzymatically. 2. EnSC are separated from the epithelial 
glands. 3. MACS separation by SUSD2 antibody W5C5. 4. CFU assay of SUSD2+ 
cells. 5. ERB formation protocol performed by seeding 5×104 MSC onto Matrigel. 6. 
A representative schematic of a formed ERB.  
B: Brightfield image of an ERB 24 hours after seeding MSC onto Matrigel, 
representative of three biological replicates in triplicate. Scale bar = 500 μm.  
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C. The data show the percentage ERB formation by MSC, TAC and unsorted fresh 
EnSC, 24 hours after seeding onto Matrigel. Five biological replicates were tested in 
triplicate. Different letters above the error bars represent statistical difference from 
other groups at P < 0.05. Group comparison by Friedman test and Dunn’s Multiple 
Comparison post hoc test. 
D. The data show individual PRL transcript levels measured in ERB after being 
decidualised for 8 days with MPA and cAMP (D8) compared to control (D0). PRL 
expression was normalised to housekeeping gene L19 mRNA levels. P ˃ 0.05 
(Wilcoxon matched pairs signed rank test). 
E. Immunofluorescence image of a sectioned epithelialised ERB, representative of 
three biological replicates. ERB were formalin fixed and paraffin embedded and 
sectioned. Channels were visualised by epifluorescent microscopy (EVOS FL Auto 
Imaging System) using a secondary antibody conjugated to Alexa 488 and 594, 
depicted in green and red, respectively. Nuclei were counterstained with DAPI, 
depicted in blue. Cytokeratin (green) labelled the epithelial cells and vimentin (red) 
labelled the EnSC. (Scale bar: 100 μm). 
The ERB model was developed by Dr Ruban Peter Durairaj (Peter Durairaj, 2017) 
and the initial preliminary data was collected in collaboration with Dr Ruban Rex Peter 
Durairaj during my MRC DTP in IBR MSc MD980 Laboratory Project 2 dissertation. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 83 
 
immunolabelled with vimentin (red) and cytokeratin (green) to visualise the MSC and 
EEC of the co-culture, respectively, by immunohistochemistry (IHC).  The IHC 
revealed epithelialisation of the ERB along the external surface (Fig. 3.2E). These 
initial data further evidenced that ERB could potentially serve as a 3D model of the 
endometrium exemplified by the ability of these cells to differentiate and be re-
epithelialised in co-culture with primary EEC. 
 
Epithelialisation of ERB 
The initial co-culture protocol produced an externally epithelialised ERB. However, 
epithelialisation of the internal surface of the ERB would better recapitulate the in vivo 
endometrium. In addition, a previous study demonstrated that EEC form a monolayer 
epithelium when seeded on top of cultured EnSC grown in 3D culture (Bentin-Ley et 
al., 1994).  The initial ERB co-culture protocol seeded EEC on a formed ERB, 24 
hours after seeding MSC on Matrigel. The external layer of epithelial cells suggested 
the EEC were unable to penetrate the ERB. Therefore, EEC were mixed with MSC 
and then seeded together on Matrigel on Day 0 (pre-formation) (Fig. 3.3A). Cells were 
stained with live cell tracker stains (MSC: red, EEC: green) and ERB were visualised 
by epifluorescence microscopy 24 hours after seeding. All ERB formed, however, the 
EEC were in the centre of the ERB, with the MSC surrounding the outside (Fig. 3.3B). 
However, a monolayer of EEC on the inward facing surface of the ERB was not 
observed suggesting co-culturing for 24 hours may not have been sufficient for ERB 
re-epithelialisation.  
 
Next, using three independent patient biopsies, I performed a time-course to 
investigate whether the EEC would reorganise themselves into a monolayer 
epithelium along the inner surfaces of the ERB. However, unexpectantly, over the 
course of 10 days, the ERB continued to contract down into a small, tight mass of  
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Figure 3.3: Re-epithelialisation of the ERB.  
A: Table of ERB re-epithelialisation methods. Day 0 represents day of seeding onto 
Matrigel, and so on. Schematics of hypothesised ERB organisation are included. 
MSC were stained with Red CellTracker CMTPX and EEC were stained with 
CellTracker Green CMFDA. Scale bar = 100 μm. 
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B: Epifluorescence images of the ‘internal method.’ Representative images of three 
biological replicates in triplicate are shown. MSC were stained with Red CellTracker 
CMTPX and EEC were stained with CellTracker Green CMFDA. Scale bar = 500 μm.  
C. Epifluorescence images of ERB formation using the ‘Internal method’ over 10 days. 
Representative images of three biological replicates performed in triplicate are 
shown. MSC were stained with Red CellTracker CMTPX and EEC were stained with 
CellTracker Green CMFDA. Scale bar = 500 μm. 
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cells, compressing EEC into the centre of the structure (Fig. 3.3C). This evidenced 
that the ERB are short-lived structures and unable to support long-term growth.  
 
Method development 
Following initial characterisation, ERB formation efficiency was still sub-optimal and 
it was unclear if this lack of reproducibility was due to technical issues or the patient-
specific characteristics, as assumed previously (Peter Durairaj, 2017). To test this, I 
developed an alternative protocol in which the Matrigel was plated and pre-incubated 
without cells before seeding (Fig. 3.4A). The hypothesis was that standardising the 
Matrigel curing time would reduce experimental inconsistencies. ERB formation 
following this new protocol was 100% efficient in five independent MSC cultures (Fig. 
3.4B and 3.4C). In comparison, the previous method formed ERB with 46% efficiency. 
Thus, this novel protocol was utilised for all subsequent experiments.  
 
ERB form from all cultured stromal cell subtypes. 
As the new method had improved ERB formation to a 100% efficiency, it was 
essential to confirm the previous observation that ERB formation is specific to MSC. 
Instead of freshly isolated EnSC, cultured EnSC and PVC were subjected to ERB 
formation to compare directly to the cultured CFU-derived MSC and TAC. ERB 
formation was imaged under time-lapse microscopy for 36 hours following the new 
protocol and the area of the cell mass was measured every 4 hours to ensure the full 
formation was captured (Fig. 3.5A). The images were then analysed by ImageJ in 
order to measure the area of the ERB at each time point to map the contraction 
kinetics of each stromal cell subtype (Fig. 3.5B). Surprisingly, all subpopulations, 
including the non-CFU-derived fractions (EnSC and PVC), formed ERB in what 
appeared to be by a cellular contraction phenomenon. However, at 16 hours, the MSC 
had contracted further than the PVC (Area ± standard deviation (SD) = 0.12 ± 0.02 
cm2 versus 0.52 ± 0.14 cm2, respectively). Similarly, the clonal TAC had also  
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Figure 3.4: ERB method optimisation.  
A: A schematic comparing the original and proposed methods for ERB formation.  
B: The data show percentage ERB formation in MSC, TAC and unsorted fresh EnSC 
24 hours after seeding onto Matrigel. The colours represent the three individual 
cultures. The line represents the mean. ERB formation was performed on three 
independent primary cultures in triplicate. P ˃ 0.05 (Wilcoxon matched pairs signed 
rank test). 
C. Brightfield images of ERB formation using the two methods, representative of five 
biological replicates in triplicate. Scale bar = 500 μm. 
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Figure 3.5: Time-lapse imaging of ERB formation in endometrial stromal 
subtypes.  
A: Representative brightfield images of ERB formation using different stromal 
subtypes (MSC, TAC, EnSC, and PVC) over a period of 38 hours. ERB formation was 
performed on three matched independent primary cultures in triplicate for each 
stromal subtype. 
B: Data show the contraction kinetics of ERB formation using the different stromal 
subpopulations over 38 hours. The data show area ± standard deviation of the cellular 
mass measured every 4 hours. The ERB formation was performed on three matched 
independent primary cultures in triplicate for each stromal subtype. 
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contracted further than the EnSC (Area ± SD = 0.14 ± 0.01 cm2 versus 0.65 ± 0.05 
cm2, respectively). However, by 24 hours, both PVC and EnSC reached a similar area 
to their clonal counterparts and ceased to contract further (Area ± SD = 0.23 ± 0.01 
cm2 and 0.26 ± 0.01 cm2, respectively). Hence, ERB formation was deemed not a 
stem cell-specific, regenerative process. Therefore, due to their greater availability, 
EnSC were used instead of MSC for all further experiments. 
 
Fibroblast activation  
From the time-lapse microscopy data, it was clear that these cellular aggregates were 
contracting, instead of reorganising, and that this was a characteristic of all in vitro 
propagated endometrial stromal subtypes when cultured on Matrigel.  I hypothesised 
that this contraction was due to fibroblast activation. Fibroblasts are known to attain 
a myo-fibroblastic contractile phenotype when activated (Tampe and Zeisberg, 2013, 
Zeisberg and Zeisberg, 2013, Kalluri, 2016). Transforming growth factor beta 1 
(TGFβ1), a growth factor and cytokine, is a major regulator of fibroblast activation 
(Rønnov-Jessen, 1993, Kalluri, 2016). TGFβ1 is also involved in the upregulation of 
extracellular collagen production during fibroblast activation-associated ECM 
remodelling (Kalluri, 2016). Therefore, three independent cultures were subjected to 
either recombinant TGFβ1 or with A83-01, a potent inhibitor of activin-like kinase 5 
(ALK5), ALK4 and ALK7 from the TGFβ1 receptor superfamily (Tojo et al., 2005a). 
EnSC from three independent cultures were plated onto Matrigel and subjected to 
either 200 nM recombinant TGFβ1 treatment or vehicle control (DMSO). At 24 hours, 
the cultures treated with recombinant TGFβ1 were more contracted than matched 
vehicle control cultures (Area ± SD = 0.22 ± 0.04 cm2 versus 0.29 ± 0.02 cm2, 
respectively (Fig. 3.6A).  This suggests that the added recombinant TGFβ1 was able 
to accelerate EnSC contraction. In addition,  when three independent cultures were 
treated with either 1 or 10 μM A83-01 when seeded onto Matrigel, a significant dose 
response was observed.  Treatment with 10 μM A83-01 maintained a significantly  
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Figure 3.6: Characterisation of fibroblast activation in ERB.  
A: Area of ERB formation from EnSC treated with 200 nM TGF-β1 or vehicle control 
(DMSO). The data show the area of ERB formed from three biological replicates 
performed in triplicate 24 hours after seeding on Matrigel. The colours represent the 
three individual cultures. The line represents the mean. P ˃ 0.05 (Wilcoxon matched 
pairs signed rank test). 
B: Data show the area of ERB from EnSC of three biological replicates in triplicate 24 
hours after seeding on Matrigel treated with 1 or 10 µM A83-01 or vehicle control 
(DMSO). The colours represent the three individual cultures. The line represents the 
mean. Normalised to Western blot probed for β-actin to ensure equal loading. 
Different letters above the error bars represent statistical difference from other groups 
at P < 0.05. Group comparison by Friedman test and Dunn’s Multiple Comparison 
post hoc test. 
C: The densitometry from western blots probed for αSMA from three biological 
replicates of standard EnSC culture (Control) and ERB (36 hours after seeding on 
Matrigel). The colours represent the three individual cultures. The line represents the 
mean. P ˃ 0.05 (Wilcoxon matched pairs signed rank test). 
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D: A representative image of an ERB stained with NucBlue Live/ NucGreen dead 
stain following formation at Day 1 (24 hours from seeding), and 48 hours (Day 2) and 
96 hours (Day 4) later. Scale bar = 200 μm.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 92 
 
larger area when compared to the vehicle control (DMSO) at 24 hours (Area ± SD = 
0.31 ± 0.02 cm2 and 0.15 ± 0.001 cm2 versus 2.15 ± 0.14 cm2, respectively, P < 0.05, 
Friedman test and Dunn’s Multiple Comparison post hoc test) (Fig. 3.6B). This 
suggests that A83-01 treatment inhibited EnSC contraction. Taken together, these 
data indicated that TGFβ1 signalling is implicated in the contraction of the ERB. 
 
I also measured, alpha smooth muscle actin (αSMA), a key cytoskeletal hallmark of 
fibroblast activation (Micallef et al., 2012, Rønnov-Jessen, 1993, Kalluri, 2016). 
Analysis of three independent primary cultures showed that αSMA was upregulated 
at protein level following ERB formation, indicating cytoskeletal remodelling (Fig. 
3.6C). Activated fibroblasts are also known to apoptose after contraction as part of 
the normal wound healing process (Kalluri, 2016, Tomasek et al., 2002). Following 
ERB formation, EnSC were stained for live (NucBlue dye; blue nuclei) and dead cells 
(NucGreen dye; green nuclei). Following 4 days of progression, many of the cells 
were stained green, indicating they were dead (Fig. 3.6D). Overall, these data 
provided evidence that EnSC undergo endometrial fibroblast activation (EFA) when 
subjected to ERB formation. Therefore, ERB formation was renamed as the 
endometrial fibroblast activation model (EFAM).  
 
Decidualisation silences fibroblast activation 
Next, the effect of decidualisation on EFA was investigated. Three independent 
cultures of EnSC were pre-treated with MPA and cAMP for four days to induce 
decidualisation prior to performing the EFAM protocol. Previous studies have 
reported that cAMP alone can induce contraction in fibroblasts (Ehrlich et al., 1986, 
Kamio et al., 2007, Schiller et al., 2010). Therefore, cultures were pre-treated with 
MPA and cAMP, either alone or in combination. Cultures were imaged under time-
lapse microscopy for 36 hours and the area of the cell mass was measured every 4 
hours (Fig. 3.7A). The area of cell mass was measured using ImageJ every 4 hours  
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Figure 3.7: ERB formation from pre-decidualised EnSC.  
A: Representative brightfield images of EFAM contraction over 38 hours of three 
independent cultures pre-treated with either MPA or cAMP or both as well as vehicle 
control (DMSO) for 4 days. Scale bar = 500 μm.  
B: The data show the contraction kinetics of the three independent EnSC cultures 
subjected to the EFAM over 38 hours when pre-treated with either MPA or cAMP or 
both as well as vehicle control (DMSO) for 4 days. Area was measured every 4 hours. 
Error bars represent standard deviation. 
C: Stromal decidual gene PRL transcript levels were measured for each pre-treatment 
group to test for decidual response in three independent cultures performed in 
triplicate. The colours represent the three individual cultures. The line represents the 
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mean. Expression was normalised to L19 mRNA levels. Different letters above the 
error bars represent statistical difference from other groups at P < 0.05. Group 
comparison by Friedman test and Dunn’s Multiple Comparison post hoc test. 
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to map the contraction kinetics under each treatment (Fig 3.7B). At 24 hours, EFA, 
as measured by the area of contraction, was attenuated in response to cAMP 
signalling when compared to MPA treatment or vehicle control (DMSO) (Area ± 
standard deviation = 0.79 ± 0.1 cm2 versus 0.48 ± 0.08 cm2 and 0.36 ± 0.02 cm2, 
respectively).  However, EFA was abolished by the combination of cAMP and MPA 
(Area ± standard deviation = 3.5 ± 0.01 cm2). Therefore, these observations indicated 
that the inhibition of EFA was mediated by a synergistic effect between MPA and 
cAMP. As shown in Figure 3.7C, cAMP and MPA also had a synergistic effect on the 
induction of EnSC decidual marker gene PRL, as reported previously (Brosens et al., 
1999). Taken together, this suggested that decidualisation of EnSC inhibits EFA. 
 
Reprogramming of the ROCK pathway upon decidualisation 
The rho-associated, coiled-coil-containing protein kinase (ROCK) pathway is involved 
in cellular contraction (Amano et al., 2010). Myosin II, a key component of the 
cytoskeleton for cellular contraction, is switched to an active state upon 
phosphorylation of regulatory myosin light chain (MLC) by myosin light chain kinase 
(MYLK) (Fig. 3.8A) (Amano et al., 2010, Totsukawa et al., 2000, Kamm and Stull, 
1985). Active myosin II cross-bridges with actin, thereby initiating cellular contraction. 
(Choi et al., 2008, Amano et al., 2010). Myosin II is deactivated by dephosphorylation 
of the MLC by myosin light chain phosphatase (MLC-P). ROCK1 can inhibit MLC-P 
by phosphorylating myosin phosphatase target subunit 1 (MYPT1). Therefore, 
ROCK1 potentiates contraction by inhibiting MLC-P. (Narayanan et al., 2016). 
ROCK2 is an isoform that is believed to have a similar role to ROCK1 (Yoneda et al., 
2005), a claim disputed more recently (Amano et al., 2010, Jerrell and Parekh, 2016).  
 
A high-throughput single-cell RNA-sequencing (scRNA-seq) reconstruction of the 
decidual pathway in cultured  primary EnSC indicates a switch in expression of key  
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Figure 3.8: Temporal expression of the ROCK pathway genes through 
decidualisation. A: A schematic of the opposing control myosin light chain 
phosphorylation, regulating cellular contraction.   
B: A heat map showing the relative expression (z-score) of key genes involved in the 
ROCK pathway over a decidual time course of EnSC (D0-D8) of treatment with cAMP 
and MPA from published scRNA-seq data (Lucas et al., 2018).  
C. K-means cluster analysis of 1,748 differentially expressed genes across an in vitro 
EnSC decidual time course (Lucas et al., 2018). Data show normalised expression 
for decidualising EnSC progress through intermittent transcriptional states between 
D0 and D4, after which they emerge as either decidual cells (DC) or senescent 
decidual cells (scDC) (Lucas et al., 2018, Lucas et al., 2019). The analysis revealed 
that genes related to the ROCK pathway were in four co-regulated decidual gene 
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networks. Networks are annotated for key genes involved in ROCK pathway. These 
data were collected and presented in collaboration with Dr Pavle Vrljicak.  
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genes in the ROCK pathway (Lucas et al., 2018). MYLK, ROCK1 and ACTA2 (αSMA) 
are significantly reduced in expression upon decidualisation (Fig. 3.8B). CALM1 and 
PPP1R12A (MYPT1) do not change significantly in expression. ROCK2 mRNA 
expression increases upon decidualisation, suggesting a possible switch in ROCK 
isoforms upon differentiation. Although Ras homolog family member A (RHOA) is 
largely unaffected by decidualisation at the RNA level, transcript levels for both Rho 
guanine nucleotide exchange factors (GEF) ARHGEF2 (GEF-H1) and ARHGEF12 
(LARG), which activate RhoA-GDP to RhoA-GTP, upstream of ROCK1, were 
downregulated upon decidualisation (Guilluy et al., 2011). 
 
In addition, from the scRNA-seq decidual pathway reconstruction, k-means cluster 
analysis, where k is the number of clusters, revealed that the decidual pathway in 
vitro is underpinned by seven networks of uniquely co-regulated genes (Lucas et al., 
2018, Lucas et al., 2019) (Fig. 3.8C). Cross referencing showed that several genes 
associated with the ROCK pathway belong to four of the networks. MYLK and ROCK1 
are in the first gene network (termed A1), which include genes that are rapidly 
‘switched off’ upon decidualisation, perhaps suggesting progesterone-dependent 
repression. ACTA2 and PPP1R12A are in a separate gene network (termed A2), 
which include genes from the decidual time course that decrease in expression at a 
slower rate. CALM1 and RHOA are in gene network B1, which peak during the initial 
phase of the decidual pathway. Collectively, these data demonstrate that the ROCK 
pathway is largely switched off upon endometrial stromal cell differentiation into 
decidual cells. However, ROCK2 is in gene network C1, which include genes that are 
most highly expressed in decidual cells.  
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The reprogramming of ROCK pathway underlies the loss of fibroblast activation in 
decidual cells 
Next, I tested the hypothesis that the silencing of signal intermediates in the ROCK 
pathway caused the loss of contraction in decidualised EnSC. The activity of the 
ROCK pathway was measured by assessing the phosphorylation status of MYPT1 in 
undifferentiated cells and cells decidualised for 4 days from three independent 
cultures. Total protein lysates were subjected to Western blot analysis using both total 
and phospho-specific MYPT1 antibodies. In addition, β-actin was probed to ensure 
equal loading. As shown in Figure 3.9A, decidualisation abolished the 
phosphorylation of MYPT1. 
 
Furthermore, to confirm whether MYLK was involved in the EnSC contraction, three 
independent primary cultures were transfected with either MYLK small interfering 
RNA (siRNA) or a non-targeting (NT) control siRNA for 24 hours. Transfected cells 
were then subjected to the EFAM. At 24 hours post-seeding onto Matrigel, the MYLK 
knock down group failed to contract as a single contractile mass when compared to 
cells transfected with NT control siRNA (Area ± SD = 1.5 ± 0.03 cm2 versus 0.31 ± 
0.09 cm2, respectively) (Fig. 3.9B) implicating its involvement in ERB associated 
contraction.  
 
In order to determine if ROCK1 was involved the contraction, three independent 
cultures of EnSC were subjected to Y-27632, a ROCK inhibitor (Narumiya et al., 2000, 
Ishizaki et al., 2000). At 24 hours, treatment of cultures with 1 µM Y-27632 attenuated 
EFA, but treatment with 10 µM Y-27632 completely abrogated EFA when compared 
to vehicle control (DMSO) (Area ± SD = 0.73 ± 0.07 cm2 and 2.89 ± 0.22 cm2 versus 
0.67 ± 0.10 cm2, respectively) (Fig. 3.9C).  
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Figure 3.9: The ROCK pathway is essential for ERB formation.  
A: Representative Western blot probed for both total MYPT1 (MYPT1) and 
phosphorylated MYPT1 (p-MYPT1) antibodies to assess the phosphorylation status 
of MYPT1 in three independent EnSC cultures that were either undifferentiated (D0) 
or decidualised for 4 days with MPA and cAMP (D4). β-actin was probed to ensure 
equal loading. The data show the densitometry for D0 and D4. The colours represent 
the three individual cultures. The line represents the mean. P ˃ 0.05 (Wilcoxon 
matched pairs signed rank test). 
B: Three independent EnSC cultures were transfected with either non-targeting 
siRNA (NT) or siRNA targeting MYLK (MYLK siRNA) for 24 hours. EnSC were 
collected and subjected to the EFAM. Representative images of the EFAM from EnSC 
transfected with NT or MYLK siRNA. Data show the area of EFA (mean ± SD) over 
time for both NT and MYLK siRNA EFAM cultures measured every 4 hours. P ˃ 0.05 
(Wilcoxon matched pairs signed rank test). 
C: Three independent EnSC cultures were subjected to the EFAM in the presence of 
1 or 10 µM ROCK inhibitor Y-27632 or vehicle control (DMSO). Data show the 
average area of EFA (mean ± SD), measured every 4 hours and plotted. 
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The scRNA-seq data indicated that ROCK2 was upregulated upon decidualisation, in 
contrast to the downregulation of ROCK1 (Lucas et al., 2018). To investigate the role 
of ROCK2, three independent cultures were subjected to the EFA protocol in the 
presence of the ROCK2-specific inhibitor KD-025. By 24 hr, KD-025 has no effect on 
EFA in undifferentiated EnSC compared to control (Area ± SD = 3.02 ± 0.05 cm2 
versus 3.02 ± 0.05 cm2, respectively) (Fig. 3.10A). The decidual response of EnSC 
cultured in the presence of KD-025 were also measured. Three independent cultures 
of EnSC were subjected to cAMP and MPA for eight days, with or without KD-025. 
Secreted PRL was measured by enzyme-linked immunosorbent assay (ELISA). KD-
025 partially reduced secreted prolactin suggesting an impaired decidual response 
when ROCK2 is inhibited (Fig. 3.10B).  
 
Taken together, these data support the hypothesis that the ROCK pathway is 
essential for EFA, and the downregulation of this pathway upon decidualisation is 
likely the cause of the loss of contractibility in decidual cells. In addition, ROCK2 
appears to have a different role to ROCK1, as it was not implicated in EFA, but instead 
it is possibly involved in EnSC decidualisation.  
 
Focal adhesions are required for EFA.  
As stated previously, fibroblast activation is a wound healing response to damage or 
cellular mechanical stress (Kalluri, 2016). Therefore, fibroblast activation requires a 
mechano-sensing pathway in order to sense the mechanical stress.  Previous studies 
have shown that change in tension between the cell and the ECM can trigger 
fibroblast activation through cell-matrix adhesions (Petrie and Yamada, 2012). 
Adhesions are found in locations where molecular interactions between a cell and the 
surrounding ECM occur. They can assemble or disassemble in response to 
extracellular cues, such as mechanical stress. Adhesions are formed of a dynamic 
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Figure 3.10: ROCK2 is not essential in ERB formation.  
A: Three independent EnSC cultures were subjected to the EFAM in the presence of 
1 µM ROCK2 inhibitor KD025 or vehicle control (DMSO). The data show the 
contraction kinetics of EFA (mean ± SD) subjected to KD025 or control, measured 
every 4 hours. 
B: Data show PRL levels measured by ELISA in spent media of three independent 
EnSC cultures.  The colours represent the three individual cultures. The line 
represents the mean. EnSC cultures were either undifferentiated (D0) or treated with 
cAMP and MPA for 8 days with or without KD-025 (D8 + KD025 and D8, respectively). 
Different letters above the error bars represent statistical difference from other groups 
at P < 0.05. Group comparison by Friedman test and Dunn’s Multiple Comparison 
post hoc test. 
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multi-protein complex that include proteins such as focal adhesion kinase (FAK), 
Proto-oncogene tyrosine-protein kinase Src (Src), paxillin (PXN), proto-oncogene c-
Crk (Crk), Crk-associated substrate (CAS), Ras-related C3 botulinum toxin substrate 
1 (RAC1), p21-activated kinase (PAK) and (GPCR)-kinase interacting protein (GIT). 
(Vicente-Manzanares et al., 2005) (Fig. 3.11A). Other proteins such as actinin 1 
(ACTN1), vinculin (VCL), tensin 1 (TNS1), talin 1 (TLN1) are also involved. Adhesion 
protein complexes bind to integrins. Integrins are a family of cell surface adhesion 
receptors. They are formed of heterodimers of alpha and beta subunits that connect 
the ECM to the cellular actin cytoskeleton. (Marjoram et al., 2014, Hynes, 2002).  
 
Under mechanical stress, Rho GTPases, such as RhoA are activated by adhesions 
and aid in adhesion maturation (Vicente-Manzanares et al., 2005). RhoA is also 
upstream of the ROCK pathway, which leads to cellular cytoskeletal contraction, as 
seen in fibroblast activation. Mechanical stress-induced RhoA activation has been 
demonstrated to be enacted through the GEFs (Guilluy et al., 2011). GEFs activate 
Rho-GTPases, such as RhoA, by exchanging GDP with GTP.  Guilley et al. identified 
that force applied to β1 integrins on fibroblasts activates two GEFs, GEF-H1 and 
LARG, encoded by ARHGEF2 and ARHGEF12, respectively. LARG is activated 
downstream of a Src kinase and GEF-H1 is activated by the phosphorylation of ERK 
(Guilluy et al., 2011) (Fig. 3.11A). This therefore suggests that these proteins couple 
the perceived mechanical stress to EFA. 
 
In addition to this, FAK, encoded by PTK2 (protein tyrosine kinase 2), is a key protein 
in establishing cell-matrix adhesions. (Moore et al., 2010, Petrie and Yamada, 2012, 
Mitra et al., 2005). To confirm that cell-matrix adhesions are indeed essential for 
contraction, three independent cultures were subjected to the EFAM protocol in the 
presence of FAK inhibitor Y15 (Golubovskaya et al., 2008). By 24 hours, exposure of 
Y15 abolished EFA compared to vehicle control (DMSO) (Area ± SD = 3.02 ± 0.05 
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Figure 3.11: Focal adhesion kinase is essential for ERB formation.  
A: Schematic representation of the link between cell-matrix adhesions and 
contraction. Cell-matrix adhesion complex proteins are coloured blue. Integrins 
coloured grey. ROCK pathway proteins coloured in red. Pointed arrowheads 
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represent activation, blunt arrowheads represent inhibition. Acto-myosin chain is 
represented in yellow and purple.    
B: Three independent EnSC cultures were subjected to the EFAM in the presence of 
50 μM Y15 (FAK inhibitor) or vehicle control (DMSO). The data show the average 
area of EFA (mean ± SD) for the treatment and control groups, measured every 4 
hours. Right: Representative images of EFAM at 0 hours and 24 hours from cultures 
treated with Y15 and vehicle control (DMSO). Scale bar = 200 μm. 
C: A heat map showing the relative expression (z-score) of key genes involved in the 
cell-matrix adhesion complex over a 8 day decidual time course of EnSC from scRNA-
seq data (Lucas et al., 2018) 
D. K-means cluster analysis of 1,748 differentially expressed genes across an in vitro 
EnSC decidual time course (Lucas et al., 2018). Data show normalised expression 
for decidualising EnSC progress through intermittent transcriptional states between 
D0 and D4, after which they emerge as either decidual cells (DC) or senescent 
decidual cells (scDC) (Lucas et al., 2018, Lucas et al., 2019). This analysis revealed 
that several genes involved in cell-matrix adhesions were found in a single co-
regulated decidual gene. The network is annotated for key genes involved in cell-
matrix adhesion complex formation. These data were collected and presented in 
collaboration with Dr Pavle Vrljicak. 
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cm2 versus 0.33 ± 0.01 cm2, respectively) (Fig. 3.11B). This therefore confirmed that 
cell-matrix adhesions are essential for cellular contraction.  
 
As decidualised EnSC are resistant to EFA, I examined the expression of genes 
related to the adhesion complex. Data mining of the scRNA-seq data identified 
multiple genes implicated in cell-matrix adhesions that are downregulated upon 
decidualisation. (Fig. 3.11C) (Lucas et al., 2018, Lucas et al., 2019). Furthermore, k-
means cluster analysis revealed that many of these genes belong to a single network 
containing genes that are progressively downregulated in decidualising EnSC (Fig. 
3.11D) (Lucas et al., 2018). This therefore indicates that adhesions may be less likely 
to occur in decidual cells. Taken together, these data suggest that multiple 
mechanisms render decidualising EnSC resistant to fibroblast activation, including 
genes involved in sensing mechanical stress. 
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3.3 Discussion 
Initial characterisation 
The aim of this study was to reconstruct the endometrium in vitro using 3D cell culture 
techniques. Here, I used a model referred to as Endometrial Regenerative Bodies 
(ERB) (Peter Durairaj, 2017). ERB were assumed to be progenitor cell-derived tissue-
like structures that formed within 24 hours when seeded on Matrigel. In collaboration, 
I initially demonstrated that this model could respond to deciduogenic cues and be 
re-epithelialised. However, with further characterisation, it became apparent that early 
interpretations of the data were erroneous and further investigation was required.  
 
First, in order to serve as a 3D model of the endometrium, after initial formation, the 
ERB were required to maintain their structure and form an epithelium when in co-
culture with EEC. A previous study has shown that EEC form a monolayer when 
seeded on top of a layer of cultured EnSC grown in a hydrogel (Bentin-Ley et al., 
1994). When MSC and EEC were seeded together on Matrigel, the EEC appeared to 
preferentially move to the centre of the ERB, as shown by cell tracker stains. 
However, co-cultured ERB cultured for more than 24 hours showed signs of 
contraction, and after 10 days were contracted completely. Hence, this questioned 
the initial interpretation that EEC preferentially move to the centre of the mass, but 
instead it was more likely these cells were compressed by collective cell contraction. 
This was the first evidence that the ERB were formed by contraction, rather than 
cellular reorganisation. 
 
Furthermore, initially, it was assumed that ERB formation was a patient-specific 
phenomenon, with only a percentage of independent primary MSC cultures capable 
of ERB formation (Peter Durairaj, 2017). However, the method optimisation revealed 
that this initial interpretation was erroneous, but instead, all primary cultured EnSC 
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form ERB. The key issue driving the previously inconsistent data was the 
unstandardized Matrigel curing time. The time lapse microscopy data provided further 
evidence that ERB formation was due to a collective contraction of the cells into the 
centre of the well, not cellular reorganisation or regeneration into a tissue-like 
structure.  
 
A shift in the paradigm  
As the original hypotheses were incorrect, a change of paradigm was required to 
understand these new observations. EnSC are fibroblastic and therefore I 
hypothesised that the contractile phenotype exhibited by these cells when cultured 
on Matrigel was due to the activation of a wound healing response.  In other tissues, 
fibroblasts have been shown to undergo a morphological differentiation process when 
subjected to mechanical stress or physical damage, called fibroblast activation 
(Kalluri, 2016, Tampe and Zeisberg, 2013, Zeisberg and Zeisberg, 2013). Activated 
fibroblasts were first observed in healing wounds in skin tissue, where it was 
hypothesised that they were responsible for the closure of dermal wounds by cellular 
contraction (Croft and Tarin, 1970, Tomasek et al., 2002, Driskell and Watt, 2015).  
Since this discovery, the sustained presence of activated fibroblasts in a tissue has 
been established as a morphological marker of fibrosis (Kalluri, 2016, Monaco and 
Lawrence, 2003, Gurtner et al., 2008).  
 
In addition to their contractility, activated fibroblasts acquire a myo-fibroblast 
phenotype, including cytoskeletal remodelling (production of αSMA), and ECM 
remodelling through collagen deposition by TGFβ1 signalling (Tomasek et al., 2002).  
Therefore, to test the hypothesis of fibroblast activation, TGFβ1 signalling was 
manipulated. The ALK5 inhibitor A83-01 impeded contraction of MSC in a dose 
dependent manner. In addition, a cytoskeletal hallmark of fibroblast activation, αSMA 
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(Rønnov-Jessen, 1993, Kalluri, 2016), was significantly increased at the protein level 
in the ERB further substantiating the fibroblast activation hypothesis.  
 
Another characteristic of wound healing-associated fibroblast activation is cell death 
or de-differentiation after contraction (Tomasek et al., 2002). Initially, activated 
fibroblasts contract and mass produce ECM proteins such as collagens to aid in 
closing the wound. However, in normal wound healing, activated fibroblast cell death 
or de-differentiation follows contraction (Kalluri, 2016, Tomasek et al., 2002). This is 
an essential step in the later stages of wound healing, to ensure excessive ECM is 
not produced. I demonstrated that most cells in the ERB died by 4 days in culture. 
Collectively, the evidence indicated that ERB formation was due to fibroblast 
activation, and not due to MSC tissue regeneration. Therefore, henceforth the ERB 
was renamed the endometrial fibroblast activation model (EFAM).  
 
Next, the impact of decidualisation of EnSC on EFA was investigated. Pre-
decidualising EnSC with MPA and cAMP for 4 days inhibited EFA. Analysis of 
published decidual time course scRNA-seq data revealed that many genes involved 
in the ROCK pathway are downregulated upon decidualisation (Lucas et al., 2018). 
The ROCK pathway has been described previously as a key pathway in cellular 
contraction (Amano et al., 2010). Validation of key genes indicated the ROCK 
pathway is essential in ERB formation. The MYLK knockdown inhibited the previously 
observed collective contractile phenotype, therefore implicating MYLK in EFA. At 
protein level, MYPT1, the phosphorylation target of ROCK1, was unphosphorylated 
in decidualised EnSC. This observation correlated with the downregulation of ROCK1 
upon decidualisation observed in the decidual time course scRNA-seq data (Lucas et 
al., 2018). Therefore, it is likely that the silencing of this pathway impedes EFA in 
decidualised EnSC.  
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These observations support a previous study showing that contraction of EnSC 
seeded in a hydrogel  is suppressed when decidualised (Tsuno et al., 2009). This 
study also identified the ROCK1 pathway as being a major pathway involved in their 
observed cellular contraction. Curiously, they presented data showing that both 
ROCK1 and ROCK2 were down regulated upon decidualisation. This opposes the 
scRNA-seq data presented in this study, in which ROCK2 is upregulated upon 
decidualisation. Additionally, when ROCK2 was inhibited there was no effect on EFA. 
Instead, inhibiting ROCK2 reduced prolactin secretion, indicating a different role in 
EnSC to ROCK1. Historically, it has been reported that the two ROCKs have similar 
roles, but recent studies in cardiac and embryonic fibroblasts indicate an opposing 
role for ROCK1 and ROCK2 (Shi et al., 2013, Jerrell and Parekh, 2016, Satoh et al., 
2018, Hartmann et al., 2015). Shi et al., demonstrated that ROCK1 in essential for 
actin destabilisation, whereas ROCK2 maintains actin stability, indicating opposing 
roles in cell-cell and cell-matrix attachment properties (Shi et al., 2013). Taken 
together, this suggests that the ROCKs maintain different and opposing roles in cell 
attachment and contraction in the endometrium.   
 
Furthermore, inhibition of FAK by inhibitor Y15 impeded EFA in EnSC. This therefore 
indicates that cell-matrix adhesions are essential for EFA. Adhesions and contractility 
have been linked through the ROCK pathway by Rho guanine nucleotide exchange 
factor proteins GEF-H1 and LARG (Heck et al., 2012, Guilluy et al., 2011, Petrie and 
Yamada, 2012). GEF-H1 and LARG activate in response to changes in matrix rigidity 
or mechanical stress from the ECM. Changes in matrix rigidity can be sensed due to 
basal actomyosin contractility tension held by cell-matrix adhesions (Lo et al., 2000, 
Moore et al., 2010, Jerrell and Parekh, 2016).  Therefore, when activated, GEF-H1 
and LARG activate RhoA by exchanging a GDP with an activating GTP. Active Rho 
can then act on ROCK1, leading to contractility. However, for decidualised EnSC, the 
scRNA-seq data evidenced that despite FAK remaining stable over the decidual time 
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course, the ROCK pathway is downregulated, including both GEF-H1 and LARG (Fig. 
3.8) (Lucas et al., 2018). In addition, many genes related to the adhesion complex 
were shown to be downregulated upon decidualisation in the scRNA-seq data further 
suggesting mechanosensing is impeded. This discrepancy between FAK and the 
ROCK pathway suggests there is an uncoupling of the ROCK pathway from cell-
matrix adhesions and therefore there is no EFA in decidual EnSC when challenged 
by the EFAM protocol (Fig. 3.12). 
 
Clinical relevance 
Human endometrial decidual cells have been shown previously to be programmed to 
resist a range of stressors, thus ensuring integrity of the interface and survival of the 
conceptus (Kajihara et al., 2006, Jones et al., 2006, Leitao et al., 2011, Muter et al., 
2015, Muter et al., 2016, Muter et al., 2017, Shah et al., 2013). Therefore, it is likely 
that the silencing of the ROCK pathway upon decidualisation is another feature of this 
programmed resistance to external stress. Excessive fibroblast activation can cause 
scaring and fibrosis of tissues and scarring of the endometrium, such as in 
Asherman’s syndrome, significantly decreases fertility and the chance of successful 
pregnancy (Yu et al., 2008). Therefore, it is possible that fibroblast activation has been 
silenced during the evolution of decidualisation and menstruation in order to protect 
the cycling endometrium from fibrosis and the healing of the endometrium scar free 
(Evans et al., 2011, Salamonsen, 2003).  
 
Furthermore, endometriosis is a disorder in which endometrial tissue grows outside 
of the endometrium, such as in the ovaries, Fallopian tubes or peritoneal cavity. It is 
often characterised by lesions that are highly painful and contain scar tissue. It has 
been proposed that retrograde ‘breakthrough’ bleeding in premenarcheal and 
adolescent women could be a cause of endometriosis in some patients  
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Figure 3.12: Proposed model of mechano-sensing of matrix rigidity and 
contraction in undecidualised and decidualised stromal cells. A schematic 
depicting the relationship between cellular adhesions and the ROCK pathway and 
subsequent contraction in undecidualised EnSC (left) and decidualised EnSC (right). 
Myosin II maintains a basal tension on actin fibres that is coupled to the matrix by 
cell-matrix adhesions. Changes in tension are sensed by myosin II and activate GEF-
H1 and LARG, which activate RhoA, which then activates ROCK1. ROCK1 
phosphorylates MYPT1 of the Myosin light chain phosphatase complex (MLC-P). 
MLC-P is therefore inhibited. MYLK phosphorylates Myosin light chain, activating the 
myosin for contraction. This cascade is inhibited in decidualised cells, and MLC-P, by 
MTP1, removes phosphate groups from myosin light chain, inactivating the myosin II. 
Green circles represent proteins upregulated at the RNA level; red circles represent 
proteins downregulated at the RNA level. Yellow circles represent genes not 
significantly different at RNA level in undecidualised and decidualised stromal cells. 
Arrows indicate the direction of action of the proteins.  
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(Brosens et al., 2013b, Brosens et al., 2013a, Brosens and Benagiano, 2016, Brosens 
et al., 2016, Gargett et al., 2014). Breakthrough bleeding is non-menstruation-
stimulated bleeding into the peritoneal cavity, usually before menarche or in 
adolescence (Brosens et al., 2013a, Brosens and Benagiano, 2016). Cells within a 
breakthrough bleed are not decidualised at the point of contact with the peritoneum. 
Therefore, it could be speculated cells that may seed and develop into lesions may 
retain their capacity for fibroblast activation, possibly resulting in lesions that are more 
likely to form inflammatory scar tissue. Further investigation into the differences 
between undifferentiated and differentiated cell seeding of endometriotic lesions may 
lead to better understanding of how they develop, and therefore how endometriosis 
can possibly be treated or even prevented in some circumstances.  
 
Impact in modelling the human endometrium in vitro 
Although this model failed to form the basis of a 3D model of the endometrium, it did 
provide key information for further study. This study highlights the potential drawback 
of using Matrigel as a scaffold for 3D in vitro culture of EnSC. As these cells activated 
upon contact with Matrigel, it is likely that they are not functioning physiologically as 
in the normal undamaged stroma.  Hydrogels that maintain the physiological 
quiescent phenotype of the undifferentiated stromal cell would be better choices for 
3D modelling, possibly such as collagen hydrogels (Bentin-Ley et al., 1994, Anguiano 
et al., 2017, Arnold et al., 2001).  Moving forward, it was clear that alternatives to 
Matrigel were required to ensure appropriate support for EnSC growth and 
differentiation in future 3D models of the human endometrium.  
 
Conclusion  
In this study, despite being unable to meet the aim of developing a 3D model of the 
endometrium in vitro, I demonstrated clear evidence that all subgroups of endometrial 
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stromal cells possess the capacity to mount a wound healing response through 
fibroblast activation and that this capacity is lost upon differentiation. From in silico 
analysis of published in vitro single cell RNA sequencing data, I observed a strong 
divergence in the expression profiles of the ROCK pathway between undifferentiated 
and decidualised EnSC. I have gone on to confirm this pathway is functionally 
implicated in the contraction of these cells on Matrigel by both small molecule 
inhibitors and gene knock down by siRNA, indicating this is this pathway that 
underpins this phenomenon. These data highlight a possible example of the evolution 
of human decidual cell stress resistance and their ability to shut off normal cellular 
pathways to help maximise the chances of successful pregnancy. Future work with 
this model could be to further investigate EFA in the context of other hydrogels for 3D 
culturing or to further investigate the role of pre-menarche breakthrough bleeding and 
the onset of endometriosis. 
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4.1 Introduction 
The endometrial glands are an essential component of studying human embryo 
implantation as they provide the nutritional support essential for the growth and 
survival of an implanting conceptus in human pregnancy (Burton et al., 1999, Bazer, 
1975, Kane et al., 1997). However, modelling endometrial epithelial glands in vitro 
has been challenging, with the major focus of in vitro endometrial studies being 
traditionally focused on EnSC. Recently, in vitro modelling of the endometrial glands 
has become possible due to the development of 3D organoid culture. Organoids are 
named due to their spheroidal ‘organ-like’ morphology and function (Lancaster and 
Knoblich, 2014b, Zimmermann, 1987). Organoids form from stem cells or progenitor 
cells that are grown in a 3D scaffold, such as Matrigel. Differentiation of progenitor 
cells into organoids is driven by a complex medium containing a specified formulation 
of growth factors and inhibitors intended to replicate the niche or cell environment in 
vivo (Lancaster and Knoblich, 2014b). There are many published examples of 
organoids from organs and tissues such as the brain, retina, liver, kidney, and 
intestine (Xinaris et al., 2012, Luni et al., 2014, Xia et al., 2013, Lancaster and 
Knoblich, 2014a, Ramsden et al., 2013). However, the most pertinent to this area of 
research is the endometrial gland organoid (Turco et al., 2017, Boretto et al., 2017).  
 
Two protocols, first published in 2017, now enable the formation of endometrial gland 
organoids that recapitulate in vivo endometrial glandular epithelium, both 
morphologically and functionally (Turco et al., 2017, Boretto et al., 2017). Spheroid-
shaped organoids expand when EEC are seeded in Matrigel and grown in a 
chemically defined medium containing growth factors and inhibitors called expansion 
medium (ExM). Single EEC expand into organoids reaching 200-500 μm in diameter 
when cultured for 4-8 days.  Organoids can be maintained long-term by passaging in 
which cultures are dissociated mechanically and plated into fresh Matrigel for re-
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expansion. Furthermore, endometrial gland organoids maintain genomic stability over 
many passages and can be cryopreserved, enabling the possibility of long-term 
biobanking (Turco et al., 2017, Boretto et al., 2017).   
 
Endometrial gland organoids label positively with EEC markers such as epithelial cell 
adhesion molecule (EpCAM), cytokeratin, and epithelial cadherin (E-cadherin). The 
cells polarise, and electron microscopy has demonstrated that a proportion of the 
cells become ciliated along the luminal apical surface when exposed to estradiol 
(Turco et al., 2017, Haider et al., 2019).  The endometrial gland organoids 
differentiate, at least partially, when exposed to MPA and cAMP, as demonstrated by 
the induction of genes related to glandular differentiation and embryo receptivity, such 
as PAEP, LIF, DPP4, HSD17B2, and secretion of glycogen and glycoproteins, such 
as mucins (Turco et al., 2017, Boretto et al., 2017).  
 
Endometrial gland organoids therefore provided an alternative basis for developing a 
3D in vitro model of the human endometrium. This study aimed to optimise a protocol 
for developing a ‘complex organoid’ system that consist of both primary gland 
organoid EEC with patient matched EnSC to establish a novel in vitro 3D model of 
the endometrium.  
 
The objectives of this study were: 
1. To determine the gel matrix conditions required to support of complex 
organoid growth 
2. To establish a medium suitable to support growth of complex organoids. 
3. To characterise functionally and morphologically differentiating complex 
organoids  
 
 
 118 
 
4.2 Results 
Establishing the growth conditions for a complex organoid culture 
In chapter 3, I described a protocol for studying EFA using Matrigel. In brief, cultured 
EnSC activate when plated on Matrigel and contract into a central mass. I concluded 
that Matrigel is not suitable for modelling the normal physiology of EnSC in vitro. 
However, the established protocol for organoid formation uses Matrigel (Turco et al., 
2017) (Fig. 4.1). In brief, endometrial biopsies are enzymatically digested, and the 
epithelial gland fraction is isolated using a cell sieve. The dissociated glands are 
mixed with Matrigel (ratio 1:20) and plated into 20 μl droplets and grown in ExM. The 
discrepancy in gel requirements between EnSC and EEC therefore posed an 
important hurdle. 
 
Previous studies have used a layered co-culture model culturing EnSC in a collagen-
based hydrogel overlaid with a monolayer of EEC (Bentin-Ley et al., 1994, Mardon et 
al., 2007). I examined EFA on an equivalent formulation of collagen hydrogel 
(PureCol® EZ Gel solution) in comparison to standard Matrigel (Fig. 4.2A). EnSC 
from three independent patient biopsies were seeded in duplicate either on top of 50 
μl Matrigel or 50 μl collagen hydrogel and cultured in Medium 200 and imaged over 
16 hours by time-lapse microscopy. On Matrigel, the EnSC contracted as predicted 
(mean area ± SD at 16 hours = 0.7 ± 0.03 cm3). However, on collagen hydrogel, the 
EnSC did not contract (mean area ± SD at 16 hours = 2.7 ± 0.12 cm3). This 
observation indicated that collagen hydrogel is more suitable at maintaining 
physiological EnSC morphology.   
 
Next, organoid expansion was tested in collagen hydrogel. Following the protocol 
from Turco et al. 2017, endometrial gland organoids from three independent patient 
biopsies were expanded in Matrigel. Passages 0 (P0) and 1 (P1) organoid cultures  
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Figure 4.1: Schematic representation of endometrial gland organoid formation 
and culture in vitro. Fresh human endometrial biopsies are dissociated 
mechanically and enzymatically, and the glandular epithelial fraction is separated by 
size by a 40 µm cell sieve. The epithelial gland fraction is mixed with Matrigel at a 
1:20 ratio and aliquoted into 20 µl droplets in a 48 well plate and cured at 37oC for 15 
min. ExM (200 μl) is added and cultures are grown for 7 days with medium refreshed 
every 48 hours (P0). By the end of P0 (day 7) very few organoids form, instead clumps 
of glandular cells can be observed. Cultures are then passaged and grown for a 
second 7 days (P1). Cultures are passaged again to P2 where the recognisable 
spheroid shaped organoids form. Images visualised by brightfield microscopy. Scale 
bar: 500 µm.  Protocol adapted from Turco, et al. 2017.  
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Figure 4.2: Determining a suitable hydrogel for in vitro culture of EnSC and 
endometrial gland organoids.  
A: Left: A schematic of the EFAM protocol. In brief, passaged EnSC are seeded onto 
Matrigel and over 24 hours contract into a mass. Middle: Representative images of 
EFAM performed on Matrigel and collagen hydrogel at 24 hours from three 
independent cultures in triplicate, visualised by brightfield microscopy. Right: Data 
show area of EnSC 24 hours after seeding onto Matrigel or collagen. This experiment 
was performed on three independent cultures in triplicate. The colours represent the 
three individual cultures. P ˃ 0.05 (Wilcoxon matched pairs signed rank test). 
B: Left: A simplified schematic of endometrial gland organoid protocol as in Fig. 4.1. 
Middle: Representative images of the organoid protocol performed on Matrigel and 
collagen hydrogel at 8 days from three independent cultures in triplicate, visualised 
by brightfield microscopy Right: Data show absolute number of endometrial gland 
organoids formed after 8 days of culture from three independent samples. The colours 
represent the three individual cultures. The line represents the mean. P ˃ 0.05 
(Wilcoxon matched pairs signed rank test). 
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contain semi-intact glands and cellular debris whereas at P2 pure organoid cultures 
emerged (Fig. 4.1). Therefore, experiments were undertaken at P2. Briefly, P1 
organoids were passaged after a growth period of 7 days by mechanical dissociation. 
Dissociated gland organoids were mixed into the gels (neat) at a 1:20 volume ratio 
(final gel concentration 95%) and aliquoted into 20 μl droplets in a 48 well plate and 
grown in ExM (Fig. 4.2B). After 4 days in culture, the number of organoids were 
counted. Organoids expanded in both gels to similar numbers (Fig 4.2B).  
 
Finally, I compared Matrigel and collagen hydrogel in complex organoid culture. In 
order to produce complex organoids, I mixed the standard volume of pelleted P1 
dissociated gland organoid EEC (1:20 volume ratio) with the same volume of pelleted 
EnSC into the gels in ExM (final gel concentration 90%). The aim of producing the 
complex organoid culture was for it to structurally resemble a simplified endometrium 
with a stroma interspersed with glandular structures, in three dimensions (Fig. 4.3A). 
Therefore, a successful complex organoid must adhere to the following criteria when 
seen under a light microscope: 
1. Gland organoid expansion present 
2. A well distributed mesh-like matrix of spindle-shaped EnSC around the 
gland organoids 
3. No indication of EnSC-driven hydrogel contraction 
 
In both Matrigel and collagen hydrogel, the gland organoid structures were able to 
form (Fig 4.3B). However, as previously described, in Matrigel, the EnSC contracted 
to the edges of the gel droplet (Fig. 4.3B, black arrows). In collagen hydrogel, the 
EnSC were able to form a matrix-like morphology without EnSC-driven hydrogel 
contraction. Collectively, these data demonstrated collagen hydrogel was able to fulfil  
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Figure 4.3: Determining a suitable hydrogel for in vitro complex organoid 
culture. 
A: A schematic of the complex organoid protocol. Equal volume of EnSC and 
dissociated gland organoid EEC were added to Matrigel or collagen hydrogel at a 
ratio of 1:20 each and aliquoted into 20 μl droplets in a 48 well plate and cured at 
37oC for 15 min. ExM (200 μl) is added and cultures are grown for 8 days with medium 
refreshed every 48 hours. The criteria for a complex organoid is included on the right 
to be used when visualising the complex organoids by light microscopy.  
B: Representative images of complex organoids grown in Matrigel or collagen 
hydrogel from three independent cultures in triplicate visualised by brightfield 
microscopy. Left: 2× magnification. Black arrows indicate areas of EnSC contraction. 
Scale bar: 1000 μm. Middle: 10× magnification. Scale bar: 100 μm. Right: 20× 
magnification. Scale bar: 200 μm.  
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the complex organoid criteria and therefore was more suitable for complex organoid 
culture and hence used for all further experimentation.  
 
Optimising the growth medium for an endometrial complex organoid culture. 
The medium was the next component of the complex organoid to optimise. For the 
initial experiments, the previously defined ExM was used (Turco et al., 2017). The 
use of collagen hydrogel had alleviated the criterion issue of EnSC-driven gel 
contraction. However, visual observation indicated that the EnSC matrix when 
cultured in ExM was sparse and without indication of EnSC expansion. Monolayer 
EnSC are cultured routinely in medium containing E2 and serum, such as fetal bovine 
serum (FBS) (Barros et al., 2016, Irwin et al., 1989). E2 is an ovarian steroid hormone 
essential for proliferation of EnSC during the proliferative phase of the human 
menstrual cycle (Gellersen and Brosens, 2014). FBS provides a source of amino 
acids for EnSC growth and proliferation.  
 
The ExM does not contain serum or E2. Instead, ExM contains N2 and B27, which 
are both commercial chemically defined supplements suitable for cell proliferation in 
serum free media (Brewer et al., 1993, Bottenstein and Sato, 1979, Turco et al., 
2017). Both were originally formulated for neuronal stem cell culture. B27 includes 
human insulin and transferrin, antioxidants, hormones, fatty acids, and amino acids 
(Bottenstein and Sato, 1979, Romijn, 1988). N2 is similar in composition, containing 
human insulin, hormones, putrescine, a precursor to polyamine biosynthesis, 
selenite, an antioxidant (Bottenstein and Sato, 1979, Needham et al., 1987).  
 
Therefore, I examined the effect of the adding E2 to the ExM on EnSC expansion. 
Additionally, I examined the growth of EnSC in complex organoids in ExM 
supplemented serum replacement 1 (SR1) and Albumax II would benefit EnSC 
growth. SR1 contains highly purified, heat-treated bovine serum albumin (BSA), heat-
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treated bovine transferrin and bovine insulin (Chase and Firpo, 2007). Albumax II is 
purified BSA (Ichikawa, 2010). These commercial serum replacements were chosen 
in order to maintain a chemically defined medium (Gstraunthaler, 2003). FBS was not 
tested because of its unspecified composition. 
 
Three independent complex organoid cultures were grown in triplicate in each of the 
tested ExM formulations for 8 days and cultures were visually examined. Complex 
organoid EnSC were rounded in standard ExM, indicating cell death (Fig. 4.4A). 
However, EnSC grown in ExM containing 1nM E2 expanded to confluency in the 
collagen hydrogel and formed a dense, well distributed matrix around the gland 
organoids when grown in this medium (Fig. 4.4B). There was no observed additional 
EnSC expansion with the addition of SR1 (1×) (Fig. 4.4C). The addition of Albumax II 
(2%) had the greatest effect in EnSC expansion visually, however it inhibited gland 
organoid expansion (Fig. 4.4D). Instead, large holes in the gel were observed 
indicating EnSC contraction.  
 
In summary, the medium composition chosen for complex organoid culture was 
defined as ExM supplemented with 1 nM E2. This formulation produced complex 
organoids that best suited the criteria set with a well distributed stroma and epithelial 
organoids present. In order to distinguish this medium from standard ExM, medium 
supplemented with E2 was designated as co-ExM as it is optimised for complex 
organoid culture. 
 
To examine whether proliferation was improved by co-ExM, complex organoids were 
immunolabelled for the proliferation marker Ki67 by IHC. Ki67 is expressed at the 
protein level in all active phases of the cell cycle but absent in quiescent cells (Mertens 
et al., 2002). Complex organoids from three independent patient biopsies grown in 
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Figure 4.4: Determining the optimal growth medium for complex organoid 
cultures. Complex organoids from three independent cultures in triplicate were 
grown in the various growth medium formulations for 7 days (A-D). Top Row: Growth 
medium formulations. Middle Row: Representative brightfield images of complex 
organoids at day 7 of culture. Magnification= 2×. Scale bar: 1000 μm. Bottom Row: 
Representative images of complex organoids grown in above medium. Magnification: 
10×. Scale bar: 100 μm. Images visualised by brightfield microscopy. 
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ExM or co-ExM were fixed with formalin, paraffin embedded and sectioned. These 
sections were immunolabelled for Ki67 by IHC (Fig. 4.5). In the ExM samples, only 
the EEC were labelled positively for Ki67 (labelled by white dotted lines). However, in 
co-ExM, some EnSC also expressed Ki67. Thus, the IHC demonstrated that EnSC 
do not proliferate in standard ExM. However, co-ExM induces some EnSC 
proliferation, although the response is partial. 
 
Differentiation of complex organoids 
In order to establish a functional complex organoid culture, I had to determine whether 
the gland organoids and the EnSC could differentiate within the optimised conditions 
presented in this study. Harvesting RNA from the complex organoids for RT-qPCR 
analysis required optimisation. The standard procedure for RNA collection from 
Matrigel involves melting the gel at 4oC, followed by mechanical dissociation for 
retrieval of cells from the gel, and then addition of RNA lysis buffer (Turco et al., 2017). 
However, collagen hydrogel forms covalent bonds when set at 37oC and so will not 
melt back into a liquid when chilled to 4oC, unlike Matrigel (Yahia et al., 2015). Instead 
the hydrogel requires enzymatic digestion with collagenase I to release the cells.  
 
Three independent complex organoid cultures were harvested with RNA lysis buffer 
and manual dissociation (300× pipetting) along with, or without, pre-treatment of 
collagenase I (500 µg/ml for 10 min at 37oC) (Fig. 4.6). Pre-treatment of collagenase 
I digestion improved RNA yield compared to control (mean ± SD: 36.0 ± 8.54 ng/µl 
versus 2.76 ± 0.33 ng/µl, respectively). Hence, collagenase I was utilised for all 
subsequent RNA harvests from collagen hydrogel.  
 
Next, to test complex organoid differentiation, three independent patient-matched 
cultures were first grown for four days in co-ExM. Following expansion, the complex 
organoids were subjected to differentiation medium (DM), composed of ExM with 
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Figure 4.5: Immunohistochemistry for Ki67 in sectioned complex organoids 
grown in ExM or co-ExM. Complex organoids from three independent cultures in 
triplicate were grown for 4 days in either ExM or co-ExM. Cultures were formalin fixed 
and paraffin embedded and sectioned. Channels were visualised by epifluorescent 
microscopy using a secondary antibody conjugated to Alexa 488, depicted in green. 
Nuclei were counterstained with DAPI, depicted in blue. Ki67 (Alexa 488, red; nuclei 
DAPI, blue) was present and localised in EEC in both ExM and co-ExM (inside the 
white dotted circle). Ki67 was also present in some EnSC in co-ExM. (Scale bar: 50 
μm). 
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Figure 4.6: Optimisation of RNA extraction protocol in complex organoids 
using collagenase I. Three independent patient cultures were grown as complex 
organoids for 7 days before being harvested for RNA isolation. Three replicate 
complex organoids of each sample were harvested by RNA lysis buffer alone, and 
three replicate complex organoids of each sample were harvested by first adding 200 
μl collagenase I and incubating at 37oC for 10 min. Samples were pelleted by 
centrifugation and RNA lysis buffer was added. RNA extraction was performed, and 
RNA quantity was measured by a NanoDrop spectrophotometer (ng/μl). Data show 
RNA quantity of three independent complex organoid cultures. The colours represent 
the three individual cultures. The line represents the mean. P ˃ 0.05 (Wilcoxon 
matched pairs signed rank test). 
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cAMP and MPA, for four days. Undifferentiated control cultures were maintained in 
co-ExM (Fig. 4.7A). Treatment with cAMP and MPA in the absence of E2 was chosen 
based on previous in vitro studies of EnSC decidualisation (Brighton et al., 2017, 
Lucas et al., 2019, Muter et al., 2016, Brosens et al., 1999). Treated complex 
organoids (D4) and untreated control cultures (D0) were harvested for RNA for RT-
qPCR analysis. A panel of genes (PAEP, CXCL14, SPP1, PRL) was used to examine 
the complex organoids’ response to DM. The panel was curated in accordance with 
previous literature (Turco et al., 2017, Gellersen and Brosens, 2014). Cell-type 
specificity of each gene from the panel was confirmed by published in vivo scRNA-
seq data (Fig 4.7B) (Lucas et al., 2018). Gland-specific differentiation markers PAEP 
and SPP1 encode proteins glycodelin and osteopontin, respectively, which are 
secreted by differentiated endometrial glands in vivo (von Wolff et al., 2001, Turco et 
al., 2017). Expression of CXCL14, encoding cytokine chemokine (C-X-C motif) ligand 
14, is also upregulated during the secretory phase but by both the glandular EEC and 
EnSC (Díaz-Gimeno et al., 2011). Finally, PRL, encoding prolactin, is a canonical 
EnSC decidual marker gene in culture, despite its modest expression in vivo 
(Gellersen and Brosens, 2014, Garrido-Gomez et al., 2017, Brosens et al., 1999).  
 
RT-qPCR analysis was used to measure the induction of the four marker genes (Fig 
4.7C). Relative expression of all genes increased in complex organoids treated with 
DM. Relative expression of CXCL14 increased 10.3-fold and PAEP increased 8.6-
fold when compared to the undifferentiated control D0. Relative expression of SPP1 
increased 8.5-fold. PRL exhibited the highest increase in relative expression by 36.7-
fold compared to matched undifferentiated control samples. However, there was 
considerable variability in the level of induction between different complex organoid 
cultures.  
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Figure 4.7: Differentiation of the complex organoid cultures.  
A: A schematic of the differentiation protocol. Three independent complex organoid 
cultures were grown in duplicate for both control and treatment groups. Control group 
(D0) was grown in co-ExM for 8 days. Treatment group were grown in co-ExM for 4 
days (D4), and then DM for 4 days. RNA was harvested at day 8 of culture. Spent 
media was collected on day 0 (D0), day 2 (D2) and day 4 (D4) of differentiation.  
B: Expression data of the four marker genes (SPP1, PAEP, CXCL14, PRL) chosen 
for differentiation analysis in EnSC and EEC from in vivo scRNA-seq data (Lucas et 
al., 2018). Data collected in collaboration with Dr Pavle Vrljicak. 
C: SPP1, PAEP, CXCL14, PRL transcript levels were measured in complex organoids 
at D0 and D4 from three independent cultures in duplicate. Gene expression was 
normalised to housekeeping gene L19 mRNA levels. The data show gene expression 
relative to D0 in three independent cultures. The line represents the mean. P ˃ 0.05 
(Wilcoxon matched pairs signed rank test). 
D: Secreted OPN, CXCL14 and PRL from the spent media of complex organoids 
collected at D0, D2 and D4 of differentiation was measured by ELISA. Data show 
secreted levels measured from three independent cultures in duplicate. The colours 
represent the three individual cultures. The line represents the mean. These 
experiments were performed in collaboration with Komal Makwana.  
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ELISA were performed on the spent culture media samples to measure the 
concentration of CXCL14, OPN (encoded by SPP1) and PRL secreted by the cultures 
(Fig. 4.7D). Average OPN protein concentration increased at D4 when compared to 
D0 (mean ± SD: 34000 ± 12400 pg/ml versus 18000 ± 9700 pg/ml, respectively, but 
decreased at D2 (mean ± SD: 13000 ± 6910 pg/ml). Average CXCL14 protein 
concentration was undetectable at D0. Increase in CXCL14 average protein 
concentration was small at D2 (mean ± SD: 170 ± 56 pg/ml).  However, CXCL14 
protein concentration increased at D4 (mean ± SD: 3100 ± 543 pg/ml). Average PRL 
protein concentration was also undetectable at D0, and low at D2 (mean ± SD:  610 
± 332 pg/ml), but at D4, average protein concentration increased to 5300 ± 2340 
pg/ml (mean ± SD). Again, the magnitude of PRL secretion by the complex organoids 
varied between cultures.  
 
Immunohistochemical analysis of complex organoids 
Finally, the aim of this study was to develop a model that not only functionally but also 
morphologically recapitulated the human endometrium. Therefore, the morphology of 
undifferentiated and differentiated complex organoids was examined in addition by 
IHC. Three independent cultures were grown for four days in co-ExM and then 
differentiated in DM for a further 4 days or maintained undifferentiated in co-ExM. 
Complex organoids were then harvested, formalin fixed, paraffin embedded and 
sectioned. First, antibodies for gland-specific structural markers cytokeratin, EpCAM 
and E-cadherin were tested (Fig. 4.8). All three antibodies labelled the endometrial 
gland organoid cells positively at the plasma membrane. The IHC revealed that 
undifferentiated EEC gland structures were small and spherical, whereas upon 
differentiation they were widened and contorted. This recapitulates the morphology 
of glands in the human endometrium (Gray et al., 2001a). Furthermore, the EnSC 
were labelled with a vimentin antibody (Fig. 4.8). Upon differentiation, the EnSC 
produced a dense matrix of decidualising stroma surrounding the gland organoids.  
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Figure 4.8: Immunohistochemistry for EEC structural markers in 
undifferentiated and differentiated complex organoids. Complex organoids from 
three independent cultures in triplicate were grown for 4 days in co-ExM and then 
differentiated in DM for a further 4 days (Differentiated) or maintained in co-ExM 
(Undifferentiated). Cultures were formalin fixed and paraffin embedded and 
sectioned. Channels were visualised by epifluorescent microscopy using a secondary 
antibody conjugated to Alexa 488, depicted in green. EnSC were immunolabelled with 
vimentin antibody and visualised using secondary antibody conjugated to Alexa 594, 
depicted in red. Nuclei were counterstained with DAPI, depicted in blue. Cytokeratin, 
E-cadherin and EpCAM (green) localised to the plasma membrane of endometrial 
gland organoid epithelial cells. Laminin (green) localised to the BM between the EnSC 
and EEC. (Scale bar: 50 μm). Data collected in collaboration with Komal Makwana. 
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Laminin was also labelled positively in a thin layer between the gland organoids and 
surrounding EnSC indicating BM formation. In differentiated samples, laminin also 
localised to the ECM surrounding the EnSC. Taken together, these data demonstrate 
complex organoids recapitulate some aspects of human endometrial morphology.  
 
Furthermore, the complex organoids were also labelled with a PGR antibody (Fig. 
4.9). Undifferentiated cultures exhibited localisation of PGR in the nuclei of both EEC 
and EnSC. However, upon differentiation, the labelling of PGR was reduced in all 
cultures. In addition, the complex organoids were labelled with a glycodelin antibody 
(Fig. 4.10). Undifferentiated samples did not label positively for glycodelin. However, 
differentiated samples displayed localisation of glycodelin to the luminal surfaces of 
the EEC. This indicated that the EEC were polarised and were actively secreting 
glycodelin into their luminal cavities. This is further evidenced by the positive labelling 
of glycodelin in the luminal cavities. Finally, in addition to antibody labelling, the 
secondary antibodies were tested on same samples to account for any non-specific 
binding of the fluorophores (Fig. 4.11). 
 
Overall the RT-qPCR, ELISA and IHC confirm that the complex organoids not only 
functionally respond to deciduogenic cues but in addition to this attain a morphology 
that partially recapitulates the human endometrium under the conditions optimised in 
this study. Figure 4.12 is a schematic summary of the established protocol for 
culturing complex organoids. 
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Figure 4.9: Immunohistochemistry for PGR in undifferentiated and 
differentiated complex organoids. Complex organoids from three independent 
cultures in triplicate were grown for 4 days in co-ExM and then differentiated in DM 
for a further 4 days (Differentiated) or maintained in co-ExM (Undifferentiated). 
Cultures were formalin fixed and paraffin embedded and sectioned. Channels were 
visualised by epifluorescent microscopy using a secondary antibody conjugated to 
Alexa 594, depicted in red. Nuclei were counterstained with DAPI, depicted in blue. 
PGR (red) localised to the nuclei of EnSC and gland organoids in undifferentiated 
samples. (Scale bar: 50 μm) Data collected in collaboration with Komal Makwana. 
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Figure 4.10: Immunohistochemistry for glycodelin in undifferentiated and 
differentiated complex organoids. Complex organoids from three independent 
cultures in triplicate were grown for 4 days in co-ExM and then differentiated in DM 
for a further 4 days (Differentiated) or maintained in co-ExM (Undifferentiated). 
Cultures were formalin fixed and paraffin embedded and sectioned. Channels were 
visualised by epifluorescent microscopy using a secondary antibody conjugated to 
Alexa 488, depicted in green. Nuclei were counterstained with DAPI, depicted in blue. 
Glycodelin (green) localised to the apical plasma membrane and lumen of 
endometrial gland organoids. (Scale bar: 50 μm) Data collected in collaboration with 
Komal Makwana. 
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Figure 4.11: Negative control for immunohistochemistry of undifferentiated and 
differentiated complex organoids. Complex organoids from three independent 
cultures in triplicate were grown for 4 days in co-ExM and then differentiated in DM 
for a further 4 days (Differentiated) or maintained in co-ExM (Undifferentiated). 
Cultures were formalin fixed and paraffin embedded and sectioned. IHC in Figure 4.5, 
4.9 and 4.10 were performed concurrently.  
A: Channels were visualised by epifluorescent microscopy using a secondary 
antibody conjugated to Alexa 594 only, depicted in red. Nuclei were counterstained 
with DAPI, depicted in blue. .  
B: Channels were visualised by epifluorescent microscopy using a secondary 
antibody conjugated to Alexa 488 only, depicted in green. Nuclei were counterstained 
with DAPI, depicted in blue. (Scale bar: 50 μm). 
Data collected in collaboration with Komal Makwana. 
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Figure 4.12: A schematic representation of the optimised protocol for 
producing an endometrial complex organoid culture. Endometrial biopsies are 
dissociated mechanical and enzymatic digestion. The endometrial digest is separated 
into gland and stromal fractions by a 40 µm cell sieve. For P0-1, gland organoids and 
EnSC are grown separately to expand the number of cells in both cultures. At P2, 
dissociated gland organoid EEC and EnSC are mixed in a collagen hydrogel at a ratio 
of 1:20 each and aliquoted into 20 μl droplets in a 48 well plate at let to cure at 37oC 
for 45 min. co-ExM (200 μl) is added and cultures are grown for 4 days (growth phase) 
with medium refreshed every 48 hours. At day 4, medium is replaced with 
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differentiation medium (DM) for a further 4 days (differentiation phase) for 
differentiation studies. DM is refreshed every 48 hours. At Day 8, complex organoid 
cultures are harvested for downstream analyses.  
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4.3 Discussion 
Determining the hydrogel matrix suitable complex organoid culture 
The aim of this study was to establish a protocol for an in vitro complex organoid 
system by culturing endometrial gland organoids with EnSC. The development of this 
system required the optimisation of the growth conditions to accommodate both the 
organoids and EnSC. The published endometrial gland organoid protocol used 
Matrigel for expansion, as it is derived from BM matrix that consists largely of BM 
proteins including laminins, collagen V and entactin (Kleinman and Martin, 2005). 
Therefore, Matrigel is a suitable gel for anchoring EEC and establishing cellular 
polarisation, essential for endometrial epithelial gland differentiation (Bentin-Ley et 
al., 1994, Classen-Linke et al., 1997). In the context of the endometrial gland 
organoids, the basal surface is in contact with Matrigel, and the apical surface lines 
the internal lumen. Endometrial gland organoid polarisation has been previously 
demonstrated in Matrigel (Turco et al., 2017).  
 
However, in Chapter 3, I demonstrated that Matrigel was inappropriate for EnSC 
culture.  Instead, a previous study used collagen hydrogels for culturing fibroblasts in 
3D in vitro (Bentin-Ley et al., 1994). In the present study, EnSC failed to contract on 
collagen hydrogel with subjected to the EFAM protocol. Previous studies have 
demonstrated that stiffer ECM, or even cell culture plastic, is more likely to activate 
fibroblasts into a myo-fibroblast-like phenotype (Balestrini et al., 2012, Lambricht et 
al., 2014). Collagen gels have been reported as being less stiff than Matrigel (Motte 
and Kaufman, 2013, Anguiano et al., 2017). Therefore, the failure of the EnSC to 
activate on the collagen hydrogel is likely attributed to the relative softness of the gel. 
In addition, collagen, particularly types I, III and VI, are the primary constituents of the 
stromal ECM of the endometrium (Iwahashi et al., 1997). This suggests the collagen 
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hydrogel, consisting of purified collagen I, recapitulates the endometrial ECM more 
faithfully than the BM-derived Matrigel and is therefore more suitable for culture.  
 
In addition to the EnSC findings, gland organoids expanded in the collagen hydrogel 
despite it being softer and containing a different ECM composition. EnSC and EEC 
can induce the production of ECM components essential for BM formation, such as 
laminins, in vivo (Classen-Linke et al., 1997, Wewer et al., 1986). The IHC revealed 
that laminin is present and localised between organoids and EnSC indicating that the 
complex organoids can produce a BM when cultured in collagen hydrogel. The 
presence of a BM suggests that the organoids polarised in the collagen hydrogel. 
Hence, these findings suggest that the EnSC support the development of EEC gland 
structures in complex organoids. 
 
Optimising the growth medium for complex organoids. 
The standard ExM medium published by Turco, et al., used for expanding gland 
organoids does not contain E2 during initial expansion (Turco et al., 2017). In this 
study, when complex organoids were cultures in ExM, the EnSC failed to show any 
visual sign of expansion. E2 is known to drive endometrial proliferation in the 
menstrual cycle. In this study, it was demonstrated that E2 is essential for EnSC 
proliferation, as evidenced by the EnSC morphology and some positive labelling of 
proliferation marker Ki67 in both complex organoid EEC and EnSC. Therefore, this 
complex organoid medium was designated co-ExM.  
 
However, unexpectedly, the additional serum replacements did not improve the 
proliferation of the complex organoids. Standard EnSC medium contains FBS which 
supports EnSC proliferation. However, FBS is known to contain an unspecified 
composition, including hormones and growth factors. These hormones can be 
stripped by dextran-coated charcoal (DCC) treatment; however, the specific 
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composition of FBS is not consistent (Gstraunthaler, 2003). Therefore, it was 
important to use a serum replacement such as serum replacement 1 (SR1) and 
Albumax II to maintain a defined medium to maintain consistency of culture. Both are 
purified BSA.  SR1 had no visual effect on EnSC morphology or proliferation at 1× 
concentration when in combination with E2. Also, although Albumax was able to 
improve EnSC proliferation, it inhibited organoid expansion. BSA is a natural carrier 
protein that binds to peptides such as growth factors in the circulatory system, as well 
as used as a carrier protein for long term storage of growth factors in vitro (Kragh-
Hansen, 1981, Friedrichs, 1997, Merlot et al., 2014). Therefore, it is possible that the 
Albumax quenched growth factors from the ExM, removing them from suspension in 
the medium and therefore inhibiting organoid expansion. As neither additive was 
beneficial to the complex organoids, they were not included in the final co-ExM 
formulation. In addition, previous studies have demonstrated that N2 and B27 alone 
are effective at increasing cell proliferation equivalent to FBS in organoid-based cell 
cultures (Crespo et al., 2017), substantiating that further serum replacement was 
unnecessary for this medium when E2 is present.  
 
Comparing the complex organoid cultures to the in vivo endometrium 
The aim of this study was to establish an optimised in vitro model that functionally 
and morphologically recapitulates the human endometrium. In this study, I have 
demonstrated that both the EnSC and EEC respond to DM treatment in complex 
organoid cultures. The EEC gland structures induced key gland-specific 
differentiation genes PAEP and SPP1 as well as CXCL14. In addition, at the protein 
level, the EEC secreted OPN and CXCL14 into the medium when differentiated, 
recapitulating endometrial glandular secretions in vivo (von Wolff et al., 2001, Díaz-
Gimeno et al., 2011). These findings are in agreement with endometrial gland 
organoid studies (Turco et al., 2017, Boretto et al., 2017). This demonstrates that 
gland organoids can respond to deciduogenic stimulation when grown in collagen 
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hydrogel and in complex organoids. In addition, EnSC were also able to decidualise 
in DM, demonstrated by the induced expression of PRL, and the subsequent 
secretion of PRL. Thereby demonstrating the EnSC can differentiate when grown in 
collagen hydrogel and in the presence of organoids. 
 
This study demonstrated that the complex organoids partially recapitulate the human 
endometrium morphologically. Previous studies have established layered co-culture 
systems that have positively stained for epithelial, stromal and BM markers (Bentin-
Ley et al., 1994). However, no published studies have yet described this complex 
organoid culture. In this present study, endometrial EEC-specific structural markers 
such as EpCAM, cytokeratin and E-cadherin labelled positively along the plasma 
membrane of the gland organoids. This confirms that in complex organoids, the gland 
organoid structures remain epithelial. These observations agree with previous gland 
organoid studies (Turco et al., 2017). Additionally, the EnSC, labelled positively with 
vimentin and negative for the gland-specific markers, formed a dense cellular matrix 
around the glands upon differentiation, recapitulating the structure of the in vivo 
endometrium (Cloke et al., 2008, Gellersen and Brosens, 2014). Furthermore, a 
positive labelling of laminin between the EnSC and EEC indicate BM formation at the 
basal surface of the EEC in the collagen hydrogel. Furthermore, the localisation of 
laminin surrounding decidualising EnSC recapitulates the ECM of the human decidua 
(Iwahashi et al., 1997, Aplin et al., 1995).  
 
Furthermore, differentiated complex organoids lost PGR expression, in keeping with 
in vivo expression (Jabbour et al., 2002, Mote et al., 1999). However, previous gland 
organoid studies have demonstrated PGR expression to be maintained in EEC, but 
these organoids were not cultured with EnSC (Turco et al., 2017). This may possibly 
suggest that the gland organoids require EnSC for differentiation. EnSC induced 
differentiation of EEC has been observed in vivo (Cooke et al., 1997, Arnold et al., 
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2001). The EEC in complex organoid cultures secreted glycodelin when 
differentiated, further demonstrating their secretory potential. Taken together, these 
data indicate that the complex organoids morphologically and functionally recapitulate 
the in vivo human endometrium.  
 
Conclusion 
Overall, the aim of this study was to establish a complex organoid model by 
coculturing the endometrial gland organoids and EnSC. The purpose of this model is 
to be the first step in bringing about a step-change improvement in the in vitro 
modelling of the human peri-implantation endometrium.  In this study, I have 
established and optimised a protocol for complex organoid culture. The endometrial 
gland organoid protocol from Turco, et al. 2017, was modified by replacing Matrigel 
with a collagen hydrogel and by adding E2 to ExM (co-ExM) to best accommodate 
both EnSC and EEC proliferation. I have demonstrated complex organoids both 
morphologically and functionally recapitulate the stroma and glands of the human 
endometrium. The next step in the optimisation of this system was to determine to 
what extent the EnSC can replace the components of the co-ExM in supporting the 
differentiation of the EEC in order to produce a more physiological in vitro model of 
the endometrium.  
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Chapter 5:  
EnSC-EEC interactions 
in complex organoid 
culture 
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5.1 Introduction 
EnSC are pivotal to the development, growth and differentiation of the overlaying 
epithelium (Bigsby and Cunha, 1986, Cooke et al., 1986). In human endometrium, 
gland differentiation is regulated via paracrine signalling by EnSC in response to rising 
progesterone levels (Cooke et al., 1997, Kurita et al., 1998). Simple in vitro models of 
human EnSC and EEC have demonstrated the regulatory role of the stroma (Arnold 
et al., 2001). In this particular study, EnSC and monolayer EEC were grown either in 
mono- or a layered co-culture, cultured either in Matrigel or on plastic, and either in 
contact with the other cell type or separated by an insert. Co-cultures grown in contact 
and in Matrigel induced a multi-fold increase in differentiation response of the EEC 
when compared to other conditions, substantiating that EnSC paracrine regulation of 
EEC differentiation can be modelled in vitro (Arnold et al., 2001). Other studies have 
characterised further the impact of EnSC on the differentiation of EEC through the 
menstrual cycle in vitro (Evron et al., 2011, Cook et al., 2017).   
 
Unlike previous studies using EEC monolayers, which are grown from a mixture of 
luminal and glandular EEC, endometrial gland organoids specifically model 
endometrial glands (Turco et al., 2017, Boretto et al., 2017).  EnSC regulation of the 
differentiation endometrial glandular epithelium has yet to be described using human 
endometrial gland organoids. Following the establishment of the complex organoid 
system in the Chapter 4, the subsequent step was to assess the impact of EnSC on 
the glandular EEC of the gland organoids. However, unlike monolayer EEC, 
endometrial gland organoids are grown in a complex medium (ExM) (Turco et al., 
2017) with multiple growth factors and inhibitors that maintain an artificial environment 
for the organoids that permits glandular differentiation without EnSC regulation (Table 
5.1). Therefore, I hypothesised that a minimal differentiation medium (DMmin.), 
consisting of only essential factors, would be necessary to observe EnSC-EEC  
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Table 5.1: A List of components of Expansion Medium (ExM). For each medium 
component, the concentration and function are stated alongside relevant references. 
The recipe taken from Turco, et al., 2017.  
Component Concentration Function  References 
 
Advanced 
DMEM/F12 
1X 
 
Base medium suitable for 
reduced serum media 
formulations 
 
(Turco et al., 2017) 
A83-01 500 nM Potent inhibitor of TGF-β type I 
receptor superfamily activin-like 
kinase ALK5 and its relatives 
ALK4 and ALK7 
(Gurung et al., 
2015, Tojo et al., 
2005b, Sato et al., 
2011, Karthaus et 
al., 2014, Bartfeld 
et al., 2015) 
R-spondin1 500 ng/ml Promotes canonical WNT/β 
catenin signalling 
 
(Binnerts et al., 
2007) 
Nicotinamide 10 mM Incorporated into coenzymes 
NAD+ (nicotinamide adenine 
dinucleotide) and NADP+ 
(nicotinamide adenine 
dinucleotide phosphate) 
essential for metabolism  
 
(Inoue et al., 1989, 
Mitaka et al., 1991, 
Koo et al., 2012) 
N-acetyl-L-
cysteine 
(NAC) 
1.25 mM Antioxidant  (Zafarullah et al., 
2003, Circu and 
Aw, 2008) 
Noggin 
 
100 ng/ml BMP (Bone morphogenetic 
protein) inhibitor 
(Krause et al., 
2011, Au - Bartfeld 
and Au - Clevers, 
2015, Sato et al., 
2009) 
Fibroblast 
Growth Factor 
10 (FGF10) 
100 ng/ml Promotes cell growth and 
proliferation 
(Chen et al., 2000, 
Chung et al., 2015) 
Hepatocyte 
Growth Factor 
(HGF) 
50 ng/ml Promotes epithelial cell growth 
and proliferation  
 
(Sugawara et al., 
1997, Bartfeld et 
al., 2015) 
Epidermal 
Growth Factor 
(EGF) 
50 ng/ml Promotes cell growth, 
proliferation and differentiation. 
 
(Suzuki et al., 2010, 
Abud et al., 2005) 
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N2 1X Supplement for serum free 
medium 
(Bottenstein and 
Sato, 1979) 
B27 1X Supplement for serum free 
medium 
(Brewer et al., 
1993) 
 
Antibiotic-
Antimycotic 
1X Prevent Infection (Barros et al., 2016) 
L-glutamine 2 mM Essential amino acid (Eagle et al., 1956) 
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interactions. When differentiated in this defined DMmin, EnSC may replace the factors 
in the standard DM (DMstd.) and produce the necessary cues for gland organoid 
differentiation. 
 
In this study, scRNA-seq was performed after 2 and 4 days of decidualisation of 
complex and simple organoids to determine the impact of decidualising EnSC on EEC 
differentiation in DMmin. Standard RNA-seq was deemed inappropriate as it does not 
yield information on changes in gene expression in different cell types of the complex 
organoids. Therefore, scRNA-seq was chosen as the method of RNA sequencing 
(Macosko et al., 2015). In this protocol, samples are digested to single cells and 
flowed through a microfluidic device. Individual cells are encapsulated into single 
aqueous droplets containing a nanoparticle bead, each bound with unique PCR 
primers that ‘barcode’ each cell. Within the droplet, the cell is lysed, and the 
messenger RNA (mRNA) is released and binds to the barcoded PCR primer. Each 
primer contains a PCR handle, a cell barcode that is unique to the bead, and a unique 
molecular identifier (UMI), which is unique to each primer. In addition, a 30-base pair 
oligo-dT sequence allows for mature mRNA poly(A) tail to bind. The mRNA-bound 
beads are collected, and subjected to a series of processes: reverse transcription, 
amplification, libraries generation and sequencing (Macosko et al., 2015). The 
transcription profiles of individual cells can be identified by their unique barcodes from 
the scRNA-seq dataset (Macosko et al., 2015).  
 
The mRNA profiles are mapped graphically by t-distributed Stochastic Neighbour 
Embedding (t-SNE) or Uniform Manifold Approximation and Projection (UMAP) 
algorithms (van der Maaten and Hinton, 2008, Kobak and Berens, 2018, Becht et al., 
2018b, McInnes et al., 2018). These are examples of nonlinear dimensionality 
reduction techniques where high-dimensional data such as RNA sequencing data can 
be visualised graphically in a 2D space.  Each point on the graph represents a single 
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cell transcriptome, where nearby points are transcriptionally similar and distant points 
are transcriptionally different. In this present study, the UMAP algorithm was utilised 
due to its faster speed and more biologically meaningful aggregation of cell clusters 
with regard to cell type and subtypes (Becht et al., 2018a). The shared nearest 
neighbour (SNN) algorithm was performed also in parallel and groups the data into 
clusters of transcription profiles based on similarity.  The SNN algorithm assumes that 
if two points share several neighbours in common, they are more likely to be similar 
(Xu and Su, 2015). The SNN clusters are represented graphically by coloured 
groupings in t-SNE or UMAP plots. Points that share the same colour are defined as 
being transcriptionally similar (Xu and Su, 2015). 
 
The aim of this chapter was to model EnSC-EEC interactions in my established 
complex organoid co-culture, demonstrating it to be a working model of the 
endometrium. The objectives to achieve this aim were: 
1. To define the DMmin. that enables decidualisation of endometrial gland 
organoids in the complex gland organoid system. 
2. To determine the impact of EnSC on the transcriptional responses in 
endometrial gland organoids in decidualising complex organoids. 
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5.2 Results 
Defining the Minimal Differentiation Medium   
The first objective was to define the DMmin. required to model EnSC-induced EEC 
differentiation in the complex organoids. Three independent patient samples were 
used to grow gland (simple) organoids alone or complex organoids with patient 
matched EnSC, as described in Chapter 4.  These cultures were grown for 4 days in 
co-ExM (Growth Phase) (Fig 5.1A). On Day 4, cultures were subjected to 
differentiation medium in which a single growth factor or inhibitor was omitted one at 
a time (Differentiation Phase). The media formulations are listed in Figure 5.1B, where 
one growth factor or inhibitor was removed per medium, as well as complete DM. All 
cultures were harvested on day 8 for RNA extraction.  
 
RT-qPCR was used to measure the induction of EEC-specific differentiation markers 
(SPP1 and PAEP), the canonical EnSC decidual marker prolactin (PRL), as well as 
CXCL14, which is expressed in both decidualising EnSC and EEC. (Fig. 5.2).  
Relative expression of both SPP1 and PAEP was consistently higher in simple 
organoids (red bars) than in matched complex organoids (blue bars) for all DM 
formulations (Fig. 5.2A and 5.2B). There was large variation in relative expression of 
CXCL14 in the samples, but expression was similar in both simple and complex 
organoid cultures (Fig. 5.2C). There was a trend towards higher expression of PRL 
upon removal of A83-01 (-A83-01) (Fig. 5.2D); however, removal of all other 
components reduced expression of PRL in complex organoid cultures. Therefore, 
removing any single factor from the DM was not sufficient to inhibit differentiation in 
simple organoids while still being able to enable the EnSC to induce EEC 
differentiation in the complex organoids. Therefore, a different approach was required 
to achieve this aim. 
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Figure 5.1: Experimental plan for defining the minimal differentiation medium 
by the systematic removal of ExM components.  
A: A schematic timetable of simple and complex organoid differentiation. The growth 
phase (blue) lasts from day 0 to day 4 and ExM medium is used. Day 4 to day 8 is 
the differentiation phase (orange) and DM is used.  
B: A table of DM formulations. Blue represents growth medium co-ExM, orange 
represents DM formulations. Ticks in white boxes indicate the component is present. 
Grey boxes indicate the component is absent from the medium. 
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Figure 5.2: Expression of selected decidual marker genes upon removal of 
specific growth factors/ inhibitors in simple and complex organoids.  
SPP1, PAEP, CXCL14, PRL transcript levels were measured in simple and complex 
organoid cultures after 4 days of differentiation in the various DM formulations from 
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three independent cultures in duplicate. Red bars represent min-max values for 
simple organoid relative expression. Blue bars represent min-max values complex 
organoid relative expression. Gene expression was normalised to housekeeping 
gene L19 mRNA levels and relative to simple or complex organoid undifferentiated 
control (co-ExM), respectively P ˃ 0.05 for all comparisons respective to 
undifferentiated control (Group comparison by Friedman test and Dunn’s Multiple 
Comparison post hoc test). A: PAEP relative expression. B: SPP1 relative expression. 
C: CXCL14 relative expression. D: PRL relative expression. Data collected in 
collaboration with Komal Makwana. 
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The next strategy to define a DMmin. was to remove all growth factors and inhibitors 
from the DMstd. and then to add back systematically one factor at a time. Three 
independent patient biopsies were used to expand simple and complex organoids.  
Figure 5.3 lists the various DM formulations tested. All cultures were harvested on 
day 8 for RNA extraction.  
 
The addition of any single factor to the DM was not sufficient to induce significant 
PAEP expression in simple organoid cultures (red bars). However, for complex 
organoid cultures (blue bars), PAEP expression was significantly induced in the 
complete DM (DM) or the DM containing NAC (+NAC) when compared to the 
undifferentiated control (ExM + E2) (P < 0.05, Friedman test and Dunn’s Multiple 
Comparison post hoc test) (Fig. 5.4A). Furthermore, the addition of any single factor 
was not sufficient to induce significant SPP1 expression in simple organoid cultures 
(Fig. 5.4B). However, SPP1 expression was significantly induced for complex 
organoid cultures treated with DM containing NAC or nicotinamide (+Nicotinamide) 
when compared to undifferentiated control (P < 0.05, Friedman test and Dunn’s 
Multiple Comparison post hoc test). Overall, expression of SPP1 was higher in 
complex organoids for all DM treatments in comparison to matched simple organoid 
expression. Similarly, the addition of any single factor resulted in lower CXCL14 
expression for both simple and complex organoids (Fig 5.4C). However, relative 
expression of CXCL14 was consistently higher in complex organoids than in matched 
simple organoid cultures. There were no significant differences in relative expression 
of PRL when any of the factors were added back systematically to the DM (P ˃ 0.05, 
Friedman test and Dunn’s Multiple Comparison post hoc test) (Fig 5.4D).  
 
Taken together, these observations indicated that it may be beneficial to retain only 
NAC in the DMmin. All other growth factors and inhibitors appeared to be dispensable  
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Figure 5.3: Experimental plan for defining the minimal differentiation medium 
by the systematic addition of ExM components.  A table of various DM 
formulations with all growth factors/ inhibitors removed and replaced one at a time. 
Blue represents growth medium co-ExM, orange represents DM formulations. Ticks 
in white boxes indicate the component is present. Grey boxes indicate the component 
is absent from the medium. 
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Figure 5.4: Expression of selected decidual marker genes upon addition of 
specific growth factors/ inhibitors in simple and complex organoids.  
SPP1, PAEP, CXCL14, PRL transcript levels were measured in simple and complex 
organoid cultures after 4 days of differentiation in the various DM formulations from 
three independent cultures in duplicate. Red bars represent min-max values for 
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simple organoid relative expression. Blue bars represent min-max values for complex 
organoid relative expression. Gene expression was normalised to housekeeping 
gene L19 mRNA levels and relative to simple or complex organoid undifferentiated 
control (co-ExM), respectively. * indicate P < 0.05 when compared to its respective 
undifferentiated control (Group comparison by Friedman test and Dunn’s Multiple 
Comparison post hoc test). A: PAEP relative expression. B: SPP1 relative expression. 
C: CXCL14 relative expression. D: PRL relative expression. Data collected in 
collaboration with Komal Makwana. 
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for the decidualisation of complex organoids when NAC was present. Therefore, DM 
containing NAC was selected as the DMmin. for future work. 
 
scRNA-seq of decidualising simple and complex organoids in DMmin. 
In order to perform scRNA-seq on the complex organoid cultures, the protocol for 
digestion of samples to a single cell suspension required optimisation. Previously, I 
optimised recovering RNA from collagen hydrogel by collagenase I. However, I 
observed that collagenase I treatment and manual digestion were sufficient for 
passaging, but not to produce a single cell suspension (See Chapter 4). TrypLE 
reagent is a trypsin alternative that is less damaging to cell surface epitopes. It has 
been used in intestinal organoid digestion previously (Grün et al., 2015). Three 
independent biopsies were grown as complex organoids for 7 days and then 
subjected to various digestion protocols. I examined whether the addition of 1× and 
5× TrypLE reagent would produce a single cell suspension when used in addition to 
collagenase I and manual digestion (Fig. 5.5). The 1×TrypLE reagent produced a 
suboptimal single cell suspension (mean ± SD: 2.70 x104 ± 0.47 X104). However, 5× 
TrypLE reagent provided improved average single cell counts compared to control 
(mean ± SD: 9.93 x104 ± 0.63 X104 versus 1.60 x104 ± 0.23 x104, respectively, P < 
0.05, Friedman test and Dunn’s Multiple Comparison post hoc test). Hence, 5× 
TrypLE reagent was included into the protocol for single cell harvesting. The final 
protocol for single cell harvest including the 5× TrypLE reagent is illustrated in Figure 
5.5B. 
Next, simple and complex organoids expanded from a single biopsy were cultured for 
4 days in co-ExM and then treated with DMmin. for a further 4 days (Fig. 5.6). At D0, 
D2 and D4 of DMmin. treatment, respectively, cultures were recovered and subjected 
to high-throughput scRNA-seq (Macosko et al., 2015). Unfortunately, the number of 
cells captured and sequenced per time-point varied (Fig. 5.7A). There was also  
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Figure 5.5: Optimisation of complex organoid digestion to single cell 
suspension.  
A: Three independent patient biopsies were grown as complex organoid cultures for 
8 days and then digested by collagenase I (500 µg/ml, 10 min at 37oC) and then split 
into three fractions and further digested by either manual digestion alone (0×), or with 
an additional step before manual digestion of a 5 min incubation with either 1× or 5× 
TrypLE reagent at 37oC. Single cells from each fraction of each sample were counted 
by haemocytometer. The colours represent the three individual cultures. The line 
represents the mean. Different letters above the error bars represent statistical 
difference from other groups at P < 0.05. Group comparison by Friedman test and 
Dunn’s Multiple Comparison post hoc test. 
B: A schematic of the final protocol for digestion to single cell suspension. Droplets of 
complex organoids cultured in hydrogel are scraped off the plastic well plate and 
collected into an Eppendorf tube. Collagenase I (500 µg/ml) is added, and the sample 
is placed in a water bath for 10 min at 37oC. The samples are centrifuged and pelleted. 
Samples are resuspended in 5× TrypLE reagent for 5 min at 37oC. The samples are 
centrifuged and pelleted. Samples are manually dissociated by 300× pipetting. Single 
cells are then counted by haemocytometer and used for downstream scRNA-seq 
protocols.  
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Figure 5.6: Experimental plan for comparing simple and complex organoid 
differentiation in DMmin. by scRNA-seq.  
A: A table of media formulations used for growth and differentiation of simple and 
complex organoids. Blue represents growth phase medium ExM, orange represents 
differentiation phase medium DMmin.. Ticks in white boxes indicate the component is 
present. Grey boxes indicate the component is absent from the medium.  
B: A schematic timetable of experimental plan for scRNA-seq of differentiated simple 
and complex organoids. The growth phase (blue) lasts from day 0 to day 4 and ExM 
medium is used. Day 4 to day 8 is the differentiation phase (orange) and DM is used. 
D0, D2 and D4 represent 0, 2 and 4 days of DMmin. treatment, respectively. At these 
time points, samples were harvest for scRNA-seq. 
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Figure 5.7: Quality control of differentiated simple and complex organoid 
culture scRNA-seq data.  
A: The number of cells captured per sample from the scRNA-seq.  
B: Violin plots of the number of genes, number of transcripts and the percentage 
mitochondrial DNA per cell from a decidual time course of 4 days (D0-4) of patient 
matched simple (S) and complex (C) organoid culture.  
All data collected and analysed in collaboration with Dr Emma Lucas and Dr Pavle 
Vrljicak. Panel figure B produced by Dr Pavle Vrljicak. 
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variation in the average number of transcripts and genes per cell (Fig 5.7B), which 
decreased over the time course. Conversely, the percentage of mitochondrial genes 
increased over the time-course (Fig. 5.7B). Quality control (QC) was performed by 
only including genes that appear in ≥ 3 cells, and cells that express ≥ 200 genes. Only 
cells with ≤ 6000 genes and < 10% mitochondrial genes were included, to minimize 
inclusion of data from doublets and low-quality (broken or damaged) cells, 
respectively.  
 
After this quality control filtering, a total of 1518 cells were graphed computationally 
by the UMAP algorithm (Fig. 5.8A). Combined with the SNN method, the cells were 
computationally assigned to 7 transcriptionally discrete cell states (Fig. 5.8B). Using 
these clusters, a heatmap of the most differentially expressed genes of each cluster 
was generated (Fig. 5.8C). Three cell types were assigned to the clusters (EnSC, 
ECC1, and ECC2) (Fig. 5.8D). Clusters 0-4 represented transcription profiles of 
ECC1. Cluster 5 represented transcription profiles of EnSC and Cluster 6 represented 
transcription profiles of ECC2. EEC2 expressed genes such as CCDC19, SPAG17 
and MNS1 indicating that these were ciliated EEC (cEEC) (Zhou et al., 2012, Osinka 
et al., 2019, Teves et al., 2013, Lucas et al., 2018). Overall, following the QC, a total 
of 103 EnSC were captured, from complex organoid samples only. In addition, the 
EEC1 cluster contained the largest number of cells (n=1368). However, only 47 cEEC 
were captured, with the majority originating from simple organoids (Fig. 5.8E).   
 
To investigate the impact of the EnSC on EEC differentiation, I focused in on the 
EEC1, non-ciliated EEC (ncEEC) fraction of the scRNA-seq data. Classifying the 
initial clusters by cell type permitted the removal of EnSC and ciliated EEC 
transcription profiles from the dataset. This was essential as the purpose of this 
experiment was to compare the EEC transcription profiles from simple and complex 
organoids directly.  Figure 5.9A is a UMAP plot of the ncEEC transcription profiles  
 169 
 
 
Figure 5.8: scRNA-seq cell type analysis of simple and complex organoids. 
A: UMAP plot with cells colour-coded by sample, labelled by day and culture type 
after quality control analysis.  
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B: UMAP plot with cells colour-coded by transcriptional state.  
C: A corresponding heat map of upregulated differentially expressed marker genes 
from the transcriptional states produced in the UMAP plot in panel B. 
D: UMAP plot with cells colour-coded by cell type determined from heat map in panel 
C. Transcriptional states 0-4 represent EEC1 (non-ciliated EEC, ncEEC), 
transcriptional state 5 represents EnSC and transcriptional state 6 represents EEC2 
(ciliated EEC, cEEC). Two EEC subpopulations were found (ncEEC and cEEC), as 
well as EnSC from complex organoid cultures.  
E: The number of cells in each cell type state by sample sequenced. 
All data collected and analysed in collaboration with Dr Emma Lucas and Dr Pavle 
Vrljicak. Panel A-D figures produced by Dr Pavle Vrljicak. 
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Figure 5.9: scRNA-seq analysis of ncEEC only in simple and complex 
organoids 
 A: UMAP plot with ncEEC in both simple and complex organoids colour-coded by 
sample, labelled by day and culture type.  
B: UMAP plot with ncEEC in both simple and complex organoids colour-coded by 
transcriptional state. 
C: A heat map of marker genes of transcriptional states of ncEEC in both simple and 
complex organoids. 
 172 
 
All data collected and analysed in collaboration with Dr Emma Lucas and Dr Pavle 
Vrljicak. Panel figures produced by Dr Pavle Vrljicak. 
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from simple and complex organoids. Figure 5.9B is colour-coded by SNN cluster 
analysis labelling discrete transcriptional states. Both D0 samples of ncEEC from both 
simple and complex organoid clustered together in cluster 5, indicating their 
transcription profiles were not significantly different. However, the ncEEC D2 and D4 
samples were divergent in simple and complex organoids, with cluster 2 representing 
the D2 complex organoid ncEEC and cluster 0 representing the D2 simple organoid 
ncEEC. D4 simple organoid ncEEC were contained largely in cluster 4. Genes in 
cluster 4, such as LUC7L3, RBM25, ANKRD11 and PNISR do not change in 
expression over the menstrual cycle indicating these are not genes associated with 
differentiation (GEO Profiles, GDS2052). However, D4 complex organoid ncEEC 
were represented by two clusters: 3 and 1. Cluster 3 genes included classical 
endometrial gland differentiation genes SPP1, IGFBP3 and TIMP3 indicating this 
cluster represented differentiated EEC. However, cluster 1 also represented some of 
the D2 simple organoid ncEEC indicating there were some shared genes in between 
simple and complex organoid EEC such as RIMKLB and AHNAK, both induced in the 
secretory phase of the menstrual cycle (GEO Profiles, GDS2052). This suggested 
therefore there was some differentiation in the simple organoid cultures. 
 
Further analysis was performed by comparing the most highly expressed genes in 
the complex organoid ncEEC at each time-point. First, as simple and complex 
organoid D0 ncEEC clustered together, the most highly expressed genes at D0 
represented ncEEC in both simple and complex organoids (Fig. 5.10). Figure 5.10A 
is a heat map representing the most differentially expressed genes at D0 when 
compared to the other time points. These genes were compared to in vivo data from 
microarray data deposited in the Gene Expression Omnibus (GEO Profiles, 
GDS2052) to map the genes to the menstrual cycle (Fig. 5.10B). The genes at D0  
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Figure 5.10: Analysis of the most differentially expressed genes in D0 organoid 
ncEEC.  
A: A heat map of the most differentially expressed genes in D0 ncEEC compared to 
the other ncEEC samples in simple and complex organoids.  
B: Expression of three representative expressed genes in D0 ncEEC across the 
menstrual cycle, across the proliferative phase and early, mid and late secretory 
phase as seen in colour key. Each bar represents relative expression data from an 
individual biopsy. PGR1 encodes progesterone receptor 1, MCM3 encodes 
minichromosome maintenance complex component 3, and SOX17 encodes SRY-Box 
Transcription Factor 17.  The data were retrieved from microarray data deposited in 
the Gene Expression Omnibus (GEO Profiles, GDS2052). 
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Figure 5.11: Gene ontology analysis of differentially expressed genes in D0 
organoid ncEEC. 
A: Significant GO terms (P < 0.05) of differentially upregulated genes in D0 organoid 
ncEEC using the Gene Ontology Consortium database. 
B: REVIGO visualization of semantic clustering of significant GO terms (P < 0.05) of 
differentially upregulated genes in D0 organoid ncEEC. The colour of the circle 
indicates the log10 P value. Colour key is present on the right. Circle size is 
representative of the number of genes in each GO term. 
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were most highly expressed in proliferative phase transcription profiles. Gene 
ontology (GO) analysis using the Gene Ontology Consortium database (Ashburner et 
al., 2000, The Gene Ontology Consortium, 2018, Mi et al., 2013) was performed, 
where significantly differential genes (P < 0.05 with Bonferroni-correction) were 
clustered by annotated biological process categories (Fig 5.11A). The GO terms 
generated were further summarised using REVIGO, a web server that groups 
redundant GO terms by semantic similarity (Supek et al., 2011) (Figure 5.11B). Many 
of the statistically significant GO terms related to endometrial gland proliferation, such 
as ‘response to estradiol’, ‘regulation of epithelial cell proliferation’ and ‘cell cycle 
phase transition’. Other GO terms involved stem cell differentiation, indicating that 
genes at D0 related to glandular development as seen in the expansion of the 
organoids.  
 
The D2 ncEEC transcription profiles of simple and complex organoids diverged. 
Therefore, D2 complex organoid ncEEC were compared to D2 simple organoid 
ncEEC, and the most significantly expressed genes of the D2 complex organoid 
ncEEC compared to the other samples were plotted on a heat map (Fig. 5.12A). 
These genes mapped to the early secretory phase of the menstrual cycle when 
compared to in vivo data (GEO Profiles, GDS2052) (Fig 5.12B). GO analysis of these 
genes further demonstrated that the D2 co-culture organoid gland cells responded to 
the deciduogenic cues of the DMmin. (Fig. 5.13A and 5.13B).  
 
However, the differentiation gene signature was more pronounced at D4 in complex 
organoid ncEEC. D4 complex organoid ncEEC were compared to D4 simple organoid 
ncEEC and the most significantly expressed genes of the D4 complex organoid 
ncEEC are shown in a heatmap (Fig. 5.14A). These genes mapped to the mid- and 
late- secretory phase of the menstrual cycle when compared to in vivo data (GEO 
Profiles, GDS2052) (Fig 5.14B). For D4 complex organoid ncEEC, there was a clear 
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Figure 5.12: Analysis of the most differentially expressed genes in D2 complex 
organoid ncEEC when compared to simple organoids.  
A: A heat map of the most differentially up-regulated genes in D2 complex organoid 
ncEEC compared to the other ncEEC samples in simple and complex organoids.  
B: Expression of three representative up-regulated genes in D2 complex organoid 
ncEEC across the menstrual cycle, across the proliferative phase and early, mid and 
late secretory phase as seen in colour key. Each bar represents relative expression 
data from an individual biopsy. NR4A2 encodes nuclear receptor related 1, OFD1 
encodes oral-facial-digital syndrome 1, and GABRP encodes gamma-aminobutyric 
acid receptor subunit pi.  The data were retrieved from microarray data deposited in 
the Gene Expression Omnibus (GEO Profiles, GDS2052) 
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Figure 5.13: Gene ontology analysis of differentially expressed genes in D2 
complex organoid ncEEC when compared to ncEEC in simple organoids.  
A: Significant GO terms (P < 0.05) of differentially upregulated genes in D2 complex 
organoid ncEEC when compared to ncEEC in simple organoids using the Gene 
Ontology Consortium database. 
B: REVIGO visualization of semantic clustering of significant GO terms (P < 0.05) of 
differentially upregulated genes in D2 complex organoid ncEEC when compared to 
ncEEC in simple organoids. The colour of the circle indicates the log10 P value. 
Colour key is present on the right. Circle size is representative of the number of genes 
in each GO term. 
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Figure 5.14: Analysis of the most differentially expressed genes in D4 complex 
organoid ncEEC when compared to ncEEC in simple organoids.  
A: A heat map of the most differentially up-regulated genes in D4 complex organoid 
ncEEC compared to the other samples in simple and complex organoids.  
B: Expression of three representative up-regulated genes in D4 complex organoid 
ncEEC across the menstrual cycle, across the proliferative phase and early, mid. and 
late secretory phase as seen in colour key. Each bar represents relative expression 
data from an individual biopsy. SPP1 encodes osteopontin, IGFBP3 encodes insulin 
like growth factor binding protein 3, and TIMP3 encodes tissue inhibitor of 
metalloproteinase 3.   The data were retrieved from microarray data deposited in the 
Gene Expression Omnibus (GEO Profiles, GDS2052) 
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Figure 5.15: Gene ontology analysis of differentially expressed genes in D4 
complex organoid ncEEC when compared to ncEEC in simple organoids.  
A: Significant GO terms (P < 0.05) of differentially upregulated genes in D4 complex 
organoid ncEEC when compared to ncEEC in simple organoids using the Gene 
Ontology Consortium database. 
B: REVIGO visualization of semantic clustering of significant GO terms (P < 0.05) of 
differentially upregulated genes in D4 complex organoid ncEEC when compared to 
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ncEEC in simple organoids. The colour of the circle indicates the log10 P value. 
Colour key is present on the right. Circle size is representative of the number of genes 
in each GO term. 
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secretory gene signature present, with genes such as LIF, SPP1 and DPP4 indicating 
that only the complex organoid derived ncEEC attained a secretory phenotype at 4 
days of DMmin. treatment. This is further demonstrated by the GO analysis, with terms 
such as ‘embryo implantation’ and ‘decidualization’ (Fig. 5.15). Taken together, the 
data indicates that the ncEEC were able to differentiate only in the presence of EnSC 
demonstrating the direct impact of decidualising EnSC on gland differentiation.  
 
Finally, the EnSC were also analysed to confirm differentiation. Unfortunately, very 
few EnSC were sequenced from the complex organoid samples and therefore the 
UMAP and heatmap of marker genes for these cells were limited (Fig. 5.16). GO 
analysis was performed on the most significantly different, upregulated genes at each 
time point (Fig. 5.17). However, Bonferroni correction was not applied to the EnSC 
dataset for GO analysis as the correction was too stringent to produce any significant 
results, due to the low cell count. Hence, the data presented here can provide only a 
suggestion of the upregulated biological processes of each time point. The GO terms 
for D0 indicated the EnSC were proliferative (Fig. 5.17A). The GO terms for D2 
suggested the EnSC had begun to differentiate following cell cycle arrest (Fig 5.17B) 
and the GO terms for D4 involved ‘embryo implantation’, ‘secretion’ and 
‘angiogenesis’ regulation (Fig 5.17C). Therefore, this suggests that the EnSC 
differentiated over 4 days of DMmin. treatment.  
 
However, some highly expressed genes in EnSC at D4 (Fig 5.16B) such as IL8, 
INHBA, FTH1 and STC2, are up-regulated in acute senescent decidual cells (Lucas 
et al., 2019), suggesting EnSC in the complex organoid culture were stressed or had 
senesced at 4 days of DMmin. treatment. Overall, the data suggest the EnSC were 
responsive to DMmin. treatment. 
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Figure 5.16: scRNA-seq analysis of EnSC only in complex organoids. 
A: UMAP plot with EnSC colour-coded by complex organoid sample labelled by day.  
B A heat map of complex organoid EnSC marker genes per day of the decidual time 
course.  
All panels produced in collaboration with Dr Emma Lucas and Dr Pavle Vrljicak. Panel 
figures produced by Dr Pavle  Vrljicak. 
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Figure 5.17: Gene ontology analysis of differentially expressed genes in EnSC 
in complex organoids across the four-day decidual time course.  
A: Left: Significant GO terms (P < 0.05) of differentially expressed genes in D0 
complex organoid EnSC using the Gene Ontology Consortium database. Right: 
REVIGO visualization of semantic clustering of significant GO terms (P < 0.05) of 
differentially upregulated genes in D0 complex organoid EnSC. The colour of the 
circle indicates the log10 P value. Colour key is present on the right. Circle size is 
representative of the number of genes in each GO term. 
B: Left: Significant GO terms (P < 0.05) of differentially expressed genes in D2 
complex organoid EnSC using the Gene Ontology Consortium database. Right: 
REVIGO visualization of semantic clustering of significant GO terms (P < 0.05) of 
differentially upregulated genes in D2 complex organoid EnSC. The colour of the 
circle indicates the log10 P value. Colour key is present on the right. Circle size is 
representative of the number of genes in each GO term. 
C: Left: Significant GO terms (P < 0.05) of differentially expressed genes in D4 
complex organoid EnSC using the Gene Ontology Consortium database. Right: 
REVIGO visualization of semantic clustering of significant GO terms (P < 0.05) of 
differentially upregulated genes in D4 complex organoid EnSC. The colour of the 
circle indicates the log10 P value. Colour key is present on the right. Circle size is 
representative of the number of genes in each GO term. 
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5.3 Discussion 
Investigating the EnSC-EEC interactions in complex organoid culture. 
In this study, I investigated and optimised the culture conditions to enable EnSC-EEC 
interactions in complex organoids. First, each component of the medium was 
removed systematically to determine if any singular component had a major effect on 
organoid differentiation. RT-qPCR analysis demonstrated that the simple organoids 
expressed higher levels of differentiation genes PAEP and SPP1 than in complex 
organoids. However, this is possibly due to housekeeping gene used as an internal 
control to normalise the data. A housekeeping gene is a gene that should maintain 
constant expression in all cells and experimental conditions which allows direct 
comparison of genes of interest between different samples (Thellin et al., 1999, 
Robinson and Oshlack, 2010). In this study, all RT-qPCR data were normalised by 
L19, that encodes ribosomal protein 60S L19, which is ubiquitously expressed in all 
cell types of the endometrium (Ayakannu et al., 2015).  
 
This is problematic because in this present study I compared simple and complex 
organoids for expression of EEC-specific differentiation genes. In simple organoid 
cultures, the total RNA would originate from EEC only; however, in complex organoid 
cultures, the total RNA harvested would originate from both EEC and EnSC, diluting 
the number of EEC RNA molecules in the samples. This dilution would lead to lower 
amplification of EEC genes and a lower CT value. However, L19 would not be diluted 
as it is expressed in both cell types, and therefore when normalising the diluted EEC 
gene expression data to L19, the perceived relative expression would be lower than 
expected.  This dilution effect is less apparent in CXCL14 likely because it is also 
expressed in the EnSC (See Chapter 4). Moreover, as L19 encodes a ribosomal 
protein, and the relative level of expression may differ between cell types depending 
on their protein synthesis requirements. Overall, it is difficult to interpret the data from 
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this experiment as it is unclear if the normalisation process had a confounding effect 
on the data presented. Future work should be to develop cell type-specific 
housekeeping genes to circumnavigate the issue of comparing normalised RT-qPCR 
data from both simple and complex organoid cultures.  
 
In the opposite experiment, all ExM factors were removed and then added back 
systematically one factor at a time. The complex organoids attained higher expression 
of the differentiation genes than simple organoid cultures in some DM formulations, 
even after L19 normalisation. This indicates the inductions may well have been higher 
than reported in this study. The minimal differentiation medium chosen contained no 
growth factors or inhibitors other than NAC (N-acetyl-L-cysteine). The presence of 
NAC had the most significant induction of differentiation genes in complex organoids 
when compared to the matched simple organoid cultures. This indicated that DM with 
NAC and EnSC together were sufficient to induce organoid differentiation, but not in 
the absence of EnSC. Furthermore, the expression of PRL was highest from EnSC 
differentiated in this medium.  
 
NAC is a prodrug for L-cysteine, which can be metabolised into glutathione, an 
antioxidant that has thiol groups that bind free radicals (Terada, 2006, Zafarullah et 
al., 2003, Circu and Aw, 2008). Free radicals are reactive molecules possessing 
unpaired electrons, such as reactive oxygen species (ROS). An imbalance in ROS 
leads to oxidative stress in cells, which can lead to cellular damage, such as DNA 
strand breaks and mutations, leading to apoptosis (Ott et al., 2007, Ozben, 2007). 
However, in EnSC, it has been previously demonstrated that rising cellular cAMP 
levels induces a burst of endogenous ROS through NADPH oxidase (NOX)-4. This 
burst of endogenous NOX-4-dependent ROS products during the initial decidual 
phase has been shown to be essential for subsequent differentiation of EnSC into 
stress resistant decidual cells (Al-Sabbagh et al., 2011). Decidual cells also confer 
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resistance to oxidative cell death upon decidualisation (Kajihara et al., 2006). Hence, 
it is unclear why using an antioxidant would not only improve EEC differentiation in 
complex organoid culture but also not inhibit EnSC decidualisation. However, it could 
possibly be required to maintain homeostasis during this period of high oxidative 
stress, protecting both EEC and EnSC from damage.  In addition to NAC, the DM 
supplemented with HGF was also a valid potential candidate for the minimal 
differentiation medium. However it was less significant than the DM containing NAC, 
and EnSC produce HGF endogenously (Sugawara et al., 1997) and therefore HGF 
was discounted and DM supplemented with NAC was chosen for the DMmin.  
 
ScRNA-seq of decidualised simple and complex organoid cultures. 
Using the established DMmin., high-throughput scRNA-seq was performed on patient-
matched simple and complex organoid cultures in order to further characterise EnSC 
regulation of EEC differentiation observed in the preliminary RT-qPCR data. The 
scRNA-seq data demonstrated the divergent response in EEC from simple or 
complex organoid cultures to DMmin, as illustrated by the segregation in clustering in 
the UMAP single cell aggregation analysis. Divergence between simple and complex 
organoids was conspicuous on day 4. Several canonical differentiation genes, 
including PAEP, DPP4 and HSD17B2 were the most significantly different 
upregulated genes in EEC from complex organoids when compared to simple 
organoids. Furthermore, decidualising complex organoids expressed genes strongly 
implicated in embryo implantation, including LIF and SPP1 (Aghajanova, 2004, Salleh 
and Giribabu, 2014, von Wolff et al., 2001) suggesting that D4 complex organoids 
were in a secretory state. These findings hold promise of the complex organoid 
system becoming a novel patient specific in vitro model for human embryo 
implantation studies.  
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However, the scRNA-seq data also revealed that EEC of simple and complex 
organoid cultures at D0 are transcriptionally similar with a gene signature mapped to 
the proliferative phase in vivo. For example, PGR1, encoding the progesterone 
receptor, is known to be downregulated when exposed to progesterone, and is highly 
expressed in the proliferative phase (Mote et al., 1999, Mangal et al., 1997, Kaya et 
al., 2015). The similarity of gene expression indicates that EnSC do not have a 
significant effect on proliferating EEC, at least not in co-ExM. This is likely due to co-
ExM containing growth factors and inhibitors which promote organoid growth, 
regardless of EnSC intervention. Future work could investigate the EnSC regulation 
of gland organoid expansion as previous literature has shown that stromal induced 
gland development occurs in vivo (Cooke et al., 1986, Cunha et al., 1985).  
 
Recently, scRNA-seq performed on endometrial gland organoids has been published 
(Fitzgerald et al., 2019). In this study, the endometrial gland organoids were grown 
and differentiated in ‘organoid medium’, containing the same components as ExM 
(Turco et al., 2017). The organoids were expanded for 4 days without E2, then primed 
in E2 for 2 days prior to differentiation by E2 and MPA and cAMP for a further 6 days. 
Despite the differences in protocol, upon differentiation, this group yielded similar 
observations with the induction of gland differentiation genes HSD17B2, LIF, PAEP, 
and SPP1 (Fitzgerald et al., 2019). This substantiates that replacing ExM with EnSC 
induces a comparable differentiation response in endometrial gland organoids.  
 
However, Fitzgerald, et al., were able to identify 6 organoid cell types (ciliated, 
epithelial, secretory, proliferative, stem, and unciliated) in comparison to the 2 
presented in this study (ncEEC, cEEC) (Fitzgerald et al., 2019). In addition, the group 
performed ligand-receptor prediction and analysis on the scRNA-seq data, in which 
they predicted EnSC receptors, which could have been confirmed by the data 
presented in this study. Unfortunately, the number of cells sequenced in this study 
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were much lower than expected. This therefore reduced the information available in 
this data set. This was particularly impactful on the analysis of the EnSC and cEEC 
of the organoids. This was unexpected as the proportion of EnSC and EEC were 
equal at the time of plating. Despite the low numbers, some analysis was performed 
on the EnSC and the GO analysis suggested that the EnSC decidualised by D4. 
However, due to low cell numbers, GO terms were presented using unadjusted p-
values (without Bonferroni correction) to give only a preliminary indication of the 
biological processes occurring at each time point. Therefore, it is essential to repeat 
this experiment to ensure that more EnSC are sequenced.  
 
The reason for the low recovery of EnSC in the scRNA-seq analysis could have been 
due to several reasons. The first reason is that there was an issue in the protocol. For 
example, the single cell digestion protocol may have favoured the digestion of the 
EEC over the EnSC. At the point of harvest, both cell types were visibly abundant by 
microscopy.  The digestion protocol could be further optimised to ensure both cell 
types are harvested. For example, the proportion of EEC and EnSC in the single cell 
suspension could be determined by staining to ensure good recovery of both cell 
types.  
 
However, it has been recently reported that during decidualisation, EnSC diverge into 
two sub-populations: acutely senescent decidual cells and decidual cells. Senescent 
cells can induce neighbouring decidual cells to senesce in a phenomenon called 
bystander senescence (Brighton et al., 2017, Lucas et al., 2018, Tewary et al., 2019, 
Nelson et al., 2012), which increases the proportion of these cells through the 
secretory phase. However, an influx of uNK cells clears the acute senescent cells in 
vivo (Brighton et al., 2017). In this complex organoid system, there is currently no 
senescent cell clearance system in place and therefore this could also explain their 
accumulation. Future experiments should focus on reducing the senescent cell 
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population in the complex organoid co-culture to mimic the in vivo environment. This 
could be achieved by senolytic small molecules such as dasatinib (Brighton et al., 
2017, Childs et al., 2017, Zhu et al., 2015) or by introducing uNK cells into the complex 
organoid system.  
 
Conclusion 
In conclusion, in this study I have demonstrated that in a complex organoid system, 
decidualising EnSC can replace ExM in culture and induce EEC differentiation. The 
use of the DMmin. and EnSC instead of the artificial environment produced by DMstd. 
presents an improved, more physiological complex organoid system in which the two 
cell types are able to directly impact upon and influence each other, instead of being 
dependent on a complex medium. Therefore, in the future, this model could be used 
to functionally study EnSC-EEC interactions in endometrial physiology, human 
embryo implantation, and implantation pathologies. Complex organoids grown from 
biopsies of patients suffering from RPL could be compared to control patients to 
determine aberrations in endometrial stromal-gland interactions. Furthermore, the 
observations presented in this study provide evidence that cross-over experiments 
could bring useful insight into endometrial pathology. However. The data of the initial 
scRNA-seq analysis should be considered as preliminary and repeat experiments are 
warranted for the reasons discussed.  
 
 
 
 
 
 
 
 
 192 
 
 
 
 
 
 
 
 
 
 
Chapter 6:  
General Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 193 
 
6. General Discussion 
Introduction 
Human embryo implantation is the rate limiting step in ART with only 25% of embryo 
transfers implanting successfully (Boomsma et al., 2009, Edwards, 2006, Ferraretti 
et al., 2012). Lack of endometrial bio-sensing of pre-implantation embryos is thought 
to be a cause of RPL (Quenby et al., 2002, Teklenburg et al., 2010a, Lucas et al., 
2013, Lucas et al., 2016). Elucidating the mechanisms underpinning the peri-
implantation endometrium would engender the discovery of novel treatments to inhibit 
inappropriate endometrial responses. However, human embryo implantation is 
exceptionally difficult to study. Animal models have been utilised, but most readily 
accessible animal models do not fully recapitulate human implantation physiology 
(Lee and DeMayo, 2004).  
 
An alternative approach uses primary endometrial cells from biopsies, sidestepping 
the issue of inter-species variability.  In vitro models have vastly developed over the 
years from simple 2D monolayers through to 3D layered co-culture approaches, to 
most recently the endometrial gland organoids (Weimar et al., 2013, Deane et al., 
2017). The endometrium is a complex tissue made up of EnSC, epithelial glands, as 
well as a vasculature and a resident immune cell population including uNK cells. 
Hence, a complex co-culture system is required to closely recapitulate the in vivo 
human peri-implantation endometrium (Weimar et al., 2013). Furthermore, the 
endometrial gland organoids have enabled the modelling of endometrial glandular 
epithelium, an essential component of the peri-implantation endometrium and in 
embryo implantation (Turco et al., 2017, Boretto et al., 2017). Therefore, the next 
logical step is to develop a complex organoid-based co-culture system to improve 
upon previous in vitro models. 
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In this thesis, I aimed to develop a novel 3D in vitro model of the human endometrium 
to study the peri-implantation environment for embryo implantation by co-culturing 
EnSC and EEC. Here, two strategies were attempted: 
1. The first strategy was to use the tissue-like MSC-derived ERB model. The 
initial conclusions were found to be erroneous upon further investigation. 
However, the renamed EFAM did provide insight into EFA and the silencing 
of the ROCK pathway upon decidualisation. 
2. The second strategy was to establish a protocol for co-culturing endometrial 
gland organoids with EnSC.  This strategy was successful, and I established 
and optimised a working protocol for a complex organoid culture consisting 
of EnSC and EEC.  
3. Following this, the impact of the EnSC on the endometrial glands was 
investigated. I confirmed that the EnSC could replace DMstd. to induce EEC 
differentiation. This was achieved by optimising a DMmin.  and performing 
scRNA-seq on matched simple and complex organoid cultures. Thus, these 
experiments demonstrated that EnSC interact with the gland organoid EEC 
in complex organoid culture. 
 
The first strategy: ERB and EFAM 
MSC reside in the perivasculature of the endometrium (Gargett, 2006, Gargett et al., 
2015). In culture, PVC can be isolated from an endometrial biopsy by separation 
techniques such as MACS, followed by a CFU assay to enrich for the clonal MSC 
(Sivasubramaniyan et al., 2013, Masuda et al., 2012). MSC have been demonstrated 
to have high regenerative potential and are the drivers of endometrial regrowth 
following menses (Gargett, 2006, Gargett et al., 2015).  
 
When seeded on Matrigel and cultured overnight, MSC formed a tissue-like mass the 
next day. It was erroneously assumed that this was endometrial regeneration enacted 
 195 
 
by the MSC (Peter Durairaj, 2017).  However, when cultured for more than 24 hours, 
I observed further contraction of the ERB. Therefore, I performed further time-lapse 
microscopy studies and hypothesised that ERB were formed by cellular contraction 
through fibroblast activation, not by stem cell-related tissue regeneration. Further in 
silico analyses of in vivo scRNA-seq in parallel with in vitro experimentation confirmed 
that the ROCK pathway and cell-matrix adhesions are implicated in the observed 
contraction of the EnSC (Lucas et al., 2018). Therefore, the ERB was renamed to 
EFAM. However, pre-decidualising EnSC for 4 days prior to performing the EFAM 
protocol abrogated contraction. Data mining of the scRNA-seq dataset revealed that 
the ROCK pathway is silenced upon decidualisation, therefore explaining the 
incapacitated activation when challenged with Matrigel. Furthermore, the inhibition of 
FAK by Y15 inhibited contraction. Overall, in this study I have described multiple 
mechanisms that disable EFA upon decidualisation: upstream mechanosensing, 
ROCK signalling and downstream contractile machinery.  
 
Despite this model not working for the purpose intended, the implication of these 
observations was important for my in vitro model development. Studies have 
indicated that the contractile phenotype is due to the relative stiffness of Matrigel, 
which causes activation of fibroblastic cells (Balestrini et al., 2012, Heck et al., 2012, 
Lo et al., 2000). Matrigel is a BM-derived hydrogel and therefore is much denser than 
the physiological ECM (Kleinman and Martin, 2005, Iwahashi et al., 1997). Collagen 
hydrogels have been used previously in EnSC 3D culture (Bentin-Ley et al., 1994).  
Therefore, I hypothesised that other gels, such as collagen hydrogels, would be more 
compatible with the in vivo human stromal ECM and thus not induce EFA.  
 
However, the EFAM may be useful for modelling other aspects of endometrial biology. 
Endometriosis is a disorder characterised by the seeding of endometrial cells in the 
peritoneal cavity. These can develop into painful fibrotic lesions. Previous studies 
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have suggested that retrograde breakthrough bleeding before adolescence is a 
potential source of endometrial cell seeding in the peritoneum (Brosens et al., 2013b, 
Brosens et al., 2013a, Brosens and Benagiano, 2016, Brosens et al., 2016, Gargett 
et al., 2014). Therefore, as these cells are undecidualised, it could be speculated that 
these cells are more likely to form a lesion as they maintain their potential for EFA. 
EFA is characterised by a wound healing response of depositing ECM, which if left 
unresolved leads to fibrosis (Kalluri, 2016). Further studies using this model to 
elucidate the lesion formation in endometriosis could lead to better understanding the 
disease. 
 
The second strategy: co-culturing endometrial gland organoids with EnSC 
The failure of the ERB necessitated a different approach. Fortuitously, a protocol for 
endometrial gland organoids was published at this time and therefore I decided to 
explore this as a different avenue for 3D endometrial modelling (Boretto et al., 2017, 
Turco et al., 2017). However, co-culturing gland organoids with EnSC to form complex 
organoids required the system to be optimised to benefit both cell populations at the 
same time. This involved investigating the hydrogel and medium composition to 
support optimal growth of both cell types.  
 
The first issue was to optimise the hydrogel composition as the organoids had been 
established in Matrigel. Matrigel contains proteins such as laminins, entactin and 
collagen IV, all of which are major constituents of the BM (Aplin et al., 1988, Timpl, 
1996, Wewer et al., 1986, Yelian et al., 1993). Therefore, Matrigel was not a suitable 
ECM substitute for the in vivo endometrial stroma, as this instead largely consists of 
collagens type I, III and V (Aplin et al., 1988, Aplin and Jones, 1989, Iwahashi et al., 
1996). Therefore, a purified type I collagen hydrogel was considered as an alternative 
to Matrigel. This collagen hydrogel was chosen because collagen type I is the most 
abundant collagen in the endometrial stromal ECM (Iwahashi et al., 1996, Aplin et al., 
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1988, Aplin and Jones, 1989). Additionally, previous literature had indicated that a 
collagen type I hydrogel was suitable for 3D EnSC culture in vitro (Bentin-Ley et al., 
1994).  
 
In the present study, when grown in the collagen hydrogel, EFA was abolished, and 
the EnSC appeared to form a well distributed matrix. In addition, the epithelial gland 
organoids were able to form in collagen hydrogel in complex organoid culture, 
suggesting that the missing BM proteins in the purified collagen hydrogel were 
secreted by the cells in culture. This was evidenced by the IHC immunostaining 
produced demonstrating laminin localised basally to the organoid EEC in both 
undifferentiated and decidualising complex organoid cultures, and around 
decidualising EnSC following treatment with DM. These observations are 
representative of the in vivo laminin distribution through the menstrual cycle (Aplin et 
al., 1995, Church et al., 1996) indicating the complex organoids were able to 
recapitulate ECM remodelling in vitro. Overall, the improved EnSC morphology in 
collagen hydrogel is likely due to the hydrogel being a more physiological model of 
the stromal ECM, therefore providing it the appropriate matrix for growth and 
differentiation. 
 
However, the purified collagen hydrogel remains a basic approach to establishing 
complex endometrial organoids. Many studies have focused producing more complex 
ECM hydrogels by developing using tissue-specific ECM (Skardal et al., 2012, Bryant 
et al., 2005, Chan and Leong, 2008, Wolf et al., 2012).  Tissue specific gels are 
believed to recapitulate the extracellular environment better than standard hydrogels. 
The hydrogel used for complex organoid culture was made of purified collagen I, 
which although is a major constituent of the endometrial ECM, it is not the only 
component (Iwahashi et al., 1997, Aplin et al., 1988, Aplin and Jones, 1989). Other 
collagens such as collagen III and VI are present in the endometrium throughout the 
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menstrual cycle, as well as many other ECM proteins and constituents. Therefore, 
porcine-extracted tissue, such as endometrium, has been utilised to make novel 
hydrogels (unpublished work, Prof. Molly Stevens group, Imperial College London). 
In collaboration, simple endometrial gland organoid cultures have been successfully 
grown in porcine endometrial ECM hydrogels. To produce a porcine endometrial 
hydrogel, the tissue is extracted and decellularized, lyophilised, and then 
reconstituted as a gel for 3D culture. However, to develop a defined tissue specific 
hydrogel, the protein composition of these gels needs to be characterised and 
quantified by proteomic analysis.  
 
The second issue to be resolved was the medium. ExM is a highly complex medium 
established for endometrial gland organoid expansion (Turco et al., 2017). This 
medium does not contain E2 or serum, which are both routinely added to EnSC 
culture medium (Barros et al., 2016). Therefore, the discrepancy in media conditions 
needed to be ameliorated. Investigation of the medium concluded that E2 was 
essential for EnSC proliferation in complex organoids. The 1 nM concentration of E2 
was chosen as it is standard in many previous EnSC culture studies (Lucas et al., 
2016, Lucas et al., 2019, Murakami et al., 2013, Muter et al., 2015, Muter et al., 2016). 
However, proliferation may be improved by an increase in the E2 concentration to 10 
nM as used in other studies (Greaves et al., 2015). However, additional serum 
replacement supplements were unnecessary. ExM does contain some serum 
replacing components such as N2 and B27, possibly providing the growth support 
required for both organoids and EnSC (Brewer et al., 1993).  
 
In this study, I have resolved two key issues for optimising complex endometrial 
organoids. These complex organoids were then morphologically examined and 
functionally tested to determine if they can serve as a suitable model of the human 
peri-implantation endometrium. Morphologically, the complex organoids were similar 
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to the in vivo endometrium. The complex endometrial organoids present a step 
forward in modelling the peri-implantation human endometrium.  
 
Mapping stromal-gland interactions using the complex organoids 
As I had formed a functioning 3D model of the endometrium, the next step was to 
further develop it by investigating the interactions between the two cell types. 
However, to be able to unpick the impact of the EnSC on the EEC of the complex 
organoids from the medium was impossible. In ExM, the EEC of the gland organoids 
could differentiate regardless of co-culture with EnSC. Therefore, I proposed a 
minimal medium would be required in which only in the presence of EnSC would the 
EEC differentiate, therefore demonstrating the impact of the EnSC directly on the 
organoids without the confounding medium. This medium was produced by removing 
components of the ExM systematically. The final composition was the base medium 
with supplements plus NAC. All other inhibitors and growth factors were unnecessary 
when EnSC were present for EEC differentiation.  
 
ScRNA-seq was performed to fully characterise the interactions between the EnSC 
and EEC. Simple and complex organoids were differentiated in DMmin., dissociated 
and the single cell suspension was subjected to high-throughput scRNA-seq. The 
scRNA-seq allowed for the discrimination of cell types so that the organoid EEC 
mRNA profiles could be compared directly without EnSC contamination. The 
sequencing revealed that undifferentiated organoids were transcriptionally 
indistinguishable in both simple and complex organoid cultures. This observation was 
most likely due to the expansion of the gland organoids in ExM, masking putative 
EnSC signals. However, upon differentiation by DMmin., the EEC of the simple and 
complex organoids diverged transcriptionally. Analysis of the most highly differentially 
upregulated genes in the complex organoid EEC demonstrated that only complex 
organoid EEC attain a secretory gene signature after four days of differentiation. The 
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secretory phenotype of the complex organoids indicates that this 3D in vitro model of 
the endometrium was successful in the primary thesis aim of modelling the 
implantation window. This suggests that this model could be useful to model 
implantation of human embryos.  
 
Furthermore, the ability for the two cell types to cross talk opens the possibility of 
cross over experiments. For example, the EEC derived from a patient with 
implantation failure or RPL could be co-cultured with EnSC derived a control patient. 
This would further our understanding of how the two cell types interact in reproductive 
pathology and pinpoint if there is a cell type that drives a specific pathology. In 
addition, previously, EnSC and EEC have been manipulated by techniques such 
siRNA knockdowns in isolation. This complex organoid culture presents an 
opportunity to investigate the impact of gene knockdown in the presence of other cell 
types. In addition, as the endometrial glands are clonal and can be passaged, these 
provide the additional opportunity of producing CRISPR lines for different gene knock 
outs. In addition, CRISPR reporter lines could be developed to see in real time the 
effect of the EnSC in complex organoid culture.  
 
Acute senescence in decidualising EnSC in complex organoids 
Decidualising EnSC of the complex organoids gave an unexpected gene signature. 
By four days in DMmin., the most differentially expressed genes in the EnSC population 
were genes relating to acute senescence. Previous studies have demonstrated that 
during decidualisation there is a fate decision made in which EnSC either differentiate 
into mature decidual cells, or into acutely senescent cells. The acute senescent cells 
are P4 resistant and produce inflammatory mediators (Brighton et al., 2017, Lucas et 
al., 2018, Salker et al., 2012b). However, in the absence of cell clearance by immune 
cells, acute senescent cells can induce neighbouring cells undergo ‘bystander’ or 
secondary senescence (Nelson et al., 2012, Brighton et al., 2017). Successful 
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transition of the cycling endometrium into the decidua of pregnancy has been 
attributed to the timely clearance of acute senescent cells by uNK cells by perforin- 
and granzyme-containing granule exocytosis (Brighton et al., 2017). Further, 
perturbations in decidualisation have been associated with RPL. The decreased 
clearance possibly destabilises the endometrium matrix, increasing the risk of 
breakdown and, later, miscarriage (Brighton et al., 2017). 
 
Balancing the decidual and acute senescent cell populations will be essential for 
developing the embryo implantation model. Therefore, it is important to develop a 
method of controlling the acute senescence and inhibiting bystander senescence. 
One method is to use a senolytic drug such as dasatinib (Zhu et al., 2015, Brighton 
et al., 2017, Lucas et al., 2019). This could be titrated to determine the optimal 
concentration for controlled clearance of acute senescent cells. Dasatinib significantly 
switches the preponderance of senescent marker genes, such as DIO2, to the 
expression of decidual marker genes such as SCARA5 (Lucas et al., 2019).   
 
In a more physiological model, senolytics could be replaced by primary uNK cells. 
The uNK cells could be introduced to the complex organoids in a similar manner to 
established protocols with monolayer EnSC. In these assays, senescence-associated 
beta-galactosidase (SA-β-gal) is used as a proxy measure of acute senescence 
(Brighton et al., 2017). When uNK cells are co-cultured with decidualised EnSC, the 
SA-β-gal is reduced, indicating killing of acute senescent cells (Brighton et al., 2017). 
In a preliminary experiment, I showed that the uNK cell killing assay works in EnSC 
in collagen hydrogel, indicating that there is scope for introducing uNK cells into the 
co-culture to form a 3D in vitro human endometrial multi-culture system (unpublished 
work).  
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Further model development 
In addition to glandular EEC, EnSC and possibly uNK cells, luminal epithelium and 
endothelial cells could possibly be incorporated into the complex organoid culture. 
First, luminal epithelial cells could be cultured as a monolayer on top of the hydrogel 
droplet, as seen previously in layered co-culture systems (Bentin-Ley et al., 1994). 
Furthermore, the Brosens group have recently developed a protocol for isolating 
endothelial cells by MACS (unpublished work). The vasculature of the endometrium 
is of high importance for directing embryonic trophoblast invasion upon implantation 
for the beginning of placentation (Gellersen and Brosens, 2014, Meekins et al., 1994). 
Furthermore, in a 3D context, trophoblast invasion could be investigated in a way 
previously impossible. Upon differentiation the endometrial spiral arteries change 
morphology and begin to form the characteristic spirals they are named after (Farrer-
Brown et al., 1970).  
 
However, the endothelial cells require a specific endothelial medium in order to 
proliferate, and therefore medium optimisation would be required. In addition, 
functional differentiation of endothelial cells requires exposure to sheer stress as it is 
the case in the vasculature (Dewey et al., 1981, Yamamoto et al., 2005, Davies et al., 
1986). This therefore suggests a multi-channel microfluidic approach may be more 
suitable for a more complex set up. There are a number of ‘organoid on a chip’ models 
already published for other tissues (Park et al., 2019, Zhang et al., 2018). For 
instance, in order to co-culture the complex organoids with endothelial cells, a two 
channel microfluidic chip could be engineered. One channel could be coated with a 
monolayer of endothelial cells to model a vessel. This channel would have endothelial 
cell medium flowed through at a rate that would cause shear stress on the cells, 
inducing endothelial maturation. This channel could be connected to another channel 
or chamber containing the EnSC and EEC in hydrogel in slow flowing or stagnant co-
ExM. A fine grating between the chambers would allow for diffusion of cytokines and 
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chemokines without the invasion of cell types. This proposed model would 
recapitulate a vascularised endometrium. The embryo could be introduced to the 
complex organoid for implantation, and then it could be visualised by time lapse 
microscopy to determine whether the trophoblasts invade toward the underlying 
endothelial ‘vessel’. 
 
Conclusion 
In summary, this thesis presents the development of a novel in vitro 3D model of the 
human endometrium. The first attempt was a misstep in achieving this aim, but the 
underlying biology of the EFAM gave interesting insight into the fibroblast activation 
potential of EnSC, silencing of the ROCK pathway in decidualising EnSC, and the 
potential impact of this in the initial development of endometriotic lesions. However, 
by exploiting the gland organoids, I was able to establish a complex organoid model 
consisting of EEC and EnSC. I established the growth conditions by optimising the 
appropriate hydrogel and ExM composition. I then confirmed direct interaction 
between the EnSC and gland organoids through the establishment of a DMmin. 
followed by scRNA-seq of a decidual time course of simple and complex organoid 
cultures. In complex organoid culture, the EnSC were able to induce endometrial 
gland organoid differentiation and attain a secretory phenotype. 
 
The next stage for this work is to study embryo implantation. In this thesis, I have 
presented evidence when differentiated in DMmin. the complex organoids attain a 
secretory phenotype indicating that the embryos could be implanted. Overall, the 
development of complex organoid itself is a continued ongoing iterative process with 
each improvement requiring protocol optimisation before progression and study. The 
manipulation of the acute senescent cells of the decidualising culture by dasatinib will 
require optimisation. Moreover, the introduction of uNK or endothelial cells will be a 
great challenge to balance the needs of each cell type without the detriment of the 
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others, as seen with only the organoids and EnSC seen in this thesis. However, if 
proven successful, long-term this model will provide potentially the most faithful in 
vitro reconstruction of the endometrium to date and a useful tool for future study of 
human endometrial physiology and embryo implantation.  
 
Finally, currently, the complex organoids have not yet been published, highlighting 
the importance and timeliness of this research.  Globally, many groups are using the 
endometrial gland organoids for study and the complex organoid protocol will 
hopefully benefit the collective effort to produce the most faithful in vitro models of the 
human endometrium. This will in turn enable the community to study female 
reproductive physiology and its related pathologies in ways previously impossible. 
The long-term aim of this research is to develop a patient specific implantation model 
that could be used for drug screens for treatments for reproductive pathologies such 
as RPL and implantation failure.  
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SIMÓN, C., MERCADER, A., GARCIA-VELASCO, J., NIKAS, G., MORENO, C., REMOHÍ, J. & 
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